Subnetwork | Dataset | Score | p-value 1 | p-value 2 | p-value 3 | Size | Highlighted genes |
---|---|---|---|---|---|---|---|
int-snw-5702 | wolf-screen-ratio-mammosphere-adherent | 0.969 | 7.65e-17 | 1.16e-03 | 2.31e-02 | 17 | 16 |
reg-snw-55660 | wolf-screen-ratio-mammosphere-adherent | 0.830 | 8.54e-07 | 2.78e-03 | 5.31e-03 | 6 | 6 |
int-snw-6240 | wolf-screen-ratio-mammosphere-adherent | 0.989 | 1.11e-17 | 7.18e-04 | 1.60e-02 | 12 | 12 |
int-snw-2023 | wolf-screen-ratio-mammosphere-adherent | 0.930 | 2.50e-15 | 2.74e-03 | 4.31e-02 | 28 | 26 |
int-snw-5687 | wolf-screen-ratio-mammosphere-adherent | 0.956 | 2.41e-16 | 1.55e-03 | 2.85e-02 | 13 | 13 |
int-snw-5713 | wolf-screen-ratio-mammosphere-adherent | 0.933 | 1.88e-15 | 2.56e-03 | 4.11e-02 | 17 | 17 |
int-snw-1798 | wolf-screen-ratio-mammosphere-adherent | 0.931 | 2.28e-15 | 2.68e-03 | 4.25e-02 | 16 | 14 |
int-snw-2357 | wolf-screen-ratio-mammosphere-adherent | 0.979 | 2.87e-17 | 9.10e-04 | 1.92e-02 | 12 | 12 |
int-snw-7879 | wolf-screen-ratio-mammosphere-adherent | 0.947 | 5.37e-16 | 1.88e-03 | 3.29e-02 | 19 | 17 |
int-snw-5621 | wolf-screen-ratio-mammosphere-adherent | 0.958 | 2.11e-16 | 1.50e-03 | 2.78e-02 | 14 | 13 |
int-snw-8317 | wolf-screen-ratio-mammosphere-adherent | 0.925 | 3.70e-15 | 3.01e-03 | 4.62e-02 | 17 | 16 |
int-snw-5243 | wolf-screen-ratio-mammosphere-adherent | 0.924 | 4.18e-15 | 3.10e-03 | 4.71e-02 | 19 | 17 |
int-snw-445 | wolf-screen-ratio-mammosphere-adherent | 0.946 | 6.14e-16 | 1.95e-03 | 3.37e-02 | 16 | 15 |
int-snw-2957 | wolf-screen-ratio-mammosphere-adherent | 0.941 | 9.03e-16 | 2.14e-03 | 3.61e-02 | 25 | 21 |
int-snw-23203 | wolf-screen-ratio-mammosphere-adherent | 0.936 | 1.48e-15 | 2.41e-03 | 3.94e-02 | 13 | 13 |
int-snw-7124 | wolf-screen-ratio-mammosphere-adherent | 0.967 | 8.73e-17 | 1.20e-03 | 2.36e-02 | 18 | 16 |
int-snw-1073 | wolf-screen-ratio-mammosphere-adherent | 1.020 | 5.60e-19 | 3.35e-04 | 8.94e-03 | 15 | 15 |
int-snw-811 | wolf-screen-ratio-mammosphere-adherent | 0.932 | 2.10e-15 | 2.63e-03 | 4.19e-02 | 24 | 22 |
int-snw-5743 | wolf-screen-ratio-mammosphere-adherent | 0.944 | 7.33e-16 | 2.03e-03 | 3.48e-02 | 12 | 11 |
int-snw-3305 | wolf-screen-ratio-mammosphere-adherent | 0.942 | 8.57e-16 | 2.11e-03 | 3.57e-02 | 23 | 22 |
int-snw-8861 | wolf-screen-ratio-mammosphere-adherent | 0.937 | 1.33e-15 | 2.35e-03 | 3.86e-02 | 13 | 13 |
int-snw-1936 | wolf-screen-ratio-mammosphere-adherent | 0.924 | 4.26e-15 | 3.12e-03 | 4.73e-02 | 18 | 16 |
int-snw-57761 | wolf-screen-ratio-mammosphere-adherent | 0.969 | 7.13e-17 | 1.14e-03 | 2.28e-02 | 16 | 14 |
int-snw-5321 | wolf-screen-ratio-mammosphere-adherent | 0.949 | 4.70e-16 | 1.82e-03 | 3.21e-02 | 13 | 11 |
int-snw-10056 | wolf-screen-ratio-mammosphere-adherent | 0.958 | 2.11e-16 | 1.50e-03 | 2.78e-02 | 19 | 17 |
Gene Symbol | Entrez Gene ID | Frequency | wolf-screen-ratio-mammosphere-adherent gene score | Best subnetwork score | Degree | wolf adherent-list Hits GI | wolf mammosphere no adherent-list Hits GI |
---|---|---|---|---|---|---|---|
PLA2G4A | 5321 | 9 | -0.137 | 0.949 | 46 | - | Yes |
PSMA3 | 5684 | 90 | 0.533 | 0.815 | 238 | Yes | - |
PSMA2 | 5683 | 112 | 1.093 | 1.106 | 108 | Yes | - |
PAFAH1B1 | 5048 | 17 | 0.691 | 0.819 | 126 | Yes | - |
TP53 | 7157 | 23 | 0.432 | 0.833 | 665 | - | - |
SMARCA4 | 6597 | 26 | 0.416 | 0.941 | 253 | - | - |
ASS1 | 445 | 17 | -0.137 | 0.946 | 49 | - | - |
DPAGT1 | 1798 | 9 | 0.325 | 0.931 | 26 | - | - |
ATP6V1B2 | 526 | 53 | 0.881 | 1.076 | 278 | - | - |
RPL11 | 6135 | 21 | 0.718 | 1.017 | 200 | Yes | - |
PRNP | 5621 | 9 | -0.135 | 0.958 | 89 | - | - |
CAD | 790 | 91 | 0.807 | 0.973 | 400 | - | - |
PSMA6 | 5687 | 19 | 0.691 | 0.956 | 137 | Yes | - |
PCNA | 5111 | 33 | 0.553 | 0.974 | 294 | Yes | - |
PSMD1 | 5707 | 86 | 0.836 | 0.830 | 118 | Yes | - |
PPP2R1A | 5518 | 19 | 0.644 | 0.985 | 249 | Yes | - |
RNF2 | 6045 | 12 | 0.423 | 0.926 | 106 | - | - |
FARSB | 10056 | 10 | 0.099 | 0.958 | 31 | - | - |
RAN | 5901 | 89 | 0.632 | 0.899 | 258 | Yes | - |
CASP8 | 841 | 12 | 0.804 | 1.041 | 141 | - | - |
ENO1 | 2023 | 28 | -0.078 | 0.930 | 180 | - | - |
CFL1 | 1072 | 18 | 0.674 | 1.020 | 203 | Yes | - |
PPARG | 5468 | 9 | -0.535 | 0.958 | 131 | - | Yes |
RBX1 | 9978 | 115 | 1.185 | 0.934 | 148 | Yes | - |
RAB7A | 7879 | 12 | 0.002 | 0.947 | 99 | - | - |
FPR1 | 2357 | 9 | -0.332 | 0.979 | 7 | - | Yes |
PSMB7 | 5695 | 118 | 0.982 | 0.934 | 90 | Yes | - |
HNRNPC | 3183 | 108 | 1.812 | 0.973 | 181 | Yes | - |
OGDH | 4967 | 72 | 0.847 | 0.802 | 126 | Yes | - |
DLST | 1743 | 22 | 0.646 | 1.026 | 135 | Yes | - |
RPSA | 3921 | 120 | 1.327 | 1.151 | 152 | Yes | - |
HSPA1L | 3305 | 34 | -0.414 | 0.942 | 125 | - | Yes |
ACO2 | 50 | 65 | 1.000 | 1.076 | 191 | Yes | - |
PTGS2 | 5743 | 11 | -0.242 | 0.944 | 14 | - | Yes |
CDC16 | 8881 | 53 | 0.950 | 1.020 | 80 | Yes | - |
RUVBL1 | 8607 | 95 | 0.720 | 0.973 | 469 | Yes | - |
PSMD13 | 5719 | 56 | 0.848 | 0.801 | 114 | Yes | - |
PSMD3 | 5709 | 100 | 0.986 | 1.106 | 201 | Yes | - |
CLTC | 1213 | 56 | 0.884 | 1.138 | 247 | Yes | - |
DARS | 1615 | 14 | 0.617 | 1.000 | 110 | Yes | - |
RPL14 | 9045 | 49 | 1.250 | 1.113 | 166 | Yes | - |
PSMB2 | 5690 | 116 | 0.877 | 0.956 | 169 | Yes | - |
ACTB | 60 | 134 | 1.153 | 1.151 | 610 | Yes | - |
PSMD6 | 9861 | 79 | 0.848 | 0.878 | 143 | Yes | - |
PSMC1 | 5700 | 51 | 0.840 | 1.018 | 137 | Yes | - |
POLR2K | 5440 | 9 | 0.912 | 0.931 | 13 | Yes | - |
PHB2 | 11331 | 43 | 0.829 | 0.956 | 151 | Yes | - |
PSMD7 | 5713 | 15 | 0.640 | 0.958 | 133 | Yes | - |
RRM1 | 6240 | 15 | 0.587 | 0.872 | 117 | Yes | - |
VARS | 7407 | 86 | 0.549 | 1.002 | 204 | Yes | - |
RPA2 | 6118 | 96 | 1.250 | 1.151 | 76 | Yes | - |
CALR | 811 | 38 | -0.418 | 0.932 | 79 | - | Yes |
EIF6 | 3692 | 67 | 0.700 | 0.876 | 316 | Yes | - |
PSMD2 | 5708 | 17 | 0.463 | 0.961 | 386 | Yes | - |
RSL24D1 | 51187 | 38 | 1.300 | 1.020 | 59 | Yes | - |
EIF2S2 | 8894 | 39 | 1.075 | 0.940 | 103 | Yes | - |
EEF2 | 1938 | 64 | 0.890 | 1.043 | 301 | Yes | - |
CDC7 | 8317 | 7 | 0.042 | 0.925 | 93 | - | - |
MCM5 | 4174 | 23 | 0.578 | 0.830 | 273 | Yes | - |
RPS11 | 6205 | 62 | 0.993 | 1.113 | 175 | Yes | - |
EFTUD2 | 9343 | 93 | 0.883 | 0.956 | 108 | Yes | - |
PMPCA | 23203 | 2 | 0.078 | 0.936 | 35 | Yes | - |
PSMD11 | 5717 | 124 | 1.095 | 1.106 | 218 | Yes | - |
POLR1B | 84172 | 12 | 0.613 | 0.988 | 184 | Yes | - |
FBL | 2091 | 42 | 0.839 | 0.956 | 79 | Yes | - |
HSPD1 | 3329 | 70 | 0.913 | 1.035 | 325 | Yes | - |
GNAI2 | 2771 | 10 | -0.516 | 1.057 | 98 | - | Yes |
EEF1D | 1936 | 11 | -0.120 | 0.924 | 117 | - | - |
POLR2B | 5431 | 12 | 0.587 | 0.940 | 146 | Yes | - |
PRPF40A | 55660 | 25 | 0.423 | 0.830 | 106 | Yes | - |
TNF | 7124 | 11 | 0.021 | 0.967 | 98 | - | - |
PSMB4 | 5692 | 11 | 0.748 | 0.933 | 69 | Yes | - |
POLA1 | 5422 | 17 | 0.593 | 0.894 | 114 | Yes | - |
LDB1 | 8861 | 8 | 0.385 | 0.937 | 45 | Yes | - |
PSMC3 | 5702 | 51 | 0.719 | 1.002 | 276 | Yes | - |
RPL8 | 6132 | 24 | 0.778 | 0.874 | 234 | Yes | - |
RPL6 | 6128 | 37 | 0.844 | 1.113 | 164 | Yes | - |
PSMA1 | 5682 | 100 | 0.996 | 0.878 | 152 | Yes | - |
CFL2 | 1073 | 10 | 0.290 | 1.020 | 9 | Yes | - |
RPS3A | 6189 | 40 | 0.835 | 1.069 | 166 | Yes | - |
PGD | 5226 | 89 | 1.201 | 1.106 | 152 | Yes | - |
TRIB3 | 57761 | 26 | 0.097 | 0.969 | 31 | - | - |
GTF2A1 | 2957 | 26 | 0.251 | 0.941 | 52 | - | - |
ABCB1 | 5243 | 12 | 0.222 | 0.924 | 21 | Yes | - |
PPP3R1 | 5534 | 10 | -0.462 | 0.994 | 76 | - | - |
ITGAV | 3685 | 39 | 0.556 | 0.949 | 37 | - | - |
RUVBL2 | 10856 | 95 | 0.693 | 0.956 | 532 | Yes | - |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
DPAGT1 | 1798 | POLR2B | 5431 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, MINT_Yeast, Tarassov_PCA |
PSMA3 | 5684 | PSMB2 | 5690 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Mouse, IntAct_Yeast, INTEROLOG, MINT_Yeast, YeastHigh, Krogan_Core |
PSMD11 | 5717 | PSMD6 | 9861 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct, IntAct_Yeast, Krogan_Core, MINT_Yeast, YeastHigh, BioGrid, INTEROLOG |
RPS11 | 6205 | RUVBL2 | 10856 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: IntAct, BioGrid |
PSMD2 | 5708 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast, MINT_Yeast, IntAct_Yeast, Krogan_Core, YeastLow |
HNRNPC | 3183 | PSMA3 | 5684 | pp | -- | int.I2D: BioGrid |
CAD | 790 | MCM5 | 4174 | pd | < | reg.ITFP.txt: no annot |
CAD | 790 | MCM5 | 4174 | pp | -- | int.I2D: IntAct_Yeast |
EEF2 | 1938 | PGD | 5226 | pp | -- | int.I2D: BioGrid_Yeast |
EEF2 | 1938 | PSMC3 | 5702 | pp | -- | int.I2D: YeastLow, BioGrid_Yeast |
PSMA1 | 5682 | PSMD13 | 5719 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: IntAct, YeastMedium, BioGrid, BioGrid_Yeast, IntAct_Yeast |
PSMB2 | 5690 | PSMC3 | 5702 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
PSMD3 | 5709 | PSMD7 | 5713 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, Krogan_Core, MINT_Yeast, YeastHigh, BioGrid, IntAct |
ITGAV | 3685 | PLA2G4A | 5321 | pp | -- | int.I2D: INNATEDB |
PSMA1 | 5682 | PSMB2 | 5690 | pp | -- | int.Intact: MI:0915(physical association), MI:0914(association); int.I2D: HPRD, IntAct, IntAct_Mouse, IntAct_Yeast, INTEROLOG, BioGrid_Yeast, Krogan_Core, MINT_Yeast, YeastHigh; int.HPRD: yeast 2-hybrid |
HSPA1L | 3305 | TP53 | 7157 | pp | -- | int.I2D: MINT, MINT_Mouse; int.Mint: MI:0915(physical association) |
EEF2 | 1938 | HSPD1 | 3329 | pp | -- | int.I2D: YeastLow, YeastMedium |
PSMD11 | 5717 | RUVBL1 | 8607 | pp | -- | int.I2D: YeastLow |
ACO2 | 50 | CFL1 | 1072 | pp | -- | int.I2D: YeastLow |
EIF6 | 3692 | MCM5 | 4174 | pp | -- | int.I2D: YeastLow |
PSMA2 | 5683 | PSMD13 | 5719 | pp | -- | int.I2D: YeastLow |
RPL11 | 6135 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast |
ACO2 | 50 | OGDH | 4967 | pp | -- | int.I2D: YeastLow |
EEF2 | 1938 | PSMD7 | 5713 | pp | -- | int.I2D: YeastLow |
PSMD2 | 5708 | RPS3A | 6189 | pp | -- | int.I2D: BioGrid_Yeast |
PSMA2 | 5683 | PSMB4 | 5692 | pp | -- | int.Intact: MI:0914(association); int.I2D: BCI, BioGrid, BioGrid_Yeast, IntAct, IntAct_Fly, IntAct_Yeast, INTEROLOG, MINT_Yeast, YeastMedium, Krogan_Core |
PSMA6 | 5687 | RBX1 | 9978 | pp | -- | int.I2D: BioGrid |
PSMA6 | 5687 | PSMC3 | 5702 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
CAD | 790 | CDC16 | 8881 | pp | -- | int.I2D: IntAct_Yeast |
PSMD2 | 5708 | FARSB | 10056 | pp | -- | int.I2D: BioGrid_Yeast |
EFTUD2 | 9343 | RUVBL2 | 10856 | pd | < | reg.ITFP.txt: no annot |
EFTUD2 | 9343 | RUVBL2 | 10856 | pp | -- | int.I2D: BioGrid |
POLR2B | 5431 | PSMC3 | 5702 | pp | -- | int.I2D: YeastLow |
ACTB | 60 | RPL11 | 6135 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
ACTB | 60 | GTF2A1 | 2957 | pp | -- | int.I2D: BioGrid_Yeast |
EIF6 | 3692 | RPL8 | 6132 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
ACTB | 60 | TNF | 7124 | pp | -- | int.I2D: IntAct_Rat |
PSMC3 | 5702 | VARS | 7407 | pp | -- | int.I2D: BioGrid_Yeast |
PPP2R1A | 5518 | PSMA6 | 5687 | pp | -- | int.I2D: IntAct_Mouse |
ACO2 | 50 | POLR1B | 84172 | pp | -- | int.I2D: YeastLow |
PSMD1 | 5707 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast, MINT_Yeast, Krogan_Core |
PSMB7 | 5695 | PSMD7 | 5713 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | CLTC | 1213 | pp | -- | int.I2D: IntAct_Yeast |
ACTB | 60 | RUVBL1 | 8607 | pp | -- | int.I2D: IntAct_Yeast, BioGrid, BioGrid_Yeast |
ACTB | 60 | HSPD1 | 3329 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, YeastLow |
PSMB2 | 5690 | PSMB4 | 5692 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, MINT_Yeast, BIND_Yeast, Krogan_Core, YeastLow, Yu_GoldStd |
PSMD2 | 5708 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast, YeastLow |
PSMB7 | 5695 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | PSMD7 | 5713 | pp | -- | int.I2D: BioGrid_Yeast |
PSMA2 | 5683 | PSMB7 | 5695 | pp | -- | int.Intact: MI:0914(association); int.I2D: BCI, BioGrid, BioGrid_Yeast, BIND_Yeast, IntAct, Krogan_Core, MINT_Yeast, YeastLow, IntAct_Yeast |
PSMD1 | 5707 | PSMD13 | 5719 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: IntAct, MINT_Yeast, BioGrid, BioGrid_Yeast, IntAct_Yeast, Krogan_Core |
PSMD1 | 5707 | CDC7 | 8317 | pp | -- | int.I2D: IntAct_Yeast |
PSMC1 | 5700 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast, MINT_Yeast, YeastHigh, Krogan_Core |
PSMD7 | 5713 | PSMD13 | 5719 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid, BioGrid_Yeast, IntAct, IntAct_Yeast, MINT_Yeast, YeastHigh, IntAct_Fly, Krogan_Core, Tarassov_PCA |
PGD | 5226 | RAN | 5901 | pp | -- | int.I2D: YeastLow |
ATP6V1B2 | 526 | OGDH | 4967 | pp | -- | int.I2D: IntAct_Yeast |
RAN | 5901 | RUVBL1 | 8607 | pd | < | reg.ITFP.txt: no annot |
RPL6 | 6128 | RPS3A | 6189 | pp | -- | int.I2D: BioGrid_Yeast |
PSMC3 | 5702 | RPS3A | 6189 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | PSMD13 | 5719 | pp | -- | int.I2D: BioGrid_Yeast |
PSMC3 | 5702 | RUVBL2 | 10856 | pp | -- | int.I2D: YeastLow |
PSMB7 | 5695 | PSMC1 | 5700 | pp | -- | int.I2D: BioGrid_Yeast |
PSMA2 | 5683 | PSMD1 | 5707 | pp | -- | int.I2D: BioGrid_Yeast |
DARS | 1615 | RAN | 5901 | pp | -- | int.I2D: YeastHigh, YeastLow |
PPP2R1A | 5518 | PSMA1 | 5682 | pp | -- | int.I2D: IntAct_Mouse |
DLST | 1743 | OGDH | 4967 | pp | -- | int.I2D: BCI, BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast, BioGrid, HPRD, YeastHigh; int.HPRD: in vitro |
CAD | 790 | RUVBL1 | 8607 | pd | < | reg.ITFP.txt: no annot |
CAD | 790 | RUVBL1 | 8607 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
OGDH | 4967 | PSMD2 | 5708 | pp | -- | int.I2D: YeastLow |
PSMA3 | 5684 | PSMD13 | 5719 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: IntAct, BioGrid |
PTGS2 | 5743 | TP53 | 7157 | pp | -- | int.I2D: BioGrid, BIND, HPRD; int.HPRD: in vivo |
PSMC3 | 5702 | PSMD2 | 5708 | pp | -- | int.I2D: IntAct_Yeast, BioGrid_Yeast, Krogan_Core, MINT_Yeast, Tarassov_PCA, YeastLow |
PSMA2 | 5683 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
MCM5 | 4174 | EFTUD2 | 9343 | pd | > | reg.ITFP.txt: no annot |
PSMD1 | 5707 | PSMD2 | 5708 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast |
PPP2R1A | 5518 | RPL8 | 6132 | pp | -- | int.I2D: IntAct_Yeast |
ASS1 | 445 | PSMC3 | 5702 | pp | -- | int.I2D: BioGrid_Yeast |
RPSA | 3921 | PSMD11 | 5717 | pp | -- | int.I2D: IntAct_Yeast |
PPP2R1A | 5518 | RAB7A | 7879 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid, HPRD, IntAct; int.HPRD: in vivo |
PPP2R1A | 5518 | PHB2 | 11331 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: IntAct |
RPA2 | 6118 | TP53 | 7157 | pp | -- | int.Transfac: - |
TP53 | 7157 | EIF2S2 | 8894 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: HPRD, IntAct, BioGrid, MINT, StelzlHigh; int.Mint: MI:0915(physical association); int.HPRD: yeast 2-hybrid |
PSMD2 | 5708 | POLR1B | 84172 | pp | -- | int.I2D: BioGrid_Yeast |
PSMD2 | 5708 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast |
ACO2 | 50 | HSPD1 | 3329 | pp | -- | int.I2D: IntAct_Yeast |
OGDH | 4967 | RUVBL1 | 8607 | pp | -- | int.I2D: YeastLow |
RPL6 | 6128 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast |
RPS3A | 6189 | PSMD6 | 9861 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
RPL11 | 6135 | SMARCA4 | 6597 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
ACO2 | 50 | PSMD11 | 5717 | pp | -- | int.I2D: YeastLow |
PCNA | 5111 | CDC7 | 8317 | pp | -- | int.I2D: BioGrid_Yeast |
PSMB2 | 5690 | PSMD13 | 5719 | pp | -- | int.I2D: BioGrid_Yeast, YeastMedium |
CALR | 811 | PSMA3 | 5684 | pp | -- | int.I2D: BioGrid |
ACTB | 60 | PSMB2 | 5690 | pp | -- | int.I2D: BioGrid_Yeast |
GTF2A1 | 2957 | SMARCA4 | 6597 | pp | -- | int.I2D: BioGrid_Yeast |
HSPD1 | 3329 | PHB2 | 11331 | pp | -- | int.I2D: IntAct_Yeast |
EEF1D | 1936 | VARS | 7407 | pp | -- | int.I2D: BioGrid, BCI; int.HPRD: in vitro |
PSMD3 | 5709 | POLR1B | 84172 | pp | -- | int.I2D: IntAct_Yeast, YeastLow |
ACTB | 60 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast |
RRM1 | 6240 | TP53 | 7157 | pd | < | reg.pazar.txt: no annot; reg.oreganno.txt: no annot |
RRM1 | 6240 | PMPCA | 23203 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, MINT_Yeast |
EIF6 | 3692 | OGDH | 4967 | pp | -- | int.I2D: YeastLow |
PSMC1 | 5700 | PSMD13 | 5719 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct, MINT_Yeast, YeastHigh, BioGrid, IntAct_Yeast, Krogan_Core |
PSMA1 | 5682 | PSMD6 | 9861 | pd | < | reg.ITFP.txt: no annot |
PSMA1 | 5682 | PSMD6 | 9861 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct, YeastMedium |
PPP2R1A | 5518 | PSMA3 | 5684 | pp | -- | int.I2D: YeastLow, IntAct_Mouse |
CALR | 811 | RAN | 5901 | pp | -- | int.I2D: IntAct_Worm, BioGrid_Worm, BIND_Worm, CORE_2, MINT_Worm |
RPSA | 3921 | VARS | 7407 | pp | -- | int.I2D: IntAct_Yeast |
PSMC3 | 5702 | PSMD3 | 5709 | pd | < | reg.ITFP.txt: no annot |
PSMC3 | 5702 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast, Krogan_NonCore, YeastHigh |
EIF6 | 3692 | RRM1 | 6240 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
PSMD3 | 5709 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast, YeastHigh, INTEROLOG |
ASS1 | 445 | RUVBL2 | 10856 | pp | -- | int.I2D: YeastLow |
CLTC | 1213 | RUVBL1 | 8607 | pp | -- | int.I2D: MINT_Worm, IntAct_Worm |
EIF6 | 3692 | PGD | 5226 | pp | -- | int.I2D: YeastLow |
PSMC3 | 5702 | RPL14 | 9045 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | PSMC1 | 5700 | pp | -- | int.I2D: BioGrid_Yeast |
PSMD1 | 5707 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast |
ATP6V1B2 | 526 | CLTC | 1213 | pp | -- | int.I2D: IntAct_Yeast |
ACTB | 60 | EEF2 | 1938 | pp | -- | int.I2D: YeastLow, IntAct_Yeast |
PSMD2 | 5708 | PSMD6 | 9861 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct, IntAct_Yeast, Krogan_Core, MINT_Yeast, YeastLow, BioGrid |
PPP2R1A | 5518 | RUVBL1 | 8607 | pp | -- | int.I2D: YeastLow |
ACTB | 60 | RBX1 | 9978 | pp | -- | int.I2D: BioGrid_Yeast |
HSPA1L | 3305 | RUVBL1 | 8607 | pp | -- | int.I2D: BioGrid |
RPS3A | 6189 | PHB2 | 11331 | pp | -- | int.I2D: IntAct_Yeast |
PSMD11 | 5717 | TP53 | 7157 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid, MINT, StelzlHigh, HPRD, IntAct; int.Mint: MI:0915(physical association); int.HPRD: yeast 2-hybrid |
HSPD1 | 3329 | EIF6 | 3692 | pp | -- | int.I2D: BioGrid_Yeast |
PSMB2 | 5690 | PSMD7 | 5713 | pp | -- | int.I2D: BioGrid_Yeast, YeastMedium |
RAN | 5901 | RPS11 | 6205 | pp | -- | int.I2D: IntAct_Worm, BioGrid_Worm, BIND_Worm, MINT_Worm, NON_CORE |
PSMA1 | 5682 | PSMA2 | 5683 | pp | -- | int.Intact: MI:0915(physical association), MI:0914(association); int.I2D: BioGrid_Worm, BioGrid_Yeast, BIND_Worm, CE_DATA, HPRD, IntAct, IntAct_Mouse, IntAct_Yeast, INTEROLOG, MINT_Worm, BioGrid, IntAct_Fly, IntAct_Worm, Krogan_Core, MINT_Yeast, YeastHigh; int.HPRD: yeast 2-hybrid |
RPSA | 3921 | RAN | 5901 | pp | -- | int.I2D: IntAct_Worm, BioGrid_Worm, BIND_Worm, CORE_2, MINT_Worm |
CFL1 | 1072 | TP53 | 7157 | pd | < | reg.ITFP.txt: no annot |
ACTB | 60 | RPSA | 3921 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct_Yeast, IntAct |
CLTC | 1213 | EIF2S2 | 8894 | pp | -- | int.I2D: YeastLow |
EEF1D | 1936 | EIF6 | 3692 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
PSMA3 | 5684 | PSMD2 | 5708 | pp | -- | int.I2D: BioGrid_Yeast |
PSMD6 | 9861 | RUVBL2 | 10856 | pp | -- | int.I2D: YeastLow |
POLA1 | 5422 | CDC7 | 8317 | pp | -- | int.I2D: BioGrid_Yeast |
PSMA6 | 5687 | PSMB4 | 5692 | pp | -- | int.I2D: BioGrid_Yeast, BIND_Yeast, Krogan_Core, MINT_Yeast, YeastMedium, IntAct_Yeast, INTEROLOG |
ACTB | 60 | PSMA3 | 5684 | pp | -- | int.I2D: BioGrid, BioGrid_Yeast |
PAFAH1B1 | 5048 | RPL14 | 9045 | pd | > | reg.ITFP.txt: no annot |
CAD | 790 | DARS | 1615 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
PLA2G4A | 5321 | PTGS2 | 5743 | pp | -- | int.I2D: INNATEDB |
RPS3A | 6189 | RUVBL2 | 10856 | pp | -- | int.I2D: IntAct_Yeast |
HSPD1 | 3329 | POLR1B | 84172 | pp | -- | int.I2D: YeastLow |
PSMA2 | 5683 | PSMA6 | 5687 | pp | -- | int.Intact: MI:0914(association), MI:0915(physical association); int.I2D: BCI, BioGrid, BioGrid_Yeast, BIND_Yeast, IntAct, IntAct_Yeast, INTEROLOG, MINT_Yeast, YeastHigh, HPRD, Krogan_Core, Tarassov_PCA, Yu_GoldStd; int.HPRD: yeast 2-hybrid |
PSMC3 | 5702 | PSMD7 | 5713 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, YeastHigh, BioGrid, IntAct, Krogan_Core, MINT_Yeast |
EEF2 | 1938 | TP53 | 7157 | pp | -- | int.I2D: BioGrid, HPRD, BCI; int.HPRD: in vivo |
PSMB2 | 5690 | PSMD2 | 5708 | pp | -- | int.I2D: BioGrid_Yeast |
ABCB1 | 5243 | RNF2 | 6045 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BCI, IntAct, HPRD; int.HPRD: in vivo, yeast 2-hybrid |
OGDH | 4967 | PSMD13 | 5719 | pp | -- | int.I2D: YeastLow |
EEF2 | 1938 | PMPCA | 23203 | pp | -- | int.I2D: YeastLow |
PPP2R1A | 5518 | POLR1B | 84172 | pp | -- | int.I2D: YeastLow |
OGDH | 4967 | PSMD6 | 9861 | pp | -- | int.I2D: YeastLow |
RUVBL1 | 8607 | RUVBL2 | 10856 | pd | <> | reg.ITFP.txt: no annot |
RUVBL1 | 8607 | RUVBL2 | 10856 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association), MI:0914(association); int.I2D: BioGrid, BioGrid_Mouse, BioGrid_Yeast, BIND_Yeast, HPRD, IntAct, IntAct_Fly, IntAct_Worm, IntAct_Yeast, INTEROLOG, MINT_Worm, MINT_Yeast, BCI, BioGrid_Fly, BIND_Fly, BIND_Worm, FlyHigh, INNATEDB, Krogan_Core, MIPS, YeastHigh, Yu_GoldStd; int.Ravasi: -; int.HPRD: in vitro, in vivo, yeast 2-hybrid; int.DIP: MI:0915(physical association) |
RPSA | 3921 | PHB2 | 11331 | pp | -- | int.I2D: IntAct_Yeast |
RPSA | 3921 | PSMC3 | 5702 | pp | -- | int.I2D: BioGrid_Yeast |
HSPD1 | 3329 | PRPF40A | 55660 | pd | < | reg.ITFP.txt: no annot |
EEF2 | 1938 | PSMA3 | 5684 | pp | -- | int.I2D: BioGrid |
ACTB | 60 | CFL1 | 1072 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, MINT_Yeast, MIPS, BioGrid, BIND_Yeast, HPRD, IntAct, IntAct_Yeast, MINT, VidalHuman_core, YeastLow, Yu_GoldStd; int.Mint: MI:0915(physical association); int.HPRD: yeast 2-hybrid |
DLST | 1743 | RPSA | 3921 | pp | -- | int.I2D: IntAct_Yeast |
ACO2 | 50 | EIF6 | 3692 | pp | -- | int.I2D: YeastLow |
POLR2B | 5431 | PSMD7 | 5713 | pp | -- | int.I2D: YeastLow |
DLST | 1743 | RUVBL2 | 10856 | pp | -- | int.I2D: YeastLow |
PSMA1 | 5682 | PSMB7 | 5695 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid_Yeast, IntAct, IntAct_Mouse, IntAct_Yeast, YeastLow, Krogan_Core, MINT_Yeast |
PSMD2 | 5708 | CDC7 | 8317 | pp | -- | int.I2D: IntAct_Yeast |
PSMA6 | 5687 | PSMD2 | 5708 | pp | -- | int.I2D: BioGrid_Yeast |
PPP2R1A | 5518 | PSMB2 | 5690 | pp | -- | int.I2D: IntAct_Mouse |
EIF6 | 3692 | PSMD7 | 5713 | pp | -- | int.I2D: YeastLow |
RPS3A | 6189 | RPL14 | 9045 | pp | -- | int.I2D: BioGrid_Yeast |
ASS1 | 445 | RPL11 | 6135 | pp | -- | int.I2D: IntAct_Yeast |
ACTB | 60 | PPP2R1A | 5518 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | PSMA1 | 5682 | pp | -- | int.I2D: BioGrid_Yeast |
EEF2 | 1938 | PSMD3 | 5709 | pp | -- | int.I2D: Krogan_NonCore |
PSMA6 | 5687 | PSMD1 | 5707 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
ACTB | 60 | CAD | 790 | pp | -- | int.I2D: IntAct_Yeast |
OGDH | 4967 | PGD | 5226 | pp | -- | int.I2D: YeastLow |
OGDH | 4967 | RPL8 | 6132 | pp | -- | int.I2D: IntAct_Yeast |
LDB1 | 8861 | POLR1B | 84172 | pp | -- | int.Intact: MI:0915(physical association) |
PSMC3 | 5702 | CDC7 | 8317 | pp | -- | int.I2D: IntAct_Yeast |
PSMB7 | 5695 | RBX1 | 9978 | pd | < | reg.ITFP.txt: no annot |
PSMA3 | 5684 | RUVBL2 | 10856 | pp | -- | int.I2D: YeastLow |
CAD | 790 | RUVBL2 | 10856 | pd | < | reg.ITFP.txt: no annot |
CAD | 790 | RUVBL2 | 10856 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
RPL8 | 6132 | RPL14 | 9045 | pp | -- | int.I2D: BioGrid_Yeast |
PSMC3 | 5702 | TP53 | 7157 | pp | -- | int.I2D: BioGrid |
ACTB | 60 | PLA2G4A | 5321 | pp | -- | int.I2D: INNATEDB |
PGD | 5226 | PSMD11 | 5717 | pp | -- | int.I2D: YeastLow |
PSMA3 | 5684 | PSMB4 | 5692 | pp | -- | int.I2D: BioGrid_Yeast, BIND_Yeast, IntAct_Yeast, MINT_Yeast, YeastLow, Krogan_Core, Yu_GoldStd |
PSMA2 | 5683 | PSMC3 | 5702 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
HNRNPC | 3183 | RUVBL1 | 8607 | pd | < | reg.ITFP.txt: no annot |
PSMD3 | 5709 | RUVBL2 | 10856 | pp | -- | int.I2D: YeastLow |
EIF6 | 3692 | RPL6 | 6128 | pp | -- | int.I2D: BioGrid, HPRD, StelzlMedium; int.HPRD: yeast 2-hybrid |
PSMB4 | 5692 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
PPP2R1A | 5518 | PSMB7 | 5695 | pp | -- | int.I2D: IntAct_Mouse |
PSMA1 | 5682 | PSMD7 | 5713 | pp | -- | int.I2D: BioGrid_Yeast, YeastMedium, IntAct_Yeast, MINT_Yeast |
RPL8 | 6132 | RPL11 | 6135 | pp | -- | int.I2D: BioGrid_Yeast, INTEROLOG, YeastMedium, IntAct_Yeast |
MCM5 | 4174 | PCNA | 5111 | pd | > | reg.ITFP.txt: no annot |
FPR1 | 2357 | GNAI2 | 2771 | pp | -- | int.I2D: HPRD; int.HPRD: in vivo |
HSPD1 | 3329 | PMPCA | 23203 | pp | -- | int.I2D: IntAct_Yeast |
PSMB7 | 5695 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast |
CAD | 790 | DLST | 1743 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
RUVBL2 | 10856 | POLR1B | 84172 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
RPL8 | 6132 | RPS3A | 6189 | pp | -- | int.I2D: BioGrid_Yeast |
PSMD2 | 5708 | VARS | 7407 | pp | -- | int.I2D: BioGrid_Yeast |
DLST | 1743 | RUVBL1 | 8607 | pp | -- | int.I2D: YeastLow |
PSMC1 | 5700 | CDC7 | 8317 | pp | -- | int.I2D: IntAct_Yeast |
ENO1 | 2023 | PCNA | 5111 | pp | -- | int.I2D: MINT, BioGrid; int.Mint: MI:0407(direct interaction), MI:0915(physical association) |
CAD | 790 | PSMC3 | 5702 | pp | -- | int.I2D: BioGrid_Yeast |
PSMA3 | 5684 | PSMA6 | 5687 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BCI, BioGrid, BioGrid_Yeast, BIND_Yeast, CE_DATA, IntAct, IntAct_Worm, IntAct_Yeast, INTEROLOG, MINT_Worm, MINT_Yeast, YeastHigh, BioGrid_Worm, HPRD, Krogan_Core, MINT, StelzlHigh, Tarassov_PCA; int.Mint: MI:0915(physical association); int.HPRD: in vitro |
PSMC3 | 5702 | PSMD13 | 5719 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: IntAct, YeastHigh, BioGrid, BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast |
ACTB | 60 | CFL2 | 1073 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid, HPRD, IntAct, MINT, VidalHuman_core, INNATEDB; int.Mint: MI:0915(physical association); int.HPRD: yeast 2-hybrid |
ACTB | 60 | ENO1 | 2023 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
HNRNPC | 3183 | RUVBL2 | 10856 | pd | < | reg.ITFP.txt: no annot |
EEF2 | 1938 | POLR2B | 5431 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
ASS1 | 445 | DLST | 1743 | pp | -- | int.I2D: YeastLow |
ATP6V1B2 | 526 | CDC16 | 8881 | pp | -- | int.I2D: IntAct_Yeast |
HNRNPC | 3183 | TP53 | 7157 | pd | < | reg.ITFP.txt: no annot |
PSMD2 | 5708 | RPL14 | 9045 | pp | -- | int.I2D: BioGrid_Yeast |
DLST | 1743 | RPL11 | 6135 | pp | -- | int.I2D: BioGrid_Yeast |
EEF1D | 1936 | PSMC1 | 5700 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
PGD | 5226 | POLR1B | 84172 | pp | -- | int.I2D: YeastLow |
PAFAH1B1 | 5048 | RAB7A | 7879 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | FBL | 2091 | pp | -- | int.I2D: MINT |
MCM5 | 4174 | RPA2 | 6118 | pp | -- | int.I2D: BioGrid, HPRD; int.HPRD: yeast 2-hybrid |
PSMC3 | 5702 | PSMD6 | 9861 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct, YeastHigh, BioGrid, IntAct_Yeast, Krogan_Core, MINT_Yeast |
VARS | 7407 | RUVBL1 | 8607 | pd | <> | reg.ITFP.txt: no annot |
RPL8 | 6132 | TNF | 7124 | pp | -- | int.I2D: IntAct_Rat |
PSMA3 | 5684 | PSMD6 | 9861 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct, YeastLow |
RPL11 | 6135 | RPL14 | 9045 | pp | -- | int.I2D: BioGrid_Yeast |
PSMC1 | 5700 | PSMD1 | 5707 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct, Krogan_Core, MINT_Yeast |
PSMD1 | 5707 | PSMD6 | 9861 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid, BioGrid_Yeast, IntAct_Yeast, MINT_Yeast, IntAct, Krogan_Core |
DLST | 1743 | HSPD1 | 3329 | pp | -- | int.I2D: IntAct_Yeast, YeastLow |
EEF2 | 1938 | PPP2R1A | 5518 | pp | -- | int.Intact: MI:0914(association); int.I2D: YeastLow, BioGrid, HPRD, IntAct; int.HPRD: in vivo |
ACO2 | 50 | PSMD2 | 5708 | pp | -- | int.I2D: YeastLow |
HNRNPC | 3183 | SMARCA4 | 6597 | pp | -- | int.I2D: BioGrid |
PSMA3 | 5684 | PSMD1 | 5707 | pp | -- | int.I2D: BioGrid, BioGrid_Yeast |
PSMA6 | 5687 | PSMD7 | 5713 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow; int.DIP: MI:0915(physical association) |
EEF2 | 1938 | PHB2 | 11331 | pp | -- | int.I2D: IntAct_Yeast |
CALR | 811 | SMARCA4 | 6597 | pd | < | reg.ITFP.txt: no annot |
ACTB | 60 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast |
PSMA3 | 5684 | EFTUD2 | 9343 | pp | -- | int.I2D: BioGrid |
PSMB2 | 5690 | RUVBL2 | 10856 | pd | < | reg.ITFP.txt: no annot |
PPARG | 5468 | PSMD1 | 5707 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
HSPD1 | 3329 | PSMA3 | 5684 | pp | -- | int.I2D: BioGrid |
DLST | 1743 | PSMA3 | 5684 | pp | -- | int.I2D: YeastLow |
HSPD1 | 3329 | PRNP | 5621 | pp | -- | int.I2D: BIND, HPRD, BCI; int.HPRD: in vitro, in vivo |
CFL1 | 1072 | MCM5 | 4174 | pp | -- | int.I2D: YeastLow |
PGD | 5226 | PSMD3 | 5709 | pp | -- | int.I2D: YeastLow |
ACO2 | 50 | PSMC1 | 5700 | pp | -- | int.I2D: YeastLow |
PSMC1 | 5700 | RUVBL2 | 10856 | pp | -- | int.I2D: YeastLow |
PCNA | 5111 | TP53 | 7157 | pd | < | reg.TRANSFAC.txt: no annot |
PSMD13 | 5719 | RUVBL2 | 10856 | pp | -- | int.I2D: YeastHigh |
PPARG | 5468 | PRNP | 5621 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
PSMB4 | 5692 | PSMD6 | 9861 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
RUVBL1 | 8607 | POLR1B | 84172 | pp | -- | int.I2D: YeastLow |
PSMD2 | 5708 | RPL6 | 6128 | pp | -- | int.I2D: BioGrid_Yeast |
PSMD11 | 5717 | POLR1B | 84172 | pp | -- | int.I2D: YeastLow |
PPARG | 5468 | SMARCA4 | 6597 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct; int.Ravasi: - |
PSMA3 | 5684 | PSMB7 | 5695 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Mouse, MINT_Yeast, YeastLow, Krogan_Core |
DPAGT1 | 1798 | PPP3R1 | 5534 | pp | -- | int.I2D: IntAct_Yeast |
RPL8 | 6132 | POLR1B | 84172 | pp | -- | int.I2D: YeastMedium |
RPL8 | 6132 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast, YeastMedium |
PSMA6 | 5687 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
CFL1 | 1072 | PGD | 5226 | pp | -- | int.I2D: YeastLow |
PSMB2 | 5690 | PSMB7 | 5695 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid_Yeast, Krogan_Core, MINT_Yeast, YeastLow, IntAct |
MCM5 | 4174 | CDC7 | 8317 | pp | -- | int.I2D: BioGrid, BioGrid_Yeast, BIND_Mouse, HPRD; int.HPRD: yeast 2-hybrid |
PSMD3 | 5709 | PSMD6 | 9861 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid_Worm, BioGrid_Yeast, BIND_Worm, CE_DATA, IntAct, IntAct_Yeast, MINT_Worm, MINT_Yeast, YeastHigh, BioGrid, BIND_Yeast, IntAct_Worm, INTEROLOG, Krogan_Core, MIPS |
ACTB | 60 | GNAI2 | 2771 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
CFL1 | 1072 | PSMD2 | 5708 | pp | -- | int.I2D: BioGrid_Yeast |
RPSA | 3921 | TRIB3 | 57761 | pp | -- | int.I2D: BioGrid |
PSMA2 | 5683 | PSMD2 | 5708 | pp | -- | int.I2D: BioGrid_Yeast |
CAD | 790 | POLR1B | 84172 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
PSMB2 | 5690 | RPL8 | 6132 | pp | -- | int.I2D: BioGrid_Yeast |
ABCB1 | 5243 | PSMB2 | 5690 | pp | -- | int.I2D: BioGrid_Yeast |
PCNA | 5111 | SMARCA4 | 6597 | pp | -- | int.I2D: BioGrid |
FBL | 2091 | RUVBL1 | 8607 | pp | -- | int.I2D: BioGrid |
ACTB | 60 | PSMD2 | 5708 | pp | -- | int.I2D: BioGrid_Yeast |
ATP6V1B2 | 526 | POLR2B | 5431 | pp | -- | int.I2D: IntAct_Yeast |
POLR2B | 5431 | RUVBL2 | 10856 | pp | -- | int.I2D: BioGrid |
RPL6 | 6128 | RPL8 | 6132 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
POLR2B | 5431 | RPL8 | 6132 | pp | -- | int.I2D: YeastMedium |
PSMC1 | 5700 | PSMD2 | 5708 | pp | -- | int.Intact: MI:0915(physical association), MI:0407(direct interaction), MI:0914(association); int.I2D: BCI, BioGrid, BioGrid_Worm, BioGrid_Yeast, BIND_Worm, CE_DATA, IntAct, IntAct_Yeast, Krogan_Core, MINT_Worm, MINT_Yeast, Tarassov_PCA, VidalHuman_core, HPRD, IntAct_Worm, YeastLow; int.HPRD: in vitro |
RPS3A | 6189 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast |
PSMD2 | 5708 | RAN | 5901 | pp | -- | int.I2D: BioGrid_Yeast |
POLA1 | 5422 | TP53 | 7157 | pp | -- | int.I2D: BCI, BioGrid, HPRD; int.HPRD: in vivo |
PSMD7 | 5713 | RBX1 | 9978 | pp | -- | int.I2D: YeastLow, BioGrid_Yeast, IntAct_Yeast, MINT_Yeast |
PSMA3 | 5684 | RUVBL1 | 8607 | pp | -- | int.I2D: BioGrid |
PSMB4 | 5692 | PSMB7 | 5695 | pp | -- | int.I2D: BioGrid_Yeast, BIND_Yeast, Krogan_Core, MINT, MINT_Yeast, YeastLow, Yu_GoldStd; int.Mint: MI:0915(physical association) |
PSMB4 | 5692 | PSMD13 | 5719 | pp | -- | int.I2D: YeastLow |
PTGS2 | 5743 | RBX1 | 9978 | pp | -- | int.I2D: BioGrid |
PSMC3 | 5702 | RPL11 | 6135 | pp | -- | int.I2D: BioGrid_Yeast |
HSPD1 | 3329 | TP53 | 7157 | pp | -- | int.Intact: MI:0914(association) |
ACTB | 60 | RPL6 | 6128 | pp | -- | int.I2D: BioGrid_Yeast |
ASS1 | 445 | PSMD2 | 5708 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | RAN | 5901 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, NON_CORE |
RAN | 5901 | VARS | 7407 | pd | < | reg.ITFP.txt: no annot |
PPP2R1A | 5518 | TP53 | 7157 | pp | -- | int.I2D: MINT; int.Mint: MI:0915(physical association) |
ACTB | 60 | PAFAH1B1 | 5048 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | RAB7A | 7879 | pp | -- | int.I2D: BioGrid_Yeast |
CAD | 790 | RAN | 5901 | pp | -- | int.I2D: IntAct_Yeast |
ASS1 | 445 | PSMA3 | 5684 | pp | -- | int.I2D: YeastLow |
ACTB | 60 | PSMD6 | 9861 | pp | -- | int.I2D: BioGrid_Yeast |
ATP6V1B2 | 526 | PPP3R1 | 5534 | pp | -- | int.I2D: BioGrid_Yeast |
PSMC1 | 5700 | PSMD6 | 9861 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct, MINT_Yeast, BioGrid, IntAct_Yeast, Krogan_Core, YeastHigh |
PSMB2 | 5690 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast, YeastMedium |
RPS11 | 6205 | RPL14 | 9045 | pp | -- | int.I2D: BioGrid_Yeast |
HSPD1 | 3329 | POLR2B | 5431 | pp | -- | int.I2D: YeastLow |
PSMA1 | 5682 | PSMD2 | 5708 | pp | -- | int.I2D: BioGrid, BioGrid_Yeast |
ACTB | 60 | POLR1B | 84172 | pp | -- | int.I2D: BIND, BIND_Mouse |
PSMB4 | 5692 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
PSMC3 | 5702 | FARSB | 10056 | pp | -- | int.I2D: BioGrid_Yeast |
PSMD3 | 5709 | VARS | 7407 | pd | <> | reg.ITFP.txt: no annot |
ACTB | 60 | PSMA6 | 5687 | pp | -- | int.I2D: BioGrid_Yeast |
PGD | 5226 | PPP2R1A | 5518 | pp | -- | int.I2D: YeastLow |
PSMB4 | 5692 | PSMC1 | 5700 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
PSMB7 | 5695 | PSMD1 | 5707 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid_Yeast, IntAct |
PSMA1 | 5682 | PSMA3 | 5684 | pp | -- | int.Intact: MI:0914(association), MI:0915(physical association); int.I2D: BioGrid_Worm, BioGrid_Yeast, CE_DATA, HPRD, IntAct, IntAct_Fly, IntAct_Mouse, IntAct_Worm, IntAct_Yeast, MINT_Worm, BioGrid, BioGrid_Fly, BIND_Fly, BIND_Yeast, FlyHigh, Krogan_Core, MINT_Fly, MINT_Yeast, YeastHigh, Yu_GoldStd; int.HPRD: in vitro |
POLR2B | 5431 | PHB2 | 11331 | pp | -- | int.I2D: IntAct_Yeast |
ATP6V1B2 | 526 | RUVBL2 | 10856 | pp | -- | int.I2D: IntAct_Yeast |
PSMA2 | 5683 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
PSMC3 | 5702 | PSMD1 | 5707 | pp | -- | int.I2D: BioGrid_Yeast, Krogan_Core, MINT_Yeast |
PSMA1 | 5682 | PSMA6 | 5687 | pp | -- | int.Intact: MI:0914(association), MI:0915(physical association); int.I2D: BioGrid_Worm, BioGrid_Yeast, BIND_Worm, CE_DATA, IntAct, IntAct_Mouse, IntAct_Yeast, INTEROLOG, MINT_Worm, YeastHigh, IntAct_Worm, Krogan_Core, MINT_Yeast; int.Mint: MI:0914(association) |
PSMA1 | 5682 | PSMC3 | 5702 | pp | -- | int.I2D: BioGrid_Yeast, YeastMedium |
ACO2 | 50 | PSMD7 | 5713 | pp | -- | int.I2D: YeastLow |
DARS | 1615 | PRPF40A | 55660 | pp | -- | int.I2D: BioGrid_Yeast, MINT_Yeast, IntAct_Yeast |
PPP3R1 | 5534 | PSMD6 | 9861 | pp | -- | int.I2D: YeastLow |
ACTB | 60 | PSMC3 | 5702 | pp | -- | int.I2D: BioGrid_Yeast |
PSMD13 | 5719 | PMPCA | 23203 | pp | -- | int.I2D: YeastLow |
PSMC3 | 5702 | PSMD11 | 5717 | pd | < | reg.ITFP.txt: no annot |
PSMC3 | 5702 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast, YeastHigh |
PSMC1 | 5700 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast, YeastHigh, INTEROLOG |
RPSA | 3921 | RUVBL2 | 10856 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
PRNP | 5621 | PSMA3 | 5684 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: HPRD, MINT, IntAct; int.Mint: MI:0915(physical association); int.HPRD: yeast 2-hybrid |
PSMA1 | 5682 | PSMD1 | 5707 | pp | -- | int.I2D: BioGrid_Yeast |
PSMA3 | 5684 | PSMC1 | 5700 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | PSMB7 | 5695 | pp | -- | int.I2D: BioGrid_Yeast |
CASP8 | 841 | PLA2G4A | 5321 | pp | -- | int.I2D: INNATEDB |
MCM5 | 4174 | PSMD13 | 5719 | pp | -- | int.I2D: YeastLow |
DLST | 1743 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast |
EIF6 | 3692 | RSL24D1 | 51187 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
PSMA3 | 5684 | TRIB3 | 57761 | pp | -- | int.I2D: BioGrid |
ACTB | 60 | RPA2 | 6118 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
OGDH | 4967 | PSMD3 | 5709 | pp | -- | int.I2D: YeastLow |
ENO1 | 2023 | TP53 | 7157 | pd | < | reg.ITFP.txt: no annot |
PSMA1 | 5682 | LDB1 | 8861 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: VidalHuman_non_core |
PSMA2 | 5683 | PSMC1 | 5700 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Fly, YeastLow |
CAD | 790 | PSMB2 | 5690 | pp | -- | int.I2D: BioGrid_Yeast |
PSMB7 | 5695 | PSMD6 | 9861 | pd | < | reg.ITFP.txt: no annot |
PSMB7 | 5695 | PSMD6 | 9861 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct |
RPL6 | 6128 | RPL11 | 6135 | pp | -- | int.I2D: BioGrid_Yeast |
PPARG | 5468 | TP53 | 7157 | pp | -- | int.Transfac: - |
PSMA6 | 5687 | PSMB2 | 5690 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast, YeastHigh, INTEROLOG, Yu_GoldStd |
PSMD11 | 5717 | EFTUD2 | 9343 | pd | > | reg.ITFP.txt: no annot |
RUVBL1 | 8607 | PSMD6 | 9861 | pp | -- | int.I2D: YeastLow |
PSMA3 | 5684 | PSMC3 | 5702 | pp | -- | int.I2D: BioGrid_Yeast, BioGrid, YeastLow |
PSMA1 | 5682 | PRPF40A | 55660 | pd | < | reg.ITFP.txt: no annot |
DARS | 1615 | PSMC3 | 5702 | pp | -- | int.I2D: BioGrid_Yeast |
ACO2 | 50 | PGD | 5226 | pp | -- | int.I2D: YeastLow |
PAFAH1B1 | 5048 | PHB2 | 11331 | pp | -- | int.I2D: BioGrid_Yeast |
ATP6V1B2 | 526 | RPSA | 3921 | pp | -- | int.I2D: IntAct_Yeast |
POLR2B | 5431 | POLR2K | 5440 | pp | -- | int.I2D: BioGrid |
ACTB | 60 | DARS | 1615 | pp | -- | int.I2D: IntAct_Yeast |
ACTB | 60 | FARSB | 10056 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct |
ACTB | 60 | CDC16 | 8881 | pp | -- | int.I2D: YeastLow |
PSMD11 | 5717 | RUVBL2 | 10856 | pp | -- | int.I2D: YeastLow |
PSMD1 | 5707 | PTGS2 | 5743 | pp | -- | int.I2D: BioGrid, INNATEDB |
OGDH | 4967 | PSMD11 | 5717 | pp | -- | int.I2D: YeastLow |
CALR | 811 | ITGAV | 3685 | pp | -- | int.I2D: HPRD, BCI; int.HPRD: in vitro, in vivo |
FBL | 2091 | RUVBL2 | 10856 | pd | < | reg.ITFP.txt: no annot |
FBL | 2091 | RUVBL2 | 10856 | pp | -- | int.I2D: BioGrid |
PSMC1 | 5700 | PSMD7 | 5713 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid, IntAct, MINT_Yeast, YeastHigh, BCI, BioGrid_Yeast, HPRD, Krogan_Core; int.HPRD: in vitro |
RPL11 | 6135 | TP53 | 7157 | pp | -- | int.I2D: BioGrid |
RPSA | 3921 | PCNA | 5111 | pp | -- | int.I2D: MINT, BioGrid; int.Mint: MI:0915(physical association) |
ACTB | 60 | RPS3A | 6189 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
PSMB7 | 5695 | PSMD13 | 5719 | pd | < | reg.ITFP.txt: no annot |
ACO2 | 50 | DARS | 1615 | pp | -- | int.I2D: IntAct_Yeast |
EEF2 | 1938 | PSMD2 | 5708 | pp | -- | int.I2D: BioGrid_Yeast |
PSMD2 | 5708 | PSMD7 | 5713 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid, BioGrid_Yeast, IntAct, IntAct_Yeast, MINT_Yeast, Krogan_Core, YeastLow |
PSMB4 | 5692 | PSMD7 | 5713 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow, IntAct_Yeast, MINT_Yeast |
CAD | 790 | PHB2 | 11331 | pp | -- | int.I2D: IntAct_Yeast |
CFL1 | 1072 | OGDH | 4967 | pp | -- | int.I2D: YeastLow |
PSMD13 | 5719 | RRM1 | 6240 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
PCNA | 5111 | RUVBL2 | 10856 | pp | -- | int.I2D: BioGrid |
CFL1 | 1072 | PSMC3 | 5702 | pp | -- | int.I2D: BioGrid_Yeast |
VARS | 7407 | RUVBL2 | 10856 | pd | <> | reg.ITFP.txt: no annot |
EIF6 | 3692 | POLR1B | 84172 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, MINT_Yeast, YeastLow |
PPP2R1A | 5518 | PSMD2 | 5708 | pp | -- | int.I2D: BioGrid_Yeast |
HSPD1 | 3329 | PPP2R1A | 5518 | pp | -- | int.Intact: MI:0914(association); int.I2D: HPRD, IntAct; int.HPRD: in vivo |
ACTB | 60 | DPAGT1 | 1798 | pp | -- | int.I2D: BioGrid_Yeast |
GNAI2 | 2771 | PSMD1 | 5707 | pp | -- | int.I2D: BioGrid_Yeast |
PSMC3 | 5702 | POLR1B | 84172 | pp | -- | int.I2D: BioGrid_Yeast |
SMARCA4 | 6597 | TP53 | 7157 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid, IntAct, BCI, HPRD; int.Transfac: -; int.Ravasi: -; int.HPRD: in vitro, in vivo |
EEF2 | 1938 | RUVBL2 | 10856 | pp | -- | int.I2D: YeastLow, BioGrid_Yeast, IntAct_Yeast |
PSMD1 | 5707 | RUVBL2 | 10856 | pp | -- | int.I2D: IntAct_Yeast |
PSMC1 | 5700 | PSMC3 | 5702 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, MINT_Yeast, YeastHigh, Krogan_Core, Tarassov_PCA |
ACO2 | 50 | RUVBL1 | 8607 | pp | -- | int.I2D: YeastLow |
PPP2R1A | 5518 | PSMB4 | 5692 | pp | -- | int.I2D: IntAct_Mouse |
PSMA3 | 5684 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
HSPA1L | 3305 | PSMA3 | 5684 | pp | -- | int.I2D: BioGrid |
PSMB2 | 5690 | PSMD6 | 9861 | pp | -- | int.I2D: BioGrid_Yeast, YeastMedium |
PSMA2 | 5683 | PSMD7 | 5713 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
HSPD1 | 3329 | RPSA | 3921 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
FBL | 2091 | RPL8 | 6132 | pd | < | reg.ITFP.txt: no annot |
PSMA1 | 5682 | PSMB4 | 5692 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid_Yeast, BIND_Yeast, IntAct, IntAct_Mouse, IntAct_Yeast, YeastMedium, Krogan_Core, MINT_Yeast, Yu_GoldStd |
PSMA3 | 5684 | PSMD7 | 5713 | pp | -- | int.I2D: BioGrid_Yeast |
CFL1 | 1072 | EIF6 | 3692 | pp | -- | int.I2D: YeastLow |
PPP2R1A | 5518 | PSMA2 | 5683 | pp | -- | int.I2D: IntAct_Mouse |
PSMA1 | 5682 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
HSPA1L | 3305 | RUVBL2 | 10856 | pp | -- | int.I2D: BioGrid |
CFL1 | 1072 | RSL24D1 | 51187 | pp | -- | int.I2D: YeastLow |
RPL11 | 6135 | RPS3A | 6189 | pp | -- | int.I2D: BioGrid_Yeast |
OGDH | 4967 | RPL6 | 6128 | pp | -- | int.I2D: IntAct_Yeast |
PRNP | 5621 | PSMD6 | 9861 | pp | -- | int.I2D: MINT_Mouse |
PSMA6 | 5687 | PSMB7 | 5695 | pp | -- | int.I2D: BioGrid_Yeast, BIND_Yeast, Krogan_Core, MINT_Yeast, YeastLow |
PSMA3 | 5684 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast |
OGDH | 4967 | RAN | 5901 | pp | -- | int.I2D: YeastLow |
HSPD1 | 3329 | OGDH | 4967 | pp | -- | int.I2D: YeastLow |
EEF2 | 1938 | PSMD13 | 5719 | pp | -- | int.I2D: YeastLow |
PSMB2 | 5690 | PSMD11 | 5717 | pd | < | reg.ITFP.txt: no annot |
PSMB2 | 5690 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
OGDH | 4967 | PSMC1 | 5700 | pp | -- | int.I2D: YeastLow |
PSMD2 | 5708 | RBX1 | 9978 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, YeastLow |
PCNA | 5111 | PSMC3 | 5702 | pp | -- | int.I2D: BioGrid_Yeast |
FPR1 | 2357 | TP53 | 7157 | pd | < | reg.TRANSFAC.txt: no annot |
ATP6V1B2 | 526 | DLST | 1743 | pp | -- | int.I2D: IntAct_Yeast |
PSMB2 | 5690 | VARS | 7407 | pd | < | reg.ITFP.txt: no annot |
PSMA2 | 5683 | PSMD6 | 9861 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct, YeastLow, BioGrid |
PSMA6 | 5687 | PSMD6 | 9861 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct, YeastLow |
PSMA1 | 5682 | PSMC1 | 5700 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct_Fly, YeastMedium, IntAct |
PSMD7 | 5713 | RUVBL1 | 8607 | pp | -- | int.I2D: YeastLow |
PSMD1 | 5707 | PSMD7 | 5713 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid, BioGrid_Yeast, IntAct, IntAct_Yeast, MINT_Yeast, Krogan_Core |
PSMC3 | 5702 | PRPF40A | 55660 | pd | < | reg.ITFP.txt: no annot |
PSMD11 | 5717 | PSMD13 | 5719 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct, IntAct_Yeast, Krogan_Core, MINT_Yeast, Tarassov_PCA, YeastHigh, BioGrid, INTEROLOG |
CFL1 | 1072 | VARS | 7407 | pp | -- | int.I2D: YeastLow |
CAD | 790 | PSMD2 | 5708 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
PSMD7 | 5713 | PSMD11 | 5717 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast, Tarassov_PCA, YeastHigh, BioGrid, IntAct |
PSMA6 | 5687 | PSMC1 | 5700 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
PSMD2 | 5708 | PSMD13 | 5719 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct, IntAct_Yeast, MINT_Yeast, YeastLow, BioGrid, Krogan_Core |
VARS | 7407 | FARSB | 10056 | pp | -- | int.I2D: Krogan_NonCore |
CFL1 | 1072 | CFL2 | 1073 | pp | -- | int.I2D: MINT |
POLR2B | 5431 | POLR1B | 84172 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
PSMD3 | 5709 | PSMD13 | 5719 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, MINT_Yeast, YeastHigh, BioGrid, BioGrid_Yeast, IntAct_Yeast, Krogan_Core |
ABCB1 | 5243 | PSMD2 | 5708 | pp | -- | int.I2D: BioGrid_Yeast |
SMARCA4 | 6597 | RUVBL2 | 10856 | pp | -- | int.I2D: YeastLow |
ATP6V1B2 | 526 | DARS | 1615 | pp | -- | int.I2D: IntAct_Yeast |
HSPD1 | 3329 | POLA1 | 5422 | pp | -- | int.I2D: YeastLow |
ABCB1 | 5243 | PHB2 | 11331 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: IntAct |
ACTB | 60 | ATP6V1B2 | 526 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | SMARCA4 | 6597 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid, IntAct, BCI, HPRD; int.HPRD: in vitro, in vivo |
PSMA6 | 5687 | PSMD13 | 5719 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: IntAct, YeastLow, BioGrid |
PSMD13 | 5719 | PSMD6 | 9861 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid, BioGrid_Yeast, IntAct, IntAct_Yeast, MINT_Yeast, YeastHigh, Krogan_Core |
ATP6V1B2 | 526 | PSMC3 | 5702 | pp | -- | int.I2D: BioGrid_Yeast |
PSMC1 | 5700 | RUVBL1 | 8607 | pp | -- | int.I2D: YeastLow |
RPSA | 3921 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
PSMD1 | 5707 | PRPF40A | 55660 | pd | < | reg.ITFP.txt: no annot |
EIF6 | 3692 | PPP2R1A | 5518 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
PSMD11 | 5717 | RRM1 | 6240 | pd | > | reg.ITFP.txt: no annot |
ATP6V1B2 | 526 | PHB2 | 11331 | pp | -- | int.I2D: IntAct_Yeast |
DARS | 1615 | PSMD2 | 5708 | pp | -- | int.I2D: BioGrid_Yeast |
PSMD2 | 5708 | RUVBL2 | 10856 | pp | -- | int.I2D: YeastLow, IntAct_Yeast |
CFL1 | 1072 | RUVBL1 | 8607 | pp | -- | int.I2D: YeastLow |
ACTB | 60 | MCM5 | 4174 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
PSMD7 | 5713 | RUVBL2 | 10856 | pp | -- | int.I2D: YeastLow |
PSMD2 | 5708 | RUVBL1 | 8607 | pp | -- | int.I2D: YeastLow |
ATP6V1B2 | 526 | MCM5 | 4174 | pp | -- | int.I2D: IntAct_Yeast |
ACTB | 60 | RUVBL2 | 10856 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, YeastLow, BioGrid |
CAD | 790 | RPSA | 3921 | pp | -- | int.I2D: IntAct_Yeast |
PSMB2 | 5690 | PSMC1 | 5700 | pp | -- | int.I2D: BioGrid_Yeast, YeastMedium |
PSMA2 | 5683 | PSMA3 | 5684 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BCI, BioGrid, BioGrid_Yeast, IntAct, IntAct_Fly, IntAct_Yeast, Krogan_Core, MINT_Yeast, YeastHigh, BIND_Yeast, HPRD; int.HPRD: yeast 2-hybrid |
PSMA1 | 5682 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast, YeastMedium |
PSMD2 | 5708 | RPL11 | 6135 | pp | -- | int.I2D: BioGrid_Yeast |
OGDH | 4967 | PSMD7 | 5713 | pp | -- | int.I2D: YeastLow |
ACTB | 60 | PHB2 | 11331 | pp | -- | int.I2D: IntAct_Yeast |
EIF6 | 3692 | PSMD2 | 5708 | pp | -- | int.I2D: YeastLow |
PSMA6 | 5687 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
DARS | 1615 | EEF1D | 1936 | pp | -- | int.I2D: BCI |
RUVBL2 | 10856 | PHB2 | 11331 | pd | > | reg.ITFP.txt: no annot |
RUVBL2 | 10856 | PHB2 | 11331 | pp | -- | int.I2D: IntAct_Yeast |
PSMD11 | 5717 | EIF2S2 | 8894 | pd | > | reg.ITFP.txt: no annot |
CAD | 790 | SMARCA4 | 6597 | pd | < | reg.ITFP.txt: no annot |
PSMB2 | 5690 | PSMD1 | 5707 | pp | -- | int.I2D: BioGrid_Yeast |
RPL6 | 6128 | RPL14 | 9045 | pp | -- | int.I2D: BioGrid_Yeast |
EEF2 | 1938 | POLR1B | 84172 | pp | -- | int.I2D: YeastLow |
PSMA2 | 5683 | PSMB2 | 5690 | pp | -- | int.Intact: MI:0914(association); int.I2D: BCI, BioGrid, BioGrid_Yeast, IntAct, INTEROLOG, MINT_Yeast, YeastHigh, IntAct_Yeast, Krogan_Core |
PSMD7 | 5713 | PSMD6 | 9861 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid, BioGrid_Yeast, IntAct, MINT_Yeast, YeastHigh, IntAct_Yeast, Krogan_Core |
EIF6 | 3692 | RUVBL1 | 8607 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
PSMC1 | 5700 | PHB2 | 11331 | pp | -- | int.I2D: BioGrid_Yeast |
PSMC3 | 5702 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast |
ENO1 | 2023 | PSMA3 | 5684 | pp | -- | int.I2D: BioGrid |
PSMD2 | 5708 | PHB2 | 11331 | pp | -- | int.I2D: IntAct_Yeast |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0010467 | gene expression | 6.87e-30 | 1.12e-25 | 3.414 | 38 | 58 | 669 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 8.12e-26 | 1.32e-21 | 5.532 | 18 | 23 | 73 |
GO:0016032 | viral process | 2.00e-25 | 3.26e-21 | 3.475 | 32 | 55 | 540 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 2.37e-25 | 3.88e-21 | 5.455 | 18 | 23 | 77 |
GO:0016071 | mRNA metabolic process | 4.11e-25 | 6.71e-21 | 4.336 | 24 | 34 | 223 |
GO:0006521 | regulation of cellular amino acid metabolic process | 4.22e-25 | 6.88e-21 | 5.908 | 16 | 21 | 50 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 6.59e-25 | 1.08e-20 | 5.617 | 17 | 24 | 65 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 6.59e-25 | 1.08e-20 | 5.617 | 17 | 22 | 65 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.82e-24 | 2.97e-20 | 4.715 | 21 | 33 | 150 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.72e-24 | 4.44e-20 | 5.510 | 17 | 24 | 70 |
GO:0016070 | RNA metabolic process | 4.97e-24 | 8.11e-20 | 4.188 | 24 | 34 | 247 |
GO:0000502 | proteasome complex | 6.63e-24 | 1.08e-19 | 5.694 | 16 | 22 | 58 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 7.80e-24 | 1.27e-19 | 5.430 | 17 | 24 | 74 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 1.22e-23 | 1.99e-19 | 5.167 | 18 | 23 | 94 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 2.66e-23 | 4.35e-19 | 5.335 | 17 | 25 | 79 |
GO:0005829 | cytosol | 1.09e-22 | 1.78e-18 | 1.983 | 54 | 125 | 2562 |
GO:0005654 | nucleoplasm | 3.80e-22 | 6.21e-18 | 2.703 | 38 | 83 | 1095 |
GO:0000278 | mitotic cell cycle | 1.36e-21 | 2.23e-17 | 3.615 | 26 | 52 | 398 |
GO:0034641 | cellular nitrogen compound metabolic process | 6.45e-20 | 1.05e-15 | 4.332 | 19 | 25 | 177 |
GO:0042981 | regulation of apoptotic process | 9.76e-20 | 1.59e-15 | 4.483 | 18 | 26 | 151 |
GO:0000209 | protein polyubiquitination | 1.13e-18 | 1.85e-14 | 4.694 | 16 | 21 | 116 |
GO:0070062 | extracellular vesicular exosome | 1.60e-18 | 2.62e-14 | 1.869 | 49 | 98 | 2516 |
GO:0016020 | membrane | 8.36e-18 | 1.36e-13 | 2.139 | 41 | 80 | 1746 |
GO:0043066 | negative regulation of apoptotic process | 7.41e-15 | 1.21e-10 | 3.186 | 21 | 30 | 433 |
GO:0022624 | proteasome accessory complex | 1.10e-14 | 1.79e-10 | 6.464 | 8 | 9 | 17 |
GO:0005838 | proteasome regulatory particle | 7.41e-14 | 1.21e-09 | 6.774 | 7 | 7 | 12 |
GO:0006915 | apoptotic process | 1.61e-12 | 2.63e-08 | 2.786 | 21 | 34 | 571 |
GO:0005515 | protein binding | 1.73e-12 | 2.83e-08 | 0.993 | 65 | 172 | 6127 |
GO:0005839 | proteasome core complex | 2.90e-12 | 4.74e-08 | 6.189 | 7 | 11 | 18 |
GO:0004298 | threonine-type endopeptidase activity | 7.01e-12 | 1.14e-07 | 6.037 | 7 | 11 | 20 |
GO:0044281 | small molecule metabolic process | 1.00e-11 | 1.64e-07 | 2.071 | 29 | 57 | 1295 |
GO:0016363 | nuclear matrix | 5.50e-11 | 8.98e-07 | 4.350 | 10 | 11 | 92 |
GO:0005730 | nucleolus | 2.28e-10 | 3.72e-06 | 1.788 | 31 | 70 | 1684 |
GO:0005634 | nucleus | 3.19e-10 | 5.21e-06 | 1.069 | 54 | 131 | 4828 |
GO:0006414 | translational elongation | 1.52e-09 | 2.48e-05 | 4.182 | 9 | 11 | 93 |
GO:0006412 | translation | 4.10e-09 | 6.70e-05 | 3.260 | 12 | 15 | 235 |
GO:0006413 | translational initiation | 3.17e-08 | 5.17e-04 | 3.688 | 9 | 12 | 131 |
GO:0044822 | poly(A) RNA binding | 3.20e-08 | 5.22e-04 | 1.937 | 22 | 50 | 1078 |
GO:0019773 | proteasome core complex, alpha-subunit complex | 5.19e-08 | 8.47e-04 | 6.551 | 4 | 5 | 8 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.63e-07 | 2.67e-03 | 3.719 | 8 | 10 | 114 |
GO:0019058 | viral life cycle | 1.75e-07 | 2.85e-03 | 3.706 | 8 | 10 | 115 |
GO:0019083 | viral transcription | 2.42e-07 | 3.95e-03 | 4.019 | 7 | 8 | 81 |
GO:0044267 | cellular protein metabolic process | 3.30e-07 | 5.39e-03 | 2.408 | 14 | 24 | 495 |
GO:0006415 | translational termination | 3.96e-07 | 6.46e-03 | 3.916 | 7 | 8 | 87 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 1.34e-06 | 2.18e-02 | 3.658 | 7 | 8 | 104 |
GO:0003723 | RNA binding | 2.82e-06 | 4.61e-02 | 2.539 | 11 | 19 | 355 |
GO:0043234 | protein complex | 4.35e-06 | 7.09e-02 | 2.645 | 10 | 17 | 300 |
GO:0005844 | polysome | 8.75e-06 | 1.43e-01 | 4.908 | 4 | 4 | 25 |
GO:0003735 | structural constituent of ribosome | 1.02e-05 | 1.66e-01 | 3.219 | 7 | 8 | 141 |
GO:0051087 | chaperone binding | 1.53e-05 | 2.50e-01 | 3.991 | 5 | 6 | 59 |
GO:0006271 | DNA strand elongation involved in DNA replication | 2.12e-05 | 3.47e-01 | 4.597 | 4 | 9 | 31 |
GO:0005524 | ATP binding | 2.24e-05 | 3.65e-01 | 1.470 | 20 | 46 | 1354 |
GO:0006272 | leading strand elongation | 2.81e-05 | 4.58e-01 | 7.551 | 2 | 2 | 2 |
GO:0045252 | oxoglutarate dehydrogenase complex | 2.81e-05 | 4.58e-01 | 7.551 | 2 | 2 | 2 |
GO:0006289 | nucleotide-excision repair | 3.29e-05 | 5.38e-01 | 3.765 | 5 | 12 | 69 |
GO:0030234 | enzyme regulator activity | 4.03e-05 | 6.57e-01 | 5.436 | 3 | 3 | 13 |
GO:0042273 | ribosomal large subunit biogenesis | 4.03e-05 | 6.57e-01 | 5.436 | 3 | 4 | 13 |
GO:0035267 | NuA4 histone acetyltransferase complex | 5.10e-05 | 8.33e-01 | 5.329 | 3 | 4 | 14 |
GO:0042176 | regulation of protein catabolic process | 7.79e-05 | 1.00e+00 | 5.136 | 3 | 3 | 16 |
GO:0006281 | DNA repair | 8.17e-05 | 1.00e+00 | 2.507 | 8 | 22 | 264 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 1.04e-04 | 1.00e+00 | 4.028 | 4 | 8 | 46 |
GO:0016887 | ATPase activity | 1.19e-04 | 1.00e+00 | 2.967 | 6 | 7 | 144 |
GO:0022625 | cytosolic large ribosomal subunit | 1.33e-04 | 1.00e+00 | 3.937 | 4 | 5 | 49 |
GO:0003678 | DNA helicase activity | 1.33e-04 | 1.00e+00 | 4.889 | 3 | 3 | 19 |
GO:0005925 | focal adhesion | 1.55e-04 | 1.00e+00 | 2.190 | 9 | 18 | 370 |
GO:0032549 | ribonucleoside binding | 1.67e-04 | 1.00e+00 | 6.551 | 2 | 2 | 4 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 1.94e-04 | 1.00e+00 | 3.797 | 4 | 5 | 54 |
GO:0032201 | telomere maintenance via semi-conservative replication | 2.09e-04 | 1.00e+00 | 4.677 | 3 | 7 | 22 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 2.09e-04 | 1.00e+00 | 4.677 | 3 | 5 | 22 |
GO:0043044 | ATP-dependent chromatin remodeling | 2.40e-04 | 1.00e+00 | 4.613 | 3 | 4 | 23 |
GO:0005759 | mitochondrial matrix | 2.45e-04 | 1.00e+00 | 2.495 | 7 | 12 | 233 |
GO:0031622 | positive regulation of fever generation | 2.78e-04 | 1.00e+00 | 6.230 | 2 | 2 | 5 |
GO:0030308 | negative regulation of cell growth | 3.42e-04 | 1.00e+00 | 3.053 | 5 | 6 | 113 |
GO:0000722 | telomere maintenance via recombination | 3.48e-04 | 1.00e+00 | 4.436 | 3 | 7 | 26 |
GO:1900740 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 3.48e-04 | 1.00e+00 | 4.436 | 3 | 3 | 26 |
GO:0030529 | ribonucleoprotein complex | 3.57e-04 | 1.00e+00 | 3.041 | 5 | 8 | 114 |
GO:0019843 | rRNA binding | 3.90e-04 | 1.00e+00 | 4.382 | 3 | 3 | 27 |
GO:0071339 | MLL1 complex | 3.90e-04 | 1.00e+00 | 4.382 | 3 | 3 | 27 |
GO:0031625 | ubiquitin protein ligase binding | 3.99e-04 | 1.00e+00 | 2.645 | 6 | 13 | 180 |
GO:0033993 | response to lipid | 4.16e-04 | 1.00e+00 | 5.967 | 2 | 2 | 6 |
GO:0030957 | Tat protein binding | 4.16e-04 | 1.00e+00 | 5.967 | 2 | 4 | 6 |
GO:0045892 | negative regulation of transcription, DNA-templated | 4.24e-04 | 1.00e+00 | 1.994 | 9 | 14 | 424 |
GO:0031492 | nucleosomal DNA binding | 4.35e-04 | 1.00e+00 | 4.329 | 3 | 4 | 28 |
GO:0006099 | tricarboxylic acid cycle | 4.84e-04 | 1.00e+00 | 4.278 | 3 | 3 | 29 |
GO:0006260 | DNA replication | 5.44e-04 | 1.00e+00 | 2.908 | 5 | 12 | 125 |
GO:0010888 | negative regulation of lipid storage | 5.80e-04 | 1.00e+00 | 5.744 | 2 | 2 | 7 |
GO:0030836 | positive regulation of actin filament depolymerization | 5.80e-04 | 1.00e+00 | 5.744 | 2 | 2 | 7 |
GO:0032355 | response to estradiol | 6.19e-04 | 1.00e+00 | 3.362 | 4 | 5 | 73 |
GO:0034644 | cellular response to UV | 6.49e-04 | 1.00e+00 | 4.136 | 3 | 5 | 32 |
GO:0009615 | response to virus | 6.97e-04 | 1.00e+00 | 2.829 | 5 | 6 | 132 |
GO:0000790 | nuclear chromatin | 7.21e-04 | 1.00e+00 | 2.818 | 5 | 7 | 133 |
GO:0005737 | cytoplasm | 7.54e-04 | 1.00e+00 | 0.724 | 35 | 98 | 3976 |
GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 7.58e-04 | 1.00e+00 | 3.285 | 4 | 6 | 77 |
GO:0006554 | lysine catabolic process | 7.70e-04 | 1.00e+00 | 5.551 | 2 | 2 | 8 |
GO:0000812 | Swr1 complex | 7.70e-04 | 1.00e+00 | 5.551 | 2 | 3 | 8 |
GO:0070182 | DNA polymerase binding | 7.70e-04 | 1.00e+00 | 5.551 | 2 | 2 | 8 |
GO:0030042 | actin filament depolymerization | 7.70e-04 | 1.00e+00 | 5.551 | 2 | 2 | 8 |
GO:0045429 | positive regulation of nitric oxide biosynthetic process | 8.46e-04 | 1.00e+00 | 4.007 | 3 | 3 | 35 |
GO:0031000 | response to caffeine | 9.87e-04 | 1.00e+00 | 5.382 | 2 | 2 | 9 |
GO:0050681 | androgen receptor binding | 1.08e-03 | 1.00e+00 | 3.889 | 3 | 4 | 38 |
GO:0006284 | base-excision repair | 1.16e-03 | 1.00e+00 | 3.851 | 3 | 7 | 39 |
GO:0022627 | cytosolic small ribosomal subunit | 1.16e-03 | 1.00e+00 | 3.851 | 3 | 3 | 39 |
GO:0006200 | ATP catabolic process | 1.17e-03 | 1.00e+00 | 2.116 | 7 | 14 | 303 |
GO:0032508 | DNA duplex unwinding | 1.45e-03 | 1.00e+00 | 3.744 | 3 | 4 | 42 |
GO:0006418 | tRNA aminoacylation for protein translation | 1.45e-03 | 1.00e+00 | 3.744 | 3 | 5 | 42 |
GO:0042470 | melanosome | 1.47e-03 | 1.00e+00 | 3.028 | 4 | 10 | 92 |
GO:0008380 | RNA splicing | 1.50e-03 | 1.00e+00 | 2.278 | 6 | 13 | 232 |
GO:0061001 | regulation of dendritic spine morphogenesis | 1.50e-03 | 1.00e+00 | 5.092 | 2 | 2 | 11 |
GO:0031571 | mitotic G1 DNA damage checkpoint | 1.50e-03 | 1.00e+00 | 5.092 | 2 | 3 | 11 |
GO:0001649 | osteoblast differentiation | 1.66e-03 | 1.00e+00 | 2.982 | 4 | 6 | 95 |
GO:0051082 | unfolded protein binding | 1.66e-03 | 1.00e+00 | 2.982 | 4 | 6 | 95 |
GO:0043968 | histone H2A acetylation | 1.79e-03 | 1.00e+00 | 4.967 | 2 | 3 | 12 |
GO:0006275 | regulation of DNA replication | 1.79e-03 | 1.00e+00 | 4.967 | 2 | 2 | 12 |
GO:0019985 | translesion synthesis | 1.79e-03 | 1.00e+00 | 4.967 | 2 | 2 | 12 |
GO:0003682 | chromatin binding | 2.03e-03 | 1.00e+00 | 1.975 | 7 | 12 | 334 |
GO:0001530 | lipopolysaccharide binding | 2.11e-03 | 1.00e+00 | 4.851 | 2 | 2 | 13 |
GO:0010745 | negative regulation of macrophage derived foam cell differentiation | 2.11e-03 | 1.00e+00 | 4.851 | 2 | 2 | 13 |
GO:0031011 | Ino80 complex | 2.45e-03 | 1.00e+00 | 4.744 | 2 | 3 | 14 |
GO:0071285 | cellular response to lithium ion | 2.45e-03 | 1.00e+00 | 4.744 | 2 | 2 | 14 |
GO:0009651 | response to salt stress | 2.45e-03 | 1.00e+00 | 4.744 | 2 | 2 | 14 |
GO:0006091 | generation of precursor metabolites and energy | 2.53e-03 | 1.00e+00 | 3.464 | 3 | 3 | 51 |
GO:0040008 | regulation of growth | 2.53e-03 | 1.00e+00 | 3.464 | 3 | 3 | 51 |
GO:0003684 | damaged DNA binding | 2.53e-03 | 1.00e+00 | 3.464 | 3 | 11 | 51 |
GO:0003714 | transcription corepressor activity | 2.68e-03 | 1.00e+00 | 2.390 | 5 | 7 | 179 |
GO:0009948 | anterior/posterior axis specification | 2.82e-03 | 1.00e+00 | 4.645 | 2 | 2 | 15 |
GO:0042026 | protein refolding | 2.82e-03 | 1.00e+00 | 4.645 | 2 | 2 | 15 |
GO:0097193 | intrinsic apoptotic signaling pathway | 3.14e-03 | 1.00e+00 | 3.355 | 3 | 4 | 55 |
GO:0002039 | p53 binding | 3.14e-03 | 1.00e+00 | 3.355 | 3 | 7 | 55 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 3.21e-03 | 1.00e+00 | 4.551 | 2 | 4 | 16 |
GO:0051603 | proteolysis involved in cellular protein catabolic process | 3.21e-03 | 1.00e+00 | 4.551 | 2 | 2 | 16 |
GO:0000932 | cytoplasmic mRNA processing body | 3.31e-03 | 1.00e+00 | 3.329 | 3 | 3 | 56 |
GO:0003746 | translation elongation factor activity | 3.63e-03 | 1.00e+00 | 4.464 | 2 | 3 | 17 |
GO:0031258 | lamellipodium membrane | 3.63e-03 | 1.00e+00 | 4.464 | 2 | 2 | 17 |
GO:0000723 | telomere maintenance | 3.83e-03 | 1.00e+00 | 3.254 | 3 | 8 | 59 |
GO:0017025 | TBP-class protein binding | 4.07e-03 | 1.00e+00 | 4.382 | 2 | 2 | 18 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 4.07e-03 | 1.00e+00 | 4.382 | 2 | 2 | 18 |
GO:0019899 | enzyme binding | 4.38e-03 | 1.00e+00 | 1.967 | 6 | 11 | 288 |
GO:0003924 | GTPase activity | 4.59e-03 | 1.00e+00 | 2.208 | 5 | 9 | 203 |
GO:0019903 | protein phosphatase binding | 4.61e-03 | 1.00e+00 | 3.159 | 3 | 4 | 63 |
GO:0005719 | nuclear euchromatin | 5.01e-03 | 1.00e+00 | 4.230 | 2 | 2 | 20 |
GO:0006298 | mismatch repair | 5.01e-03 | 1.00e+00 | 4.230 | 2 | 6 | 20 |
GO:2000230 | negative regulation of pancreatic stellate cell proliferation | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0002502 | peptide antigen assembly with MHC class I protein complex | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0032077 | positive regulation of deoxyribonuclease activity | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0070243 | regulation of thymocyte apoptotic process | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0004088 | carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0061048 | negative regulation of branching involved in lung morphogenesis | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0030690 | Noc1p-Noc2p complex | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0035639 | purine ribonucleoside triphosphate binding | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0045994 | positive regulation of translational initiation by iron | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0004055 | argininosuccinate synthase activity | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0036270 | response to diuretic | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:1903038 | negative regulation of leukocyte cell-cell adhesion | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0008963 | phospho-N-acetylmuramoyl-pentapeptide-transferase activity | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0004149 | dihydrolipoyllysine-residue succinyltransferase activity | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:1990259 | histone-glutamine methyltransferase activity | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0051660 | establishment of centrosome localization | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0036353 | histone H2A-K119 monoubiquitination | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0004070 | aspartate carbamoyltransferase activity | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0000053 | argininosuccinate metabolic process | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0035633 | maintenance of blood-brain barrier | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0002842 | positive regulation of T cell mediated immune response to tumor cell | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0004955 | prostaglandin receptor activity | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0090271 | positive regulation of fibroblast growth factor production | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0000235 | astral microtubule | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0000701 | purine-specific mismatch base pair DNA N-glycosylase activity | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0048291 | isotype switching to IgG isotypes | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0007174 | epidermal growth factor catabolic process | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0090362 | positive regulation of platelet-derived growth factor production | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0052066 | entry of symbiont into host cell by promotion of host phagocytosis | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0003975 | UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0006422 | aspartyl-tRNA aminoacylation | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0022607 | cellular component assembly | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0070262 | peptidyl-serine dephosphorylation | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0019521 | D-gluconate metabolic process | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0043973 | histone H3-K4 acetylation | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0016074 | snoRNA metabolic process | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0002368 | B cell cytokine production | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0019408 | dolichol biosynthetic process | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0070335 | aspartate binding | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0002037 | negative regulation of L-glutamate transport | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0060694 | regulation of cholesterol transporter activity | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0043626 | PCNA complex | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:2000425 | regulation of apoptotic cell clearance | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:1990258 | histone glutamine methylation | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0004151 | dihydroorotase activity | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0045713 | low-density lipoprotein particle receptor biosynthetic process | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0000054 | ribosomal subunit export from nucleus | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:2000536 | negative regulation of entry of bacterium into host cell | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:1901558 | response to metformin | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0046469 | platelet activating factor metabolic process | 5.33e-03 | 1.00e+00 | 7.551 | 1 | 1 | 1 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 5.48e-03 | 1.00e+00 | 3.070 | 3 | 6 | 67 |
GO:0001702 | gastrulation with mouth forming second | 5.52e-03 | 1.00e+00 | 4.159 | 2 | 2 | 21 |
GO:0046686 | response to cadmium ion | 6.05e-03 | 1.00e+00 | 4.092 | 2 | 3 | 22 |
GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle | 6.05e-03 | 1.00e+00 | 4.092 | 2 | 3 | 22 |
GO:0033574 | response to testosterone | 6.05e-03 | 1.00e+00 | 4.092 | 2 | 2 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 6.05e-03 | 1.00e+00 | 4.092 | 2 | 4 | 22 |
GO:0006270 | DNA replication initiation | 6.05e-03 | 1.00e+00 | 4.092 | 2 | 5 | 22 |
GO:0006184 | GTP catabolic process | 6.42e-03 | 1.00e+00 | 2.092 | 5 | 9 | 220 |
GO:0006362 | transcription elongation from RNA polymerase I promoter | 6.61e-03 | 1.00e+00 | 4.028 | 2 | 3 | 23 |
GO:0007584 | response to nutrient | 6.69e-03 | 1.00e+00 | 2.967 | 3 | 3 | 72 |
GO:0007507 | heart development | 6.83e-03 | 1.00e+00 | 2.412 | 4 | 5 | 141 |
GO:0000785 | chromatin | 6.96e-03 | 1.00e+00 | 2.947 | 3 | 5 | 73 |
GO:0006363 | termination of RNA polymerase I transcription | 7.18e-03 | 1.00e+00 | 3.967 | 2 | 3 | 24 |
GO:0008135 | translation factor activity, nucleic acid binding | 7.18e-03 | 1.00e+00 | 3.967 | 2 | 4 | 24 |
GO:0006206 | pyrimidine nucleobase metabolic process | 7.18e-03 | 1.00e+00 | 3.967 | 2 | 2 | 24 |
GO:0000060 | protein import into nucleus, translocation | 7.18e-03 | 1.00e+00 | 3.967 | 2 | 4 | 24 |
GO:0002020 | protease binding | 7.22e-03 | 1.00e+00 | 2.927 | 3 | 4 | 74 |
GO:0019901 | protein kinase binding | 7.25e-03 | 1.00e+00 | 1.815 | 6 | 21 | 320 |
GO:0042113 | B cell activation | 7.78e-03 | 1.00e+00 | 3.908 | 2 | 2 | 25 |
GO:0006611 | protein export from nucleus | 7.78e-03 | 1.00e+00 | 3.908 | 2 | 4 | 25 |
GO:0003899 | DNA-directed RNA polymerase activity | 7.78e-03 | 1.00e+00 | 3.908 | 2 | 2 | 25 |
GO:0007067 | mitotic nuclear division | 7.85e-03 | 1.00e+00 | 2.022 | 5 | 13 | 231 |
GO:0006361 | transcription initiation from RNA polymerase I promoter | 8.40e-03 | 1.00e+00 | 3.851 | 2 | 3 | 26 |
GO:0030331 | estrogen receptor binding | 9.04e-03 | 1.00e+00 | 3.797 | 2 | 2 | 27 |
GO:0051301 | cell division | 9.26e-03 | 1.00e+00 | 2.797 | 3 | 6 | 81 |
GO:0001889 | liver development | 9.57e-03 | 1.00e+00 | 2.779 | 3 | 3 | 82 |
GO:0043022 | ribosome binding | 9.70e-03 | 1.00e+00 | 3.744 | 2 | 3 | 28 |
GO:0043967 | histone H4 acetylation | 9.70e-03 | 1.00e+00 | 3.744 | 2 | 3 | 28 |
GO:0034612 | response to tumor necrosis factor | 9.70e-03 | 1.00e+00 | 3.744 | 2 | 2 | 28 |
GO:0009409 | response to cold | 1.04e-02 | 1.00e+00 | 3.694 | 2 | 2 | 29 |
GO:0034686 | integrin alphav-beta8 complex | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0006407 | rRNA export from nucleus | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0042824 | MHC class I peptide loading complex | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0036035 | osteoclast development | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 2 | 2 |
GO:1990430 | extracellular matrix protein binding | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0033144 | negative regulation of intracellular steroid hormone receptor signaling pathway | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0090343 | positive regulation of cell aging | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0046985 | positive regulation of hemoglobin biosynthetic process | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0004832 | valine-tRNA ligase activity | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0010046 | response to mycotoxin | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0032227 | negative regulation of synaptic transmission, dopaminergic | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0051538 | 3 iron, 4 sulfur cluster binding | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:1901525 | negative regulation of macromitophagy | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0070557 | PCNA-p21 complex | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0034684 | integrin alphav-beta5 complex | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0007070 | negative regulation of transcription from RNA polymerase II promoter during mitosis | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 2 | 2 |
GO:0097252 | oligodendrocyte apoptotic process | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0071306 | cellular response to vitamin E | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0035887 | aortic smooth muscle cell differentiation | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0003994 | aconitate hydratase activity | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:1990268 | response to gold nanoparticle | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0002439 | chronic inflammatory response to antigenic stimulus | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0001846 | opsonin binding | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0060557 | positive regulation of vitamin D biosynthetic process | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0071418 | cellular response to amine stimulus | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0071242 | cellular response to ammonium ion | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0061034 | olfactory bulb mitral cell layer development | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0004982 | N-formyl peptide receptor activity | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0000461 | endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0046456 | icosanoid biosynthetic process | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0019322 | pentose biosynthetic process | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0004815 | aspartate-tRNA ligase activity | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0034683 | integrin alphav-beta3 complex | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0030337 | DNA polymerase processivity factor activity | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0051081 | nuclear envelope disassembly | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0006438 | valyl-tRNA aminoacylation | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0005055 | laminin receptor activity | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0007127 | meiosis I | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0004666 | prostaglandin-endoperoxide synthase activity | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0070409 | carbamoyl phosphate biosynthetic process | 1.06e-02 | 1.00e+00 | 6.551 | 1 | 1 | 2 |
GO:0045121 | membrane raft | 1.08e-02 | 1.00e+00 | 2.221 | 4 | 8 | 161 |
GO:0047485 | protein N-terminus binding | 1.09e-02 | 1.00e+00 | 2.710 | 3 | 4 | 86 |
GO:0006360 | transcription from RNA polymerase I promoter | 1.11e-02 | 1.00e+00 | 3.645 | 2 | 4 | 30 |
GO:0005164 | tumor necrosis factor receptor binding | 1.11e-02 | 1.00e+00 | 3.645 | 2 | 3 | 30 |
GO:0006370 | 7-methylguanosine mRNA capping | 1.11e-02 | 1.00e+00 | 3.645 | 2 | 4 | 30 |
GO:0034504 | protein localization to nucleus | 1.11e-02 | 1.00e+00 | 3.645 | 2 | 2 | 30 |
GO:0000398 | mRNA splicing, via spliceosome | 1.17e-02 | 1.00e+00 | 2.185 | 4 | 12 | 165 |
GO:0050873 | brown fat cell differentiation | 1.18e-02 | 1.00e+00 | 3.597 | 2 | 2 | 31 |
GO:0046677 | response to antibiotic | 1.18e-02 | 1.00e+00 | 3.597 | 2 | 2 | 31 |
GO:0016604 | nuclear body | 1.18e-02 | 1.00e+00 | 3.597 | 2 | 2 | 31 |
GO:0033572 | transferrin transport | 1.26e-02 | 1.00e+00 | 3.551 | 2 | 6 | 32 |
GO:0006928 | cellular component movement | 1.31e-02 | 1.00e+00 | 2.613 | 3 | 7 | 92 |
GO:0030971 | receptor tyrosine kinase binding | 1.33e-02 | 1.00e+00 | 3.507 | 2 | 2 | 33 |
GO:0045335 | phagocytic vesicle | 1.33e-02 | 1.00e+00 | 3.507 | 2 | 2 | 33 |
GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity | 1.34e-02 | 1.00e+00 | 2.597 | 3 | 5 | 93 |
GO:0007611 | learning or memory | 1.41e-02 | 1.00e+00 | 3.464 | 2 | 2 | 34 |
GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors | 1.41e-02 | 1.00e+00 | 3.464 | 2 | 2 | 34 |
GO:0006364 | rRNA processing | 1.46e-02 | 1.00e+00 | 2.551 | 3 | 5 | 96 |
GO:0045599 | negative regulation of fat cell differentiation | 1.49e-02 | 1.00e+00 | 3.422 | 2 | 2 | 35 |
GO:0071456 | cellular response to hypoxia | 1.55e-02 | 1.00e+00 | 2.522 | 3 | 4 | 98 |
GO:0032755 | positive regulation of interleukin-6 production | 1.57e-02 | 1.00e+00 | 3.382 | 2 | 2 | 36 |
GO:0042802 | identical protein binding | 1.58e-02 | 1.00e+00 | 1.419 | 7 | 18 | 491 |
GO:0009263 | deoxyribonucleotide biosynthetic process | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0043243 | positive regulation of protein complex disassembly | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0006458 | 'de novo' protein folding | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0035033 | histone deacetylase regulator activity | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0002360 | T cell lineage commitment | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0006432 | phenylalanyl-tRNA aminoacylation | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0005726 | perichromatin fibrils | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0006526 | arginine biosynthetic process | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0044205 | 'de novo' UMP biosynthetic process | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0032741 | positive regulation of interleukin-18 production | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0045505 | dynein intermediate chain binding | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0009750 | response to fructose | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0046321 | positive regulation of fatty acid oxidation | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0051097 | negative regulation of helicase activity | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0008559 | xenobiotic-transporting ATPase activity | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0055106 | ubiquitin-protein transferase regulator activity | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0021540 | corpus callosum morphogenesis | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0071400 | cellular response to oleic acid | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0030730 | sequestering of triglyceride | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0055098 | response to low-density lipoprotein particle | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0001012 | RNA polymerase II regulatory region DNA binding | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0010424 | DNA methylation on cytosine within a CG sequence | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0032800 | receptor biosynthetic process | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:1900126 | negative regulation of hyaluronan biosynthetic process | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0006047 | UDP-N-acetylglucosamine metabolic process | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0090385 | phagosome-lysosome fusion | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0007403 | glial cell fate determination | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0034103 | regulation of tissue remodeling | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0030135 | coated vesicle | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0071535 | RING-like zinc finger domain binding | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0010871 | negative regulation of receptor biosynthetic process | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0036462 | TRAIL-activated apoptotic signaling pathway | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0060559 | positive regulation of calcidiol 1-monooxygenase activity | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0032139 | dinucleotide insertion or deletion binding | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0035794 | positive regulation of mitochondrial membrane permeability | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0071899 | negative regulation of estrogen receptor binding | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0071733 | transcriptional activation by promoter-enhancer looping | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0071677 | positive regulation of mononuclear cell migration | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0001832 | blastocyst growth | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0000056 | ribosomal small subunit export from nucleus | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0090336 | positive regulation of brown fat cell differentiation | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0071439 | clathrin complex | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0050473 | arachidonate 15-lipoxygenase activity | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 1 | 3 |
GO:0016301 | kinase activity | 1.66e-02 | 1.00e+00 | 3.342 | 2 | 3 | 37 |
GO:0051539 | 4 iron, 4 sulfur cluster binding | 1.66e-02 | 1.00e+00 | 3.342 | 2 | 3 | 37 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.69e-02 | 1.00e+00 | 2.028 | 4 | 8 | 184 |
GO:0097191 | extrinsic apoptotic signaling pathway | 1.74e-02 | 1.00e+00 | 3.304 | 2 | 2 | 38 |
GO:0090382 | phagosome maturation | 1.74e-02 | 1.00e+00 | 3.304 | 2 | 5 | 38 |
GO:0032092 | positive regulation of protein binding | 1.83e-02 | 1.00e+00 | 3.266 | 2 | 3 | 39 |
GO:0021766 | hippocampus development | 1.83e-02 | 1.00e+00 | 3.266 | 2 | 4 | 39 |
GO:0071407 | cellular response to organic cyclic compound | 1.83e-02 | 1.00e+00 | 3.266 | 2 | 2 | 39 |
GO:0006096 | glycolytic process | 1.83e-02 | 1.00e+00 | 3.266 | 2 | 4 | 39 |
GO:0032729 | positive regulation of interferon-gamma production | 1.83e-02 | 1.00e+00 | 3.266 | 2 | 2 | 39 |
GO:0042493 | response to drug | 1.89e-02 | 1.00e+00 | 1.704 | 5 | 11 | 288 |
GO:0001228 | RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 1.92e-02 | 1.00e+00 | 3.230 | 2 | 2 | 40 |
GO:0005741 | mitochondrial outer membrane | 2.00e-02 | 1.00e+00 | 2.382 | 3 | 4 | 108 |
GO:0045785 | positive regulation of cell adhesion | 2.01e-02 | 1.00e+00 | 3.194 | 2 | 5 | 41 |
GO:0071230 | cellular response to amino acid stimulus | 2.11e-02 | 1.00e+00 | 3.159 | 2 | 2 | 42 |
GO:0090383 | phagosome acidification | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0000052 | citrulline metabolic process | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0031428 | box C/D snoRNP complex | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0043141 | ATP-dependent 5'-3' DNA helicase activity | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0006273 | lagging strand elongation | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0003896 | DNA primase activity | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 2 | 4 |
GO:2000510 | positive regulation of dendritic cell chemotaxis | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0005853 | eukaryotic translation elongation factor 1 complex | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 2 | 4 |
GO:0005658 | alpha DNA polymerase:primase complex | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0051533 | positive regulation of NFAT protein import into nucleus | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0051222 | positive regulation of protein transport | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0004634 | phosphopyruvate hydratase activity | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 2 | 4 |
GO:0060318 | definitive erythrocyte differentiation | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0035877 | death effector domain binding | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0006104 | succinyl-CoA metabolic process | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0000055 | ribosomal large subunit export from nucleus | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0050805 | negative regulation of synaptic transmission | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0032369 | negative regulation of lipid transport | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0051208 | sequestering of calcium ion | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0010693 | negative regulation of alkaline phosphatase activity | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0030686 | 90S preribosome | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0019788 | NEDD8 ligase activity | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0001652 | granular component | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0043242 | negative regulation of protein complex disassembly | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0060693 | regulation of branching involved in salivary gland morphogenesis | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0035357 | peroxisome proliferator activated receptor signaling pathway | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0010669 | epithelial structure maintenance | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0006663 | platelet activating factor biosynthetic process | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0002326 | B cell lineage commitment | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0032051 | clathrin light chain binding | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0000015 | phosphopyruvate hydratase complex | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 2 | 4 |
GO:0090403 | oxidative stress-induced premature senescence | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0001842 | neural fold formation | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0004826 | phenylalanine-tRNA ligase activity | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0004046 | aminoacylase activity | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0006543 | glutamine catabolic process | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0001835 | blastocyst hatching | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 2 | 4 |
GO:0031467 | Cul7-RING ubiquitin ligase complex | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0005955 | calcineurin complex | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:1903077 | negative regulation of protein localization to plasma membrane | 2.12e-02 | 1.00e+00 | 5.551 | 1 | 1 | 4 |
GO:0006461 | protein complex assembly | 2.15e-02 | 1.00e+00 | 2.342 | 3 | 6 | 111 |
GO:0015630 | microtubule cytoskeleton | 2.20e-02 | 1.00e+00 | 2.329 | 3 | 5 | 112 |
GO:0042110 | T cell activation | 2.20e-02 | 1.00e+00 | 3.125 | 2 | 3 | 43 |
GO:0050434 | positive regulation of viral transcription | 2.30e-02 | 1.00e+00 | 3.092 | 2 | 5 | 44 |
GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding | 2.30e-02 | 1.00e+00 | 3.092 | 2 | 2 | 44 |
GO:0015030 | Cajal body | 2.40e-02 | 1.00e+00 | 3.060 | 2 | 2 | 45 |
GO:0005635 | nuclear envelope | 2.41e-02 | 1.00e+00 | 2.278 | 3 | 6 | 116 |
GO:0043525 | positive regulation of neuron apoptotic process | 2.50e-02 | 1.00e+00 | 3.028 | 2 | 2 | 46 |
GO:0044297 | cell body | 2.50e-02 | 1.00e+00 | 3.028 | 2 | 2 | 46 |
GO:0044237 | cellular metabolic process | 2.52e-02 | 1.00e+00 | 2.254 | 3 | 3 | 118 |
GO:0009986 | cell surface | 2.52e-02 | 1.00e+00 | 1.415 | 6 | 9 | 422 |
GO:0050727 | regulation of inflammatory response | 2.60e-02 | 1.00e+00 | 2.997 | 2 | 3 | 47 |
GO:0060100 | positive regulation of phagocytosis, engulfment | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0005672 | transcription factor TFIIA complex | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0070852 | cell body fiber | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0045986 | negative regulation of smooth muscle contraction | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0006269 | DNA replication, synthesis of RNA primer | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 2 | 5 |
GO:0030891 | VCB complex | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 2 | 5 |
GO:0043405 | regulation of MAP kinase activity | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0006734 | NADH metabolic process | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0003407 | neural retina development | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0002740 | negative regulation of cytokine secretion involved in immune response | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0035965 | cardiolipin acyl-chain remodeling | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0042908 | xenobiotic transport | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0071636 | positive regulation of transforming growth factor beta production | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0031461 | cullin-RING ubiquitin ligase complex | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0051023 | regulation of immunoglobulin secretion | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0010891 | negative regulation of sequestering of triglyceride | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0046696 | lipopolysaccharide receptor complex | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0031915 | positive regulation of synaptic plasticity | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0060336 | negative regulation of interferon-gamma-mediated signaling pathway | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0006102 | isocitrate metabolic process | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0000730 | DNA recombinase assembly | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 3 | 5 |
GO:0005638 | lamin filament | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0048730 | epidermis morphogenesis | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0031394 | positive regulation of prostaglandin biosynthetic process | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0030976 | thiamine pyrophosphate binding | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0044770 | cell cycle phase transition | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0042256 | mature ribosome assembly | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0032966 | negative regulation of collagen biosynthetic process | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0001882 | nucleoside binding | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:2000001 | regulation of DNA damage checkpoint | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0048562 | embryonic organ morphogenesis | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0051798 | positive regulation of hair follicle development | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0010571 | positive regulation of nuclear cell cycle DNA replication | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0043248 | proteasome assembly | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0050544 | arachidonic acid binding | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0051414 | response to cortisol | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 2 | 5 |
GO:0019932 | second-messenger-mediated signaling | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0038027 | apolipoprotein A-I-mediated signaling pathway | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0031023 | microtubule organizing center organization | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0097371 | MDM2/MDM4 family protein binding | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0071169 | establishment of protein localization to chromatin | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0071803 | positive regulation of podosome assembly | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0060850 | regulation of transcription involved in cell fate commitment | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0032025 | response to cobalt ion | 2.64e-02 | 1.00e+00 | 5.230 | 1 | 1 | 5 |
GO:0005507 | copper ion binding | 2.70e-02 | 1.00e+00 | 2.967 | 2 | 2 | 48 |
GO:0019003 | GDP binding | 2.70e-02 | 1.00e+00 | 2.967 | 2 | 2 | 48 |
GO:0006325 | chromatin organization | 2.80e-02 | 1.00e+00 | 2.194 | 3 | 4 | 123 |
GO:0048661 | positive regulation of smooth muscle cell proliferation | 2.81e-02 | 1.00e+00 | 2.937 | 2 | 2 | 49 |
GO:0019369 | arachidonic acid metabolic process | 2.81e-02 | 1.00e+00 | 2.937 | 2 | 2 | 49 |
GO:0003743 | translation initiation factor activity | 2.81e-02 | 1.00e+00 | 2.937 | 2 | 4 | 49 |
GO:0031100 | organ regeneration | 2.92e-02 | 1.00e+00 | 2.908 | 2 | 4 | 50 |
GO:0035690 | cellular response to drug | 2.92e-02 | 1.00e+00 | 2.908 | 2 | 2 | 50 |
GO:0007050 | cell cycle arrest | 2.98e-02 | 1.00e+00 | 2.159 | 3 | 7 | 126 |
GO:0006986 | response to unfolded protein | 3.03e-02 | 1.00e+00 | 2.879 | 2 | 2 | 51 |
GO:0005525 | GTP binding | 3.09e-02 | 1.00e+00 | 1.516 | 5 | 11 | 328 |
GO:0005663 | DNA replication factor C complex | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:0010666 | positive regulation of cardiac muscle cell apoptotic process | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:0006101 | citrate metabolic process | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:0010042 | response to manganese ion | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:0008090 | retrograde axon cargo transport | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:0021695 | cerebellar cortex development | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:0031264 | death-inducing signaling complex | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:0050764 | regulation of phagocytosis | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:0010887 | negative regulation of cholesterol storage | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:0002181 | cytoplasmic translation | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:0097527 | necroptotic signaling pathway | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:0006346 | methylation-dependent chromatin silencing | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:0021860 | pyramidal neuron development | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:0001667 | ameboidal-type cell migration | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:0043023 | ribosomal large subunit binding | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 2 | 6 |
GO:0031466 | Cul5-RING ubiquitin ligase complex | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:0031265 | CD95 death-inducing signaling complex | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:0007406 | negative regulation of neuroblast proliferation | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:0006927 | transformed cell apoptotic process | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:0032405 | MutLalpha complex binding | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 2 | 6 |
GO:0003688 | DNA replication origin binding | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:1901379 | regulation of potassium ion transmembrane transport | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:0006531 | aspartate metabolic process | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:0002309 | T cell proliferation involved in immune response | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:0030118 | clathrin coat | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:0097208 | alveolar lamellar body | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:0070245 | positive regulation of thymocyte apoptotic process | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:0040020 | regulation of meiosis | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:0000791 | euchromatin | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:0030130 | clathrin coat of trans-Golgi network vesicle | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:0060744 | mammary gland branching involved in thelarche | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:0002862 | negative regulation of inflammatory response to antigenic stimulus | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:0034452 | dynactin binding | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 1 | 6 |
GO:0006356 | regulation of transcription from RNA polymerase I promoter | 3.16e-02 | 1.00e+00 | 4.967 | 1 | 2 | 6 |
GO:0008283 | cell proliferation | 3.19e-02 | 1.00e+00 | 1.503 | 5 | 12 | 331 |
GO:0003725 | double-stranded RNA binding | 3.36e-02 | 1.00e+00 | 2.797 | 2 | 6 | 54 |
GO:0031982 | vesicle | 3.48e-02 | 1.00e+00 | 2.070 | 3 | 10 | 134 |
GO:0005813 | centrosome | 3.48e-02 | 1.00e+00 | 1.468 | 5 | 12 | 339 |
GO:0060546 | negative regulation of necroptotic process | 3.67e-02 | 1.00e+00 | 4.744 | 1 | 1 | 7 |
GO:0042921 | glucocorticoid receptor signaling pathway | 3.67e-02 | 1.00e+00 | 4.744 | 1 | 1 | 7 |
GO:0072089 | stem cell proliferation | 3.67e-02 | 1.00e+00 | 4.744 | 1 | 1 | 7 |
GO:0001849 | complement component C1q binding | 3.67e-02 | 1.00e+00 | 4.744 | 1 | 1 | 7 |
GO:0043008 | ATP-dependent protein binding | 3.67e-02 | 1.00e+00 | 4.744 | 1 | 1 | 7 |
GO:0060416 | response to growth hormone | 3.67e-02 | 1.00e+00 | 4.744 | 1 | 1 | 7 |
GO:0071455 | cellular response to hyperoxia | 3.67e-02 | 1.00e+00 | 4.744 | 1 | 1 | 7 |
GO:0046007 | negative regulation of activated T cell proliferation | 3.67e-02 | 1.00e+00 | 4.744 | 1 | 1 | 7 |
GO:0001961 | positive regulation of cytokine-mediated signaling pathway | 3.67e-02 | 1.00e+00 | 4.744 | 1 | 1 | 7 |
GO:0000028 | ribosomal small subunit assembly | 3.67e-02 | 1.00e+00 | 4.744 | 1 | 1 | 7 |
GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis | 3.67e-02 | 1.00e+00 | 4.744 | 1 | 1 | 7 |
GO:0006690 | icosanoid metabolic process | 3.67e-02 | 1.00e+00 | 4.744 | 1 | 1 | 7 |
GO:2000785 | regulation of autophagic vacuole assembly | 3.67e-02 | 1.00e+00 | 4.744 | 1 | 1 | 7 |
GO:0097342 | ripoptosome | 3.67e-02 | 1.00e+00 | 4.744 | 1 | 1 | 7 |
GO:0017145 | stem cell division | 3.67e-02 | 1.00e+00 | 4.744 | 1 | 1 | 7 |
GO:0015909 | long-chain fatty acid transport | 3.67e-02 | 1.00e+00 | 4.744 | 1 | 1 | 7 |
GO:0001775 | cell activation | 3.67e-02 | 1.00e+00 | 4.744 | 1 | 1 | 7 |
GO:0071499 | cellular response to laminar fluid shear stress | 3.67e-02 | 1.00e+00 | 4.744 | 1 | 1 | 7 |
GO:0031497 | chromatin assembly | 3.67e-02 | 1.00e+00 | 4.744 | 1 | 1 | 7 |
GO:0031462 | Cul2-RING ubiquitin ligase complex | 3.67e-02 | 1.00e+00 | 4.744 | 1 | 2 | 7 |
GO:0030274 | LIM domain binding | 3.67e-02 | 1.00e+00 | 4.744 | 1 | 1 | 7 |
GO:0002674 | negative regulation of acute inflammatory response | 3.67e-02 | 1.00e+00 | 4.744 | 1 | 1 | 7 |
GO:0031994 | insulin-like growth factor I binding | 3.67e-02 | 1.00e+00 | 4.744 | 1 | 1 | 7 |
GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis | 3.67e-02 | 1.00e+00 | 4.744 | 1 | 1 | 7 |
GO:0007097 | nuclear migration | 3.67e-02 | 1.00e+00 | 4.744 | 1 | 1 | 7 |
GO:0002161 | aminoacyl-tRNA editing activity | 3.67e-02 | 1.00e+00 | 4.744 | 1 | 2 | 7 |
GO:0001739 | sex chromatin | 3.67e-02 | 1.00e+00 | 4.744 | 1 | 1 | 7 |
GO:0045760 | positive regulation of action potential | 3.67e-02 | 1.00e+00 | 4.744 | 1 | 1 | 7 |
GO:0033180 | proton-transporting V-type ATPase, V1 domain | 3.67e-02 | 1.00e+00 | 4.744 | 1 | 2 | 7 |
GO:0030132 | clathrin coat of coated pit | 3.67e-02 | 1.00e+00 | 4.744 | 1 | 1 | 7 |
GO:0045647 | negative regulation of erythrocyte differentiation | 3.67e-02 | 1.00e+00 | 4.744 | 1 | 1 | 7 |
GO:0000086 | G2/M transition of mitotic cell cycle | 3.68e-02 | 1.00e+00 | 2.038 | 3 | 7 | 137 |
GO:0007596 | blood coagulation | 3.75e-02 | 1.00e+00 | 1.278 | 6 | 14 | 464 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 3.76e-02 | 1.00e+00 | 1.157 | 7 | 12 | 589 |
GO:0008217 | regulation of blood pressure | 3.83e-02 | 1.00e+00 | 2.694 | 2 | 5 | 58 |
GO:0003713 | transcription coactivator activity | 3.89e-02 | 1.00e+00 | 1.651 | 4 | 10 | 239 |
GO:0051974 | negative regulation of telomerase activity | 4.19e-02 | 1.00e+00 | 4.551 | 1 | 1 | 8 |
GO:0097202 | activation of cysteine-type endopeptidase activity | 4.19e-02 | 1.00e+00 | 4.551 | 1 | 1 | 8 |
GO:0000733 | DNA strand renaturation | 4.19e-02 | 1.00e+00 | 4.551 | 1 | 1 | 8 |
GO:0046325 | negative regulation of glucose import | 4.19e-02 | 1.00e+00 | 4.551 | 1 | 1 | 8 |
GO:0031512 | motile primary cilium | 4.19e-02 | 1.00e+00 | 4.551 | 1 | 1 | 8 |
GO:0047498 | calcium-dependent phospholipase A2 activity | 4.19e-02 | 1.00e+00 | 4.551 | 1 | 1 | 8 |
GO:0043068 | positive regulation of programmed cell death | 4.19e-02 | 1.00e+00 | 4.551 | 1 | 1 | 8 |
GO:0030728 | ovulation | 4.19e-02 | 1.00e+00 | 4.551 | 1 | 1 | 8 |
GO:0033018 | sarcoplasmic reticulum lumen | 4.19e-02 | 1.00e+00 | 4.551 | 1 | 1 | 8 |
GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex | 4.19e-02 | 1.00e+00 | 4.551 | 1 | 2 | 8 |
GO:0071316 | cellular response to nicotine | 4.19e-02 | 1.00e+00 | 4.551 | 1 | 1 | 8 |
GO:0060539 | diaphragm development | 4.19e-02 | 1.00e+00 | 4.551 | 1 | 1 | 8 |
GO:0016757 | transferase activity, transferring glycosyl groups | 4.19e-02 | 1.00e+00 | 4.551 | 1 | 1 | 8 |
GO:0045416 | positive regulation of interleukin-8 biosynthetic process | 4.19e-02 | 1.00e+00 | 4.551 | 1 | 1 | 8 |
GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain | 4.19e-02 | 1.00e+00 | 4.551 | 1 | 1 | 8 |
GO:0045116 | protein neddylation | 4.19e-02 | 1.00e+00 | 4.551 | 1 | 2 | 8 |
GO:0043596 | nuclear replication fork | 4.19e-02 | 1.00e+00 | 4.551 | 1 | 1 | 8 |
GO:0001055 | RNA polymerase II activity | 4.19e-02 | 1.00e+00 | 4.551 | 1 | 3 | 8 |
GO:0070688 | MLL5-L complex | 4.19e-02 | 1.00e+00 | 4.551 | 1 | 1 | 8 |
GO:2000010 | positive regulation of protein localization to cell surface | 4.19e-02 | 1.00e+00 | 4.551 | 1 | 2 | 8 |
GO:0051384 | response to glucocorticoid | 4.32e-02 | 1.00e+00 | 2.597 | 2 | 2 | 62 |
GO:0006302 | double-strand break repair | 4.32e-02 | 1.00e+00 | 2.597 | 2 | 8 | 62 |
GO:0042995 | cell projection | 4.45e-02 | 1.00e+00 | 2.574 | 2 | 6 | 63 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 4.46e-02 | 1.00e+00 | 1.927 | 3 | 3 | 148 |
GO:0010628 | positive regulation of gene expression | 4.54e-02 | 1.00e+00 | 1.917 | 3 | 4 | 149 |
GO:0006457 | protein folding | 4.54e-02 | 1.00e+00 | 1.917 | 3 | 8 | 149 |
GO:0032869 | cellular response to insulin stimulus | 4.58e-02 | 1.00e+00 | 2.551 | 2 | 3 | 64 |
GO:0045087 | innate immune response | 4.60e-02 | 1.00e+00 | 1.092 | 7 | 20 | 616 |
GO:0034116 | positive regulation of heterotypic cell-cell adhesion | 4.70e-02 | 1.00e+00 | 4.382 | 1 | 1 | 9 |
GO:0007494 | midgut development | 4.70e-02 | 1.00e+00 | 4.382 | 1 | 1 | 9 |
GO:0006983 | ER overload response | 4.70e-02 | 1.00e+00 | 4.382 | 1 | 2 | 9 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 4.70e-02 | 1.00e+00 | 4.382 | 1 | 1 | 9 |
GO:0033690 | positive regulation of osteoblast proliferation | 4.70e-02 | 1.00e+00 | 4.382 | 1 | 1 | 9 |
GO:0014075 | response to amine | 4.70e-02 | 1.00e+00 | 4.382 | 1 | 1 | 9 |
GO:0042555 | MCM complex | 4.70e-02 | 1.00e+00 | 4.382 | 1 | 2 | 9 |
GO:0000185 | activation of MAPKKK activity | 4.70e-02 | 1.00e+00 | 4.382 | 1 | 2 | 9 |
GO:0060322 | head development | 4.70e-02 | 1.00e+00 | 4.382 | 1 | 1 | 9 |
GO:0032319 | regulation of Rho GTPase activity | 4.70e-02 | 1.00e+00 | 4.382 | 1 | 2 | 9 |
GO:0022417 | protein maturation by protein folding | 4.70e-02 | 1.00e+00 | 4.382 | 1 | 1 | 9 |
GO:0044183 | protein binding involved in protein folding | 4.70e-02 | 1.00e+00 | 4.382 | 1 | 1 | 9 |
GO:0097284 | hepatocyte apoptotic process | 4.70e-02 | 1.00e+00 | 4.382 | 1 | 2 | 9 |
GO:0031065 | positive regulation of histone deacetylation | 4.70e-02 | 1.00e+00 | 4.382 | 1 | 1 | 9 |
GO:0001973 | adenosine receptor signaling pathway | 4.70e-02 | 1.00e+00 | 4.382 | 1 | 1 | 9 |
GO:0021895 | cerebral cortex neuron differentiation | 4.70e-02 | 1.00e+00 | 4.382 | 1 | 1 | 9 |
GO:0008494 | translation activator activity | 4.70e-02 | 1.00e+00 | 4.382 | 1 | 1 | 9 |
GO:0006228 | UTP biosynthetic process | 4.70e-02 | 1.00e+00 | 4.382 | 1 | 1 | 9 |
GO:0045080 | positive regulation of chemokine biosynthetic process | 4.70e-02 | 1.00e+00 | 4.382 | 1 | 1 | 9 |
GO:0071380 | cellular response to prostaglandin E stimulus | 4.70e-02 | 1.00e+00 | 4.382 | 1 | 1 | 9 |
GO:0030855 | epithelial cell differentiation | 4.71e-02 | 1.00e+00 | 2.529 | 2 | 4 | 65 |
GO:0071260 | cellular response to mechanical stimulus | 4.84e-02 | 1.00e+00 | 2.507 | 2 | 4 | 66 |
GO:0006310 | DNA recombination | 4.97e-02 | 1.00e+00 | 2.485 | 2 | 4 | 67 |
GO:0006338 | chromatin remodeling | 5.10e-02 | 1.00e+00 | 2.464 | 2 | 4 | 68 |
GO:0032703 | negative regulation of interleukin-2 production | 5.21e-02 | 1.00e+00 | 4.230 | 1 | 1 | 10 |
GO:0051604 | protein maturation | 5.21e-02 | 1.00e+00 | 4.230 | 1 | 1 | 10 |
GO:0032700 | negative regulation of interleukin-17 production | 5.21e-02 | 1.00e+00 | 4.230 | 1 | 1 | 10 |
GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway | 5.21e-02 | 1.00e+00 | 4.230 | 1 | 1 | 10 |
GO:0071318 | cellular response to ATP | 5.21e-02 | 1.00e+00 | 4.230 | 1 | 1 | 10 |
GO:0006622 | protein targeting to lysosome | 5.21e-02 | 1.00e+00 | 4.230 | 1 | 1 | 10 |
GO:0002199 | zona pellucida receptor complex | 5.21e-02 | 1.00e+00 | 4.230 | 1 | 1 | 10 |
GO:0043032 | positive regulation of macrophage activation | 5.21e-02 | 1.00e+00 | 4.230 | 1 | 1 | 10 |
GO:0090399 | replicative senescence | 5.21e-02 | 1.00e+00 | 4.230 | 1 | 1 | 10 |
GO:0070307 | lens fiber cell development | 5.21e-02 | 1.00e+00 | 4.230 | 1 | 2 | 10 |
GO:0046902 | regulation of mitochondrial membrane permeability | 5.21e-02 | 1.00e+00 | 4.230 | 1 | 1 | 10 |
GO:0006450 | regulation of translational fidelity | 5.21e-02 | 1.00e+00 | 4.230 | 1 | 2 | 10 |
GO:0015643 | toxic substance binding | 5.21e-02 | 1.00e+00 | 4.230 | 1 | 1 | 10 |
GO:0010226 | response to lithium ion | 5.21e-02 | 1.00e+00 | 4.230 | 1 | 2 | 10 |
GO:0000731 | DNA synthesis involved in DNA repair | 5.21e-02 | 1.00e+00 | 4.230 | 1 | 1 | 10 |
GO:0001675 | acrosome assembly | 5.21e-02 | 1.00e+00 | 4.230 | 1 | 1 | 10 |
GO:0007084 | mitotic nuclear envelope reassembly | 5.21e-02 | 1.00e+00 | 4.230 | 1 | 1 | 10 |
GO:0021756 | striatum development | 5.21e-02 | 1.00e+00 | 4.230 | 1 | 1 | 10 |
GO:0003697 | single-stranded DNA binding | 5.24e-02 | 1.00e+00 | 2.443 | 2 | 9 | 69 |
GO:0003677 | DNA binding | 5.43e-02 | 1.00e+00 | 0.737 | 12 | 26 | 1351 |
GO:0032587 | ruffle membrane | 5.65e-02 | 1.00e+00 | 2.382 | 2 | 4 | 72 |
GO:0021846 | cell proliferation in forebrain | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 1 | 11 |
GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 1 | 11 |
GO:0048387 | negative regulation of retinoic acid receptor signaling pathway | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 1 | 11 |
GO:0048714 | positive regulation of oligodendrocyte differentiation | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 2 | 11 |
GO:0045120 | pronucleus | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 1 | 11 |
GO:0000050 | urea cycle | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 1 | 11 |
GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 1 | 11 |
GO:0050786 | RAGE receptor binding | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 1 | 11 |
GO:0008340 | determination of adult lifespan | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 1 | 11 |
GO:0019395 | fatty acid oxidation | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 1 | 11 |
GO:0001054 | RNA polymerase I activity | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 3 | 11 |
GO:0035518 | histone H2A monoubiquitination | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 2 | 11 |
GO:0071564 | npBAF complex | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 2 | 11 |
GO:0001841 | neural tube formation | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 1 | 11 |
GO:0051290 | protein heterotetramerization | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 2 | 11 |
GO:0021819 | layer formation in cerebral cortex | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 1 | 11 |
GO:0045502 | dynein binding | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 2 | 11 |
GO:0032727 | positive regulation of interferon-alpha production | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 1 | 11 |
GO:0009395 | phospholipid catabolic process | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 1 | 11 |
GO:0006693 | prostaglandin metabolic process | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 1 | 11 |
GO:0045651 | positive regulation of macrophage differentiation | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 2 | 11 |
GO:0043122 | regulation of I-kappaB kinase/NF-kappaB signaling | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 1 | 11 |
GO:0006098 | pentose-phosphate shunt | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 3 | 11 |
GO:0010569 | regulation of double-strand break repair via homologous recombination | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 1 | 11 |
GO:0071850 | mitotic cell cycle arrest | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 1 | 11 |
GO:0043923 | positive regulation by host of viral transcription | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 2 | 11 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 5.79e-02 | 1.00e+00 | 2.362 | 2 | 5 | 73 |
GO:0043065 | positive regulation of apoptotic process | 5.87e-02 | 1.00e+00 | 1.453 | 4 | 8 | 274 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 6.07e-02 | 1.00e+00 | 1.744 | 3 | 5 | 168 |
GO:0046982 | protein heterodimerization activity | 6.20e-02 | 1.00e+00 | 1.233 | 5 | 11 | 399 |
GO:0042633 | hair cycle | 6.21e-02 | 1.00e+00 | 3.967 | 1 | 1 | 12 |
GO:0035102 | PRC1 complex | 6.21e-02 | 1.00e+00 | 3.967 | 1 | 1 | 12 |
GO:0021702 | cerebellar Purkinje cell differentiation | 6.21e-02 | 1.00e+00 | 3.967 | 1 | 1 | 12 |
GO:0019372 | lipoxygenase pathway | 6.21e-02 | 1.00e+00 | 3.967 | 1 | 1 | 12 |
GO:0050872 | white fat cell differentiation | 6.21e-02 | 1.00e+00 | 3.967 | 1 | 1 | 12 |
GO:0032784 | regulation of DNA-templated transcription, elongation | 6.21e-02 | 1.00e+00 | 3.967 | 1 | 1 | 12 |
GO:0006878 | cellular copper ion homeostasis | 6.21e-02 | 1.00e+00 | 3.967 | 1 | 1 | 12 |
GO:0006855 | drug transmembrane transport | 6.21e-02 | 1.00e+00 | 3.967 | 1 | 1 | 12 |
GO:0036150 | phosphatidylserine acyl-chain remodeling | 6.21e-02 | 1.00e+00 | 3.967 | 1 | 1 | 12 |
GO:0050806 | positive regulation of synaptic transmission | 6.21e-02 | 1.00e+00 | 3.967 | 1 | 1 | 12 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 6.21e-02 | 1.00e+00 | 3.967 | 1 | 2 | 12 |
GO:0042953 | lipoprotein transport | 6.21e-02 | 1.00e+00 | 3.967 | 1 | 1 | 12 |
GO:0005736 | DNA-directed RNA polymerase I complex | 6.21e-02 | 1.00e+00 | 3.967 | 1 | 3 | 12 |
GO:0021794 | thalamus development | 6.21e-02 | 1.00e+00 | 3.967 | 1 | 1 | 12 |
GO:0070266 | necroptotic process | 6.21e-02 | 1.00e+00 | 3.967 | 1 | 1 | 12 |
GO:0032461 | positive regulation of protein oligomerization | 6.21e-02 | 1.00e+00 | 3.967 | 1 | 1 | 12 |
GO:0009303 | rRNA transcription | 6.21e-02 | 1.00e+00 | 3.967 | 1 | 1 | 12 |
GO:0071236 | cellular response to antibiotic | 6.21e-02 | 1.00e+00 | 3.967 | 1 | 1 | 12 |
GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle | 6.21e-02 | 1.00e+00 | 3.967 | 1 | 1 | 12 |
GO:0071565 | nBAF complex | 6.21e-02 | 1.00e+00 | 3.967 | 1 | 2 | 12 |
GO:0047496 | vesicle transport along microtubule | 6.21e-02 | 1.00e+00 | 3.967 | 1 | 1 | 12 |
GO:1903543 | positive regulation of exosomal secretion | 6.21e-02 | 1.00e+00 | 3.967 | 1 | 1 | 12 |
GO:0030111 | regulation of Wnt signaling pathway | 6.21e-02 | 1.00e+00 | 3.967 | 1 | 1 | 12 |
GO:0044212 | transcription regulatory region DNA binding | 6.33e-02 | 1.00e+00 | 1.719 | 3 | 6 | 171 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 6.36e-02 | 1.00e+00 | 2.285 | 2 | 5 | 77 |
GO:0008584 | male gonad development | 6.36e-02 | 1.00e+00 | 2.285 | 2 | 2 | 77 |
GO:0071013 | catalytic step 2 spliceosome | 6.65e-02 | 1.00e+00 | 2.248 | 2 | 7 | 79 |
GO:0046688 | response to copper ion | 6.71e-02 | 1.00e+00 | 3.851 | 1 | 1 | 13 |
GO:0050995 | negative regulation of lipid catabolic process | 6.71e-02 | 1.00e+00 | 3.851 | 1 | 1 | 13 |
GO:0004623 | phospholipase A2 activity | 6.71e-02 | 1.00e+00 | 3.851 | 1 | 1 | 13 |
GO:0005662 | DNA replication factor A complex | 6.71e-02 | 1.00e+00 | 3.851 | 1 | 3 | 13 |
GO:0050860 | negative regulation of T cell receptor signaling pathway | 6.71e-02 | 1.00e+00 | 3.851 | 1 | 1 | 13 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 6.71e-02 | 1.00e+00 | 3.851 | 1 | 1 | 13 |
GO:0051926 | negative regulation of calcium ion transport | 6.71e-02 | 1.00e+00 | 3.851 | 1 | 1 | 13 |
GO:0036149 | phosphatidylinositol acyl-chain remodeling | 6.71e-02 | 1.00e+00 | 3.851 | 1 | 1 | 13 |
GO:0008266 | poly(U) RNA binding | 6.71e-02 | 1.00e+00 | 3.851 | 1 | 1 | 13 |
GO:0051131 | chaperone-mediated protein complex assembly | 6.71e-02 | 1.00e+00 | 3.851 | 1 | 1 | 13 |
GO:0070542 | response to fatty acid | 7.21e-02 | 1.00e+00 | 3.744 | 1 | 1 | 14 |
GO:0050482 | arachidonic acid secretion | 7.21e-02 | 1.00e+00 | 3.744 | 1 | 1 | 14 |
GO:0019371 | cyclooxygenase pathway | 7.21e-02 | 1.00e+00 | 3.744 | 1 | 1 | 14 |
GO:0032465 | regulation of cytokinesis | 7.21e-02 | 1.00e+00 | 3.744 | 1 | 1 | 14 |
GO:0001516 | prostaglandin biosynthetic process | 7.21e-02 | 1.00e+00 | 3.744 | 1 | 1 | 14 |
GO:0043277 | apoptotic cell clearance | 7.21e-02 | 1.00e+00 | 3.744 | 1 | 1 | 14 |
GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 7.21e-02 | 1.00e+00 | 3.744 | 1 | 1 | 14 |
GO:0004622 | lysophospholipase activity | 7.21e-02 | 1.00e+00 | 3.744 | 1 | 1 | 14 |
GO:0033189 | response to vitamin A | 7.21e-02 | 1.00e+00 | 3.744 | 1 | 1 | 14 |
GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 7.21e-02 | 1.00e+00 | 3.744 | 1 | 2 | 14 |
GO:2000378 | negative regulation of reactive oxygen species metabolic process | 7.21e-02 | 1.00e+00 | 3.744 | 1 | 1 | 14 |
GO:0048566 | embryonic digestive tract development | 7.21e-02 | 1.00e+00 | 3.744 | 1 | 1 | 14 |
GO:0031334 | positive regulation of protein complex assembly | 7.21e-02 | 1.00e+00 | 3.744 | 1 | 2 | 14 |
GO:0048568 | embryonic organ development | 7.21e-02 | 1.00e+00 | 3.744 | 1 | 1 | 14 |
GO:0005681 | spliceosomal complex | 7.24e-02 | 1.00e+00 | 2.176 | 2 | 3 | 83 |
GO:0009897 | external side of plasma membrane | 7.43e-02 | 1.00e+00 | 1.621 | 3 | 4 | 183 |
GO:0005743 | mitochondrial inner membrane | 7.64e-02 | 1.00e+00 | 1.323 | 4 | 5 | 300 |
GO:0051443 | positive regulation of ubiquitin-protein transferase activity | 7.71e-02 | 1.00e+00 | 3.645 | 1 | 1 | 15 |
GO:0045022 | early endosome to late endosome transport | 7.71e-02 | 1.00e+00 | 3.645 | 1 | 1 | 15 |
GO:0030225 | macrophage differentiation | 7.71e-02 | 1.00e+00 | 3.645 | 1 | 1 | 15 |
GO:0046961 | proton-transporting ATPase activity, rotational mechanism | 7.71e-02 | 1.00e+00 | 3.645 | 1 | 3 | 15 |
GO:0016514 | SWI/SNF complex | 7.71e-02 | 1.00e+00 | 3.645 | 1 | 3 | 15 |
GO:0005123 | death receptor binding | 7.71e-02 | 1.00e+00 | 3.645 | 1 | 1 | 15 |
GO:0046965 | retinoid X receptor binding | 7.71e-02 | 1.00e+00 | 3.645 | 1 | 2 | 15 |
GO:0050431 | transforming growth factor beta binding | 7.71e-02 | 1.00e+00 | 3.645 | 1 | 1 | 15 |
GO:0051044 | positive regulation of membrane protein ectodomain proteolysis | 7.71e-02 | 1.00e+00 | 3.645 | 1 | 1 | 15 |
GO:0050901 | leukocyte tethering or rolling | 7.71e-02 | 1.00e+00 | 3.645 | 1 | 1 | 15 |
GO:0033280 | response to vitamin D | 7.71e-02 | 1.00e+00 | 3.645 | 1 | 1 | 15 |
GO:0036148 | phosphatidylglycerol acyl-chain remodeling | 7.71e-02 | 1.00e+00 | 3.645 | 1 | 1 | 15 |
GO:0030904 | retromer complex | 7.71e-02 | 1.00e+00 | 3.645 | 1 | 2 | 15 |
GO:0060749 | mammary gland alveolus development | 7.71e-02 | 1.00e+00 | 3.645 | 1 | 1 | 15 |
GO:0045987 | positive regulation of smooth muscle contraction | 7.71e-02 | 1.00e+00 | 3.645 | 1 | 1 | 15 |
GO:0006672 | ceramide metabolic process | 7.71e-02 | 1.00e+00 | 3.645 | 1 | 1 | 15 |
GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand | 7.71e-02 | 1.00e+00 | 3.645 | 1 | 2 | 15 |
GO:0035066 | positive regulation of histone acetylation | 7.71e-02 | 1.00e+00 | 3.645 | 1 | 1 | 15 |
GO:0048854 | brain morphogenesis | 7.71e-02 | 1.00e+00 | 3.645 | 1 | 1 | 15 |
GO:0060347 | heart trabecula formation | 7.71e-02 | 1.00e+00 | 3.645 | 1 | 1 | 15 |
GO:0042562 | hormone binding | 8.20e-02 | 1.00e+00 | 3.551 | 1 | 1 | 16 |
GO:0030101 | natural killer cell activation | 8.20e-02 | 1.00e+00 | 3.551 | 1 | 1 | 16 |
GO:0030902 | hindbrain development | 8.20e-02 | 1.00e+00 | 3.551 | 1 | 1 | 16 |
GO:0019226 | transmission of nerve impulse | 8.20e-02 | 1.00e+00 | 3.551 | 1 | 1 | 16 |
GO:0000132 | establishment of mitotic spindle orientation | 8.20e-02 | 1.00e+00 | 3.551 | 1 | 1 | 16 |
GO:0071682 | endocytic vesicle lumen | 8.20e-02 | 1.00e+00 | 3.551 | 1 | 1 | 16 |
GO:0008408 | 3'-5' exonuclease activity | 8.20e-02 | 1.00e+00 | 3.551 | 1 | 2 | 16 |
GO:0031589 | cell-substrate adhesion | 8.20e-02 | 1.00e+00 | 3.551 | 1 | 1 | 16 |
GO:0030224 | monocyte differentiation | 8.20e-02 | 1.00e+00 | 3.551 | 1 | 1 | 16 |
GO:0007405 | neuroblast proliferation | 8.20e-02 | 1.00e+00 | 3.551 | 1 | 1 | 16 |
GO:0050998 | nitric-oxide synthase binding | 8.20e-02 | 1.00e+00 | 3.551 | 1 | 1 | 16 |
GO:0001056 | RNA polymerase III activity | 8.20e-02 | 1.00e+00 | 3.551 | 1 | 3 | 16 |
GO:0001891 | phagocytic cup | 8.20e-02 | 1.00e+00 | 3.551 | 1 | 2 | 16 |
GO:0051968 | positive regulation of synaptic transmission, glutamatergic | 8.20e-02 | 1.00e+00 | 3.551 | 1 | 1 | 16 |
GO:0032722 | positive regulation of chemokine production | 8.20e-02 | 1.00e+00 | 3.551 | 1 | 1 | 16 |
GO:0046034 | ATP metabolic process | 8.20e-02 | 1.00e+00 | 3.551 | 1 | 1 | 16 |
GO:0046716 | muscle cell cellular homeostasis | 8.20e-02 | 1.00e+00 | 3.551 | 1 | 2 | 16 |
GO:0006103 | 2-oxoglutarate metabolic process | 8.20e-02 | 1.00e+00 | 3.551 | 1 | 1 | 16 |
GO:0000187 | activation of MAPK activity | 8.33e-02 | 1.00e+00 | 2.060 | 2 | 4 | 90 |
GO:0006979 | response to oxidative stress | 8.33e-02 | 1.00e+00 | 2.060 | 2 | 4 | 90 |
GO:0018279 | protein N-linked glycosylation via asparagine | 8.49e-02 | 1.00e+00 | 2.044 | 2 | 2 | 91 |
GO:0050821 | protein stabilization | 8.49e-02 | 1.00e+00 | 2.044 | 2 | 2 | 91 |
GO:0016605 | PML body | 8.65e-02 | 1.00e+00 | 2.028 | 2 | 5 | 92 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 8.65e-02 | 1.00e+00 | 2.028 | 2 | 4 | 92 |
GO:0042149 | cellular response to glucose starvation | 8.69e-02 | 1.00e+00 | 3.464 | 1 | 1 | 17 |
GO:0007263 | nitric oxide mediated signal transduction | 8.69e-02 | 1.00e+00 | 3.464 | 1 | 2 | 17 |
GO:0075733 | intracellular transport of virus | 8.69e-02 | 1.00e+00 | 3.464 | 1 | 2 | 17 |
GO:0043274 | phospholipase binding | 8.69e-02 | 1.00e+00 | 3.464 | 1 | 1 | 17 |
GO:0035902 | response to immobilization stress | 8.69e-02 | 1.00e+00 | 3.464 | 1 | 1 | 17 |
GO:0022604 | regulation of cell morphogenesis | 8.69e-02 | 1.00e+00 | 3.464 | 1 | 1 | 17 |
GO:0010243 | response to organonitrogen compound | 8.69e-02 | 1.00e+00 | 3.464 | 1 | 2 | 17 |
GO:0050919 | negative chemotaxis | 8.69e-02 | 1.00e+00 | 3.464 | 1 | 1 | 17 |
GO:0005666 | DNA-directed RNA polymerase III complex | 8.69e-02 | 1.00e+00 | 3.464 | 1 | 3 | 17 |
GO:2000377 | regulation of reactive oxygen species metabolic process | 8.69e-02 | 1.00e+00 | 3.464 | 1 | 1 | 17 |
GO:0050870 | positive regulation of T cell activation | 8.69e-02 | 1.00e+00 | 3.464 | 1 | 1 | 17 |
GO:0006337 | nucleosome disassembly | 8.69e-02 | 1.00e+00 | 3.464 | 1 | 4 | 17 |
GO:0031528 | microvillus membrane | 8.69e-02 | 1.00e+00 | 3.464 | 1 | 1 | 17 |
GO:0001158 | enhancer sequence-specific DNA binding | 8.69e-02 | 1.00e+00 | 3.464 | 1 | 1 | 17 |
GO:0070577 | lysine-acetylated histone binding | 8.69e-02 | 1.00e+00 | 3.464 | 1 | 1 | 17 |
GO:0031527 | filopodium membrane | 8.69e-02 | 1.00e+00 | 3.464 | 1 | 1 | 17 |
GO:0044130 | negative regulation of growth of symbiont in host | 8.69e-02 | 1.00e+00 | 3.464 | 1 | 1 | 17 |
GO:0005615 | extracellular space | 8.87e-02 | 1.00e+00 | 0.741 | 9 | 17 | 1010 |
GO:0001525 | angiogenesis | 9.12e-02 | 1.00e+00 | 1.493 | 3 | 4 | 200 |
GO:0046718 | viral entry into host cell | 9.18e-02 | 1.00e+00 | 3.382 | 1 | 1 | 18 |
GO:0071392 | cellular response to estradiol stimulus | 9.18e-02 | 1.00e+00 | 3.382 | 1 | 1 | 18 |
GO:0035861 | site of double-strand break | 9.18e-02 | 1.00e+00 | 3.382 | 1 | 1 | 18 |
GO:0005657 | replication fork | 9.18e-02 | 1.00e+00 | 3.382 | 1 | 3 | 18 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 9.18e-02 | 1.00e+00 | 3.382 | 1 | 3 | 18 |
GO:0036152 | phosphatidylethanolamine acyl-chain remodeling | 9.18e-02 | 1.00e+00 | 3.382 | 1 | 1 | 18 |
GO:0006303 | double-strand break repair via nonhomologous end joining | 9.18e-02 | 1.00e+00 | 3.382 | 1 | 3 | 18 |
GO:0070064 | proline-rich region binding | 9.18e-02 | 1.00e+00 | 3.382 | 1 | 2 | 18 |
GO:0045773 | positive regulation of axon extension | 9.18e-02 | 1.00e+00 | 3.382 | 1 | 2 | 18 |
GO:0015949 | nucleobase-containing small molecule interconversion | 9.18e-02 | 1.00e+00 | 3.382 | 1 | 2 | 18 |
GO:0033613 | activating transcription factor binding | 9.18e-02 | 1.00e+00 | 3.382 | 1 | 1 | 18 |
GO:0031674 | I band | 9.18e-02 | 1.00e+00 | 3.382 | 1 | 1 | 18 |
GO:0006386 | termination of RNA polymerase III transcription | 9.18e-02 | 1.00e+00 | 3.382 | 1 | 3 | 18 |
GO:0006541 | glutamine metabolic process | 9.18e-02 | 1.00e+00 | 3.382 | 1 | 1 | 18 |
GO:0070371 | ERK1 and ERK2 cascade | 9.18e-02 | 1.00e+00 | 3.382 | 1 | 1 | 18 |
GO:0051721 | protein phosphatase 2A binding | 9.18e-02 | 1.00e+00 | 3.382 | 1 | 1 | 18 |
GO:0007010 | cytoskeleton organization | 9.29e-02 | 1.00e+00 | 1.967 | 2 | 2 | 96 |
GO:0030168 | platelet activation | 9.65e-02 | 1.00e+00 | 1.457 | 3 | 9 | 205 |
GO:0050840 | extracellular matrix binding | 9.66e-02 | 1.00e+00 | 3.304 | 1 | 1 | 19 |
GO:0035035 | histone acetyltransferase binding | 9.66e-02 | 1.00e+00 | 3.304 | 1 | 1 | 19 |
GO:0007088 | regulation of mitosis | 9.66e-02 | 1.00e+00 | 3.304 | 1 | 1 | 19 |
GO:0055007 | cardiac muscle cell differentiation | 9.66e-02 | 1.00e+00 | 3.304 | 1 | 1 | 19 |
GO:0010165 | response to X-ray | 9.66e-02 | 1.00e+00 | 3.304 | 1 | 2 | 19 |
GO:0045453 | bone resorption | 9.66e-02 | 1.00e+00 | 3.304 | 1 | 2 | 19 |
GO:0045672 | positive regulation of osteoclast differentiation | 9.66e-02 | 1.00e+00 | 3.304 | 1 | 1 | 19 |
GO:0031430 | M band | 9.66e-02 | 1.00e+00 | 3.304 | 1 | 1 | 19 |
GO:0030866 | cortical actin cytoskeleton organization | 9.66e-02 | 1.00e+00 | 3.304 | 1 | 1 | 19 |
GO:0006259 | DNA metabolic process | 9.66e-02 | 1.00e+00 | 3.304 | 1 | 3 | 19 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 9.66e-02 | 1.00e+00 | 3.304 | 1 | 1 | 19 |
GO:0071158 | positive regulation of cell cycle arrest | 9.66e-02 | 1.00e+00 | 3.304 | 1 | 1 | 19 |
GO:0046697 | decidualization | 9.66e-02 | 1.00e+00 | 3.304 | 1 | 1 | 19 |
GO:0055088 | lipid homeostasis | 9.66e-02 | 1.00e+00 | 3.304 | 1 | 1 | 19 |
GO:0032733 | positive regulation of interleukin-10 production | 9.66e-02 | 1.00e+00 | 3.304 | 1 | 1 | 19 |
GO:1903506 | regulation of nucleic acid-templated transcription | 9.66e-02 | 1.00e+00 | 3.304 | 1 | 1 | 19 |
GO:0034113 | heterotypic cell-cell adhesion | 9.66e-02 | 1.00e+00 | 3.304 | 1 | 1 | 19 |
GO:0001819 | positive regulation of cytokine production | 9.66e-02 | 1.00e+00 | 3.304 | 1 | 1 | 19 |
GO:0048863 | stem cell differentiation | 9.66e-02 | 1.00e+00 | 3.304 | 1 | 1 | 19 |
GO:0003009 | skeletal muscle contraction | 9.66e-02 | 1.00e+00 | 3.304 | 1 | 1 | 19 |
GO:0004601 | peroxidase activity | 9.66e-02 | 1.00e+00 | 3.304 | 1 | 1 | 19 |
GO:0007411 | axon guidance | 9.72e-02 | 1.00e+00 | 1.198 | 4 | 9 | 327 |
GO:0015078 | hydrogen ion transmembrane transporter activity | 1.01e-01 | 1.00e+00 | 3.230 | 1 | 3 | 20 |
GO:0090398 | cellular senescence | 1.01e-01 | 1.00e+00 | 3.230 | 1 | 1 | 20 |
GO:0032715 | negative regulation of interleukin-6 production | 1.01e-01 | 1.00e+00 | 3.230 | 1 | 1 | 20 |
GO:0007214 | gamma-aminobutyric acid signaling pathway | 1.01e-01 | 1.00e+00 | 3.230 | 1 | 1 | 20 |
GO:0097194 | execution phase of apoptosis | 1.01e-01 | 1.00e+00 | 3.230 | 1 | 1 | 20 |
GO:0008601 | protein phosphatase type 2A regulator activity | 1.01e-01 | 1.00e+00 | 3.230 | 1 | 3 | 20 |
GO:0005680 | anaphase-promoting complex | 1.01e-01 | 1.00e+00 | 3.230 | 1 | 4 | 20 |
GO:0071549 | cellular response to dexamethasone stimulus | 1.01e-01 | 1.00e+00 | 3.230 | 1 | 1 | 20 |
GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 1.01e-01 | 1.00e+00 | 3.230 | 1 | 2 | 20 |
GO:0002931 | response to ischemia | 1.01e-01 | 1.00e+00 | 3.230 | 1 | 1 | 20 |
GO:0043231 | intracellular membrane-bounded organelle | 1.01e-01 | 1.00e+00 | 1.176 | 4 | 8 | 332 |
GO:0000159 | protein phosphatase type 2A complex | 1.01e-01 | 1.00e+00 | 3.230 | 1 | 2 | 20 |
GO:0016597 | amino acid binding | 1.01e-01 | 1.00e+00 | 3.230 | 1 | 1 | 20 |
GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator | 1.01e-01 | 1.00e+00 | 3.230 | 1 | 1 | 20 |
GO:0005739 | mitochondrion | 1.05e-01 | 1.00e+00 | 0.691 | 9 | 24 | 1046 |
GO:0045595 | regulation of cell differentiation | 1.06e-01 | 1.00e+00 | 3.159 | 1 | 1 | 21 |
GO:0009306 | protein secretion | 1.06e-01 | 1.00e+00 | 3.159 | 1 | 1 | 21 |
GO:0008156 | negative regulation of DNA replication | 1.06e-01 | 1.00e+00 | 3.159 | 1 | 1 | 21 |
GO:0000281 | mitotic cytokinesis | 1.06e-01 | 1.00e+00 | 3.159 | 1 | 2 | 21 |
GO:0007369 | gastrulation | 1.06e-01 | 1.00e+00 | 3.159 | 1 | 1 | 21 |
GO:0045862 | positive regulation of proteolysis | 1.06e-01 | 1.00e+00 | 3.159 | 1 | 1 | 21 |
GO:0071364 | cellular response to epidermal growth factor stimulus | 1.06e-01 | 1.00e+00 | 3.159 | 1 | 1 | 21 |
GO:0004860 | protein kinase inhibitor activity | 1.06e-01 | 1.00e+00 | 3.159 | 1 | 2 | 21 |
GO:0030010 | establishment of cell polarity | 1.06e-01 | 1.00e+00 | 3.159 | 1 | 2 | 21 |
GO:0000718 | nucleotide-excision repair, DNA damage removal | 1.06e-01 | 1.00e+00 | 3.159 | 1 | 5 | 21 |
GO:0007194 | negative regulation of adenylate cyclase activity | 1.06e-01 | 1.00e+00 | 3.159 | 1 | 1 | 21 |
GO:0031683 | G-protein beta/gamma-subunit complex binding | 1.06e-01 | 1.00e+00 | 3.159 | 1 | 1 | 21 |
GO:0030316 | osteoclast differentiation | 1.11e-01 | 1.00e+00 | 3.092 | 1 | 2 | 22 |
GO:0005669 | transcription factor TFIID complex | 1.11e-01 | 1.00e+00 | 3.092 | 1 | 1 | 22 |
GO:0000792 | heterochromatin | 1.11e-01 | 1.00e+00 | 3.092 | 1 | 2 | 22 |
GO:0006487 | protein N-linked glycosylation | 1.11e-01 | 1.00e+00 | 3.092 | 1 | 1 | 22 |
GO:0030863 | cortical cytoskeleton | 1.11e-01 | 1.00e+00 | 3.092 | 1 | 1 | 22 |
GO:0007052 | mitotic spindle organization | 1.11e-01 | 1.00e+00 | 3.092 | 1 | 2 | 22 |
GO:0005790 | smooth endoplasmic reticulum | 1.11e-01 | 1.00e+00 | 3.092 | 1 | 1 | 22 |
GO:0051924 | regulation of calcium ion transport | 1.11e-01 | 1.00e+00 | 3.092 | 1 | 1 | 22 |
GO:0090200 | positive regulation of release of cytochrome c from mitochondria | 1.11e-01 | 1.00e+00 | 3.092 | 1 | 1 | 22 |
GO:0036151 | phosphatidylcholine acyl-chain remodeling | 1.11e-01 | 1.00e+00 | 3.092 | 1 | 1 | 22 |
GO:0031463 | Cul3-RING ubiquitin ligase complex | 1.16e-01 | 1.00e+00 | 3.028 | 1 | 2 | 23 |
GO:0043236 | laminin binding | 1.16e-01 | 1.00e+00 | 3.028 | 1 | 1 | 23 |
GO:0045907 | positive regulation of vasoconstriction | 1.16e-01 | 1.00e+00 | 3.028 | 1 | 1 | 23 |
GO:0045787 | positive regulation of cell cycle | 1.16e-01 | 1.00e+00 | 3.028 | 1 | 1 | 23 |
GO:0010575 | positive regulation vascular endothelial growth factor production | 1.16e-01 | 1.00e+00 | 3.028 | 1 | 1 | 23 |
GO:0043200 | response to amino acid | 1.16e-01 | 1.00e+00 | 3.028 | 1 | 1 | 23 |
GO:0006513 | protein monoubiquitination | 1.16e-01 | 1.00e+00 | 3.028 | 1 | 1 | 23 |
GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading | 1.16e-01 | 1.00e+00 | 3.028 | 1 | 2 | 23 |
GO:0008305 | integrin complex | 1.16e-01 | 1.00e+00 | 3.028 | 1 | 1 | 23 |
GO:0071346 | cellular response to interferon-gamma | 1.16e-01 | 1.00e+00 | 3.028 | 1 | 1 | 23 |
GO:0005815 | microtubule organizing center | 1.17e-01 | 1.00e+00 | 1.770 | 2 | 4 | 110 |
GO:0045893 | positive regulation of transcription, DNA-templated | 1.18e-01 | 1.00e+00 | 0.946 | 5 | 17 | 487 |
GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 1.20e-01 | 1.00e+00 | 2.967 | 1 | 1 | 24 |
GO:0001836 | release of cytochrome c from mitochondria | 1.20e-01 | 1.00e+00 | 2.967 | 1 | 2 | 24 |
GO:0046329 | negative regulation of JNK cascade | 1.20e-01 | 1.00e+00 | 2.967 | 1 | 1 | 24 |
GO:0048147 | negative regulation of fibroblast proliferation | 1.20e-01 | 1.00e+00 | 2.967 | 1 | 1 | 24 |
GO:0001105 | RNA polymerase II transcription coactivator activity | 1.20e-01 | 1.00e+00 | 2.967 | 1 | 1 | 24 |
GO:0050766 | positive regulation of phagocytosis | 1.20e-01 | 1.00e+00 | 2.967 | 1 | 1 | 24 |
GO:0032689 | negative regulation of interferon-gamma production | 1.20e-01 | 1.00e+00 | 2.967 | 1 | 1 | 24 |
GO:0043388 | positive regulation of DNA binding | 1.20e-01 | 1.00e+00 | 2.967 | 1 | 1 | 24 |
GO:2000379 | positive regulation of reactive oxygen species metabolic process | 1.20e-01 | 1.00e+00 | 2.967 | 1 | 1 | 24 |
GO:0005819 | spindle | 1.24e-01 | 1.00e+00 | 1.719 | 2 | 7 | 114 |
GO:0042100 | B cell proliferation | 1.25e-01 | 1.00e+00 | 2.908 | 1 | 1 | 25 |
GO:0001968 | fibronectin binding | 1.25e-01 | 1.00e+00 | 2.908 | 1 | 1 | 25 |
GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway | 1.25e-01 | 1.00e+00 | 2.908 | 1 | 2 | 25 |
GO:0032735 | positive regulation of interleukin-12 production | 1.25e-01 | 1.00e+00 | 2.908 | 1 | 1 | 25 |
GO:0006654 | phosphatidic acid biosynthetic process | 1.25e-01 | 1.00e+00 | 2.908 | 1 | 1 | 25 |
GO:0031519 | PcG protein complex | 1.25e-01 | 1.00e+00 | 2.908 | 1 | 4 | 25 |
GO:0030016 | myofibril | 1.25e-01 | 1.00e+00 | 2.908 | 1 | 1 | 25 |
GO:0051059 | NF-kappaB binding | 1.25e-01 | 1.00e+00 | 2.908 | 1 | 3 | 25 |
GO:0071479 | cellular response to ionizing radiation | 1.25e-01 | 1.00e+00 | 2.908 | 1 | 1 | 25 |
GO:0030864 | cortical actin cytoskeleton | 1.25e-01 | 1.00e+00 | 2.908 | 1 | 1 | 25 |
GO:0050715 | positive regulation of cytokine secretion | 1.25e-01 | 1.00e+00 | 2.908 | 1 | 1 | 25 |
GO:0007569 | cell aging | 1.25e-01 | 1.00e+00 | 2.908 | 1 | 2 | 25 |
GO:0017144 | drug metabolic process | 1.25e-01 | 1.00e+00 | 2.908 | 1 | 1 | 25 |
GO:0072562 | blood microparticle | 1.27e-01 | 1.00e+00 | 1.694 | 2 | 4 | 116 |
GO:0097190 | apoptotic signaling pathway | 1.27e-01 | 1.00e+00 | 1.694 | 2 | 4 | 116 |
GO:0035987 | endodermal cell differentiation | 1.30e-01 | 1.00e+00 | 2.851 | 1 | 1 | 26 |
GO:0010043 | response to zinc ion | 1.30e-01 | 1.00e+00 | 2.851 | 1 | 1 | 26 |
GO:0045931 | positive regulation of mitotic cell cycle | 1.30e-01 | 1.00e+00 | 2.851 | 1 | 1 | 26 |
GO:0070979 | protein K11-linked ubiquitination | 1.30e-01 | 1.00e+00 | 2.851 | 1 | 3 | 26 |
GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 1.30e-01 | 1.00e+00 | 2.851 | 1 | 2 | 26 |
GO:0045214 | sarcomere organization | 1.30e-01 | 1.00e+00 | 2.851 | 1 | 1 | 26 |
GO:0071556 | integral component of lumenal side of endoplasmic reticulum membrane | 1.30e-01 | 1.00e+00 | 2.851 | 1 | 1 | 26 |
GO:0006006 | glucose metabolic process | 1.33e-01 | 1.00e+00 | 1.657 | 2 | 4 | 119 |
GO:0004003 | ATP-dependent DNA helicase activity | 1.34e-01 | 1.00e+00 | 2.797 | 1 | 3 | 27 |
GO:0000188 | inactivation of MAPK activity | 1.34e-01 | 1.00e+00 | 2.797 | 1 | 1 | 27 |
GO:0034080 | CENP-A containing nucleosome assembly | 1.34e-01 | 1.00e+00 | 2.797 | 1 | 2 | 27 |
GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway | 1.34e-01 | 1.00e+00 | 2.797 | 1 | 1 | 27 |
GO:0009314 | response to radiation | 1.34e-01 | 1.00e+00 | 2.797 | 1 | 1 | 27 |
GO:0007339 | binding of sperm to zona pellucida | 1.34e-01 | 1.00e+00 | 2.797 | 1 | 1 | 27 |
GO:0032496 | response to lipopolysaccharide | 1.38e-01 | 1.00e+00 | 1.621 | 2 | 4 | 122 |
GO:0033209 | tumor necrosis factor-mediated signaling pathway | 1.39e-01 | 1.00e+00 | 2.744 | 1 | 1 | 28 |
GO:0019894 | kinesin binding | 1.39e-01 | 1.00e+00 | 2.744 | 1 | 1 | 28 |
GO:0030177 | positive regulation of Wnt signaling pathway | 1.39e-01 | 1.00e+00 | 2.744 | 1 | 3 | 28 |
GO:0005875 | microtubule associated complex | 1.39e-01 | 1.00e+00 | 2.744 | 1 | 2 | 28 |
GO:0048662 | negative regulation of smooth muscle cell proliferation | 1.39e-01 | 1.00e+00 | 2.744 | 1 | 1 | 28 |
GO:0043507 | positive regulation of JUN kinase activity | 1.39e-01 | 1.00e+00 | 2.744 | 1 | 2 | 28 |
GO:0042626 | ATPase activity, coupled to transmembrane movement of substances | 1.39e-01 | 1.00e+00 | 2.744 | 1 | 1 | 28 |
GO:0010033 | response to organic substance | 1.39e-01 | 1.00e+00 | 2.744 | 1 | 2 | 28 |
GO:0015991 | ATP hydrolysis coupled proton transport | 1.39e-01 | 1.00e+00 | 2.744 | 1 | 4 | 28 |
GO:0003823 | antigen binding | 1.39e-01 | 1.00e+00 | 2.744 | 1 | 1 | 28 |
GO:0045840 | positive regulation of mitosis | 1.39e-01 | 1.00e+00 | 2.744 | 1 | 1 | 28 |
GO:0007017 | microtubule-based process | 1.39e-01 | 1.00e+00 | 2.744 | 1 | 3 | 28 |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 1.43e-01 | 1.00e+00 | 1.586 | 2 | 4 | 125 |
GO:0007219 | Notch signaling pathway | 1.43e-01 | 1.00e+00 | 1.586 | 2 | 4 | 125 |
GO:0031252 | cell leading edge | 1.44e-01 | 1.00e+00 | 2.694 | 1 | 3 | 29 |
GO:0003730 | mRNA 3'-UTR binding | 1.44e-01 | 1.00e+00 | 2.694 | 1 | 2 | 29 |
GO:0048365 | Rac GTPase binding | 1.44e-01 | 1.00e+00 | 2.694 | 1 | 2 | 29 |
GO:0003887 | DNA-directed DNA polymerase activity | 1.44e-01 | 1.00e+00 | 2.694 | 1 | 3 | 29 |
GO:0019005 | SCF ubiquitin ligase complex | 1.44e-01 | 1.00e+00 | 2.694 | 1 | 1 | 29 |
GO:0015631 | tubulin binding | 1.44e-01 | 1.00e+00 | 2.694 | 1 | 1 | 29 |
GO:0010332 | response to gamma radiation | 1.44e-01 | 1.00e+00 | 2.694 | 1 | 2 | 29 |
GO:0008333 | endosome to lysosome transport | 1.44e-01 | 1.00e+00 | 2.694 | 1 | 1 | 29 |
GO:0030669 | clathrin-coated endocytic vesicle membrane | 1.44e-01 | 1.00e+00 | 2.694 | 1 | 1 | 29 |
GO:0031663 | lipopolysaccharide-mediated signaling pathway | 1.44e-01 | 1.00e+00 | 2.694 | 1 | 1 | 29 |
GO:0005506 | iron ion binding | 1.47e-01 | 1.00e+00 | 1.563 | 2 | 3 | 127 |
GO:0010977 | negative regulation of neuron projection development | 1.48e-01 | 1.00e+00 | 2.645 | 1 | 2 | 30 |
GO:0021549 | cerebellum development | 1.48e-01 | 1.00e+00 | 2.645 | 1 | 1 | 30 |
GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 1.48e-01 | 1.00e+00 | 2.645 | 1 | 2 | 30 |
GO:0001618 | virus receptor activity | 1.48e-01 | 1.00e+00 | 2.645 | 1 | 1 | 30 |
GO:0051262 | protein tetramerization | 1.48e-01 | 1.00e+00 | 2.645 | 1 | 3 | 30 |
GO:0042254 | ribosome biogenesis | 1.48e-01 | 1.00e+00 | 2.645 | 1 | 1 | 30 |
GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling | 1.48e-01 | 1.00e+00 | 2.645 | 1 | 1 | 30 |
GO:0001755 | neural crest cell migration | 1.48e-01 | 1.00e+00 | 2.645 | 1 | 2 | 30 |
GO:0035116 | embryonic hindlimb morphogenesis | 1.48e-01 | 1.00e+00 | 2.645 | 1 | 1 | 30 |
GO:0030036 | actin cytoskeleton organization | 1.51e-01 | 1.00e+00 | 1.540 | 2 | 5 | 129 |
GO:0045171 | intercellular bridge | 1.53e-01 | 1.00e+00 | 2.597 | 1 | 2 | 31 |
GO:0010827 | regulation of glucose transport | 1.53e-01 | 1.00e+00 | 2.597 | 1 | 1 | 31 |
GO:0007094 | mitotic spindle assembly checkpoint | 1.53e-01 | 1.00e+00 | 2.597 | 1 | 5 | 31 |
GO:0061077 | chaperone-mediated protein folding | 1.53e-01 | 1.00e+00 | 2.597 | 1 | 2 | 31 |
GO:0031623 | receptor internalization | 1.53e-01 | 1.00e+00 | 2.597 | 1 | 1 | 31 |
GO:0043025 | neuronal cell body | 1.54e-01 | 1.00e+00 | 1.148 | 3 | 4 | 254 |
GO:0016477 | cell migration | 1.54e-01 | 1.00e+00 | 1.518 | 2 | 6 | 131 |
GO:0008284 | positive regulation of cell proliferation | 1.57e-01 | 1.00e+00 | 0.937 | 4 | 8 | 392 |
GO:0042594 | response to starvation | 1.57e-01 | 1.00e+00 | 2.551 | 1 | 1 | 32 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 1.57e-01 | 1.00e+00 | 2.551 | 1 | 2 | 32 |
GO:0015992 | proton transport | 1.57e-01 | 1.00e+00 | 2.551 | 1 | 3 | 32 |
GO:0051219 | phosphoprotein binding | 1.57e-01 | 1.00e+00 | 2.551 | 1 | 3 | 32 |
GO:0050661 | NADP binding | 1.57e-01 | 1.00e+00 | 2.551 | 1 | 1 | 32 |
GO:0043491 | protein kinase B signaling | 1.57e-01 | 1.00e+00 | 2.551 | 1 | 1 | 32 |
GO:0014823 | response to activity | 1.57e-01 | 1.00e+00 | 2.551 | 1 | 1 | 32 |
GO:0005544 | calcium-dependent phospholipid binding | 1.57e-01 | 1.00e+00 | 2.551 | 1 | 2 | 32 |
GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway | 1.62e-01 | 1.00e+00 | 2.507 | 1 | 1 | 33 |
GO:0030282 | bone mineralization | 1.62e-01 | 1.00e+00 | 2.507 | 1 | 1 | 33 |
GO:0031072 | heat shock protein binding | 1.62e-01 | 1.00e+00 | 2.507 | 1 | 2 | 33 |
GO:0006488 | dolichol-linked oligosaccharide biosynthetic process | 1.62e-01 | 1.00e+00 | 2.507 | 1 | 1 | 33 |
GO:0033077 | T cell differentiation in thymus | 1.62e-01 | 1.00e+00 | 2.507 | 1 | 2 | 33 |
GO:0008094 | DNA-dependent ATPase activity | 1.66e-01 | 1.00e+00 | 2.464 | 1 | 1 | 34 |
GO:0008180 | COP9 signalosome | 1.66e-01 | 1.00e+00 | 2.464 | 1 | 1 | 34 |
GO:0001890 | placenta development | 1.66e-01 | 1.00e+00 | 2.464 | 1 | 1 | 34 |
GO:0030017 | sarcomere | 1.66e-01 | 1.00e+00 | 2.464 | 1 | 1 | 34 |
GO:0097110 | scaffold protein binding | 1.66e-01 | 1.00e+00 | 2.464 | 1 | 2 | 34 |
GO:0005834 | heterotrimeric G-protein complex | 1.66e-01 | 1.00e+00 | 2.464 | 1 | 1 | 34 |
GO:0045071 | negative regulation of viral genome replication | 1.66e-01 | 1.00e+00 | 2.464 | 1 | 1 | 34 |
GO:0001085 | RNA polymerase II transcription factor binding | 1.66e-01 | 1.00e+00 | 2.464 | 1 | 2 | 34 |
GO:0004175 | endopeptidase activity | 1.66e-01 | 1.00e+00 | 2.464 | 1 | 2 | 34 |
GO:2001240 | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | 1.66e-01 | 1.00e+00 | 2.464 | 1 | 1 | 34 |
GO:0051701 | interaction with host | 1.66e-01 | 1.00e+00 | 2.464 | 1 | 4 | 34 |
GO:0005876 | spindle microtubule | 1.66e-01 | 1.00e+00 | 2.464 | 1 | 3 | 34 |
GO:2001237 | negative regulation of extrinsic apoptotic signaling pathway | 1.71e-01 | 1.00e+00 | 2.422 | 1 | 1 | 35 |
GO:0042277 | peptide binding | 1.71e-01 | 1.00e+00 | 2.422 | 1 | 2 | 35 |
GO:0097192 | extrinsic apoptotic signaling pathway in absence of ligand | 1.71e-01 | 1.00e+00 | 2.422 | 1 | 2 | 35 |
GO:0001942 | hair follicle development | 1.71e-01 | 1.00e+00 | 2.422 | 1 | 2 | 35 |
GO:0006953 | acute-phase response | 1.71e-01 | 1.00e+00 | 2.422 | 1 | 1 | 35 |
GO:0045600 | positive regulation of fat cell differentiation | 1.71e-01 | 1.00e+00 | 2.422 | 1 | 1 | 35 |
GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process | 1.75e-01 | 1.00e+00 | 2.382 | 1 | 1 | 36 |
GO:0051402 | neuron apoptotic process | 1.75e-01 | 1.00e+00 | 2.382 | 1 | 2 | 36 |
GO:0006605 | protein targeting | 1.75e-01 | 1.00e+00 | 2.382 | 1 | 2 | 36 |
GO:0004879 | ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity | 1.75e-01 | 1.00e+00 | 2.382 | 1 | 1 | 36 |
GO:0032588 | trans-Golgi network membrane | 1.75e-01 | 1.00e+00 | 2.382 | 1 | 1 | 36 |
GO:0034332 | adherens junction organization | 1.75e-01 | 1.00e+00 | 2.382 | 1 | 1 | 36 |
GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway | 1.75e-01 | 1.00e+00 | 2.382 | 1 | 1 | 36 |
GO:0007566 | embryo implantation | 1.75e-01 | 1.00e+00 | 2.382 | 1 | 1 | 36 |
GO:0034446 | substrate adhesion-dependent cell spreading | 1.75e-01 | 1.00e+00 | 2.382 | 1 | 2 | 36 |
GO:0001895 | retina homeostasis | 1.75e-01 | 1.00e+00 | 2.382 | 1 | 1 | 36 |
GO:0008286 | insulin receptor signaling pathway | 1.79e-01 | 1.00e+00 | 1.382 | 2 | 6 | 144 |
GO:0008234 | cysteine-type peptidase activity | 1.80e-01 | 1.00e+00 | 2.342 | 1 | 2 | 37 |
GO:0001102 | RNA polymerase II activating transcription factor binding | 1.80e-01 | 1.00e+00 | 2.342 | 1 | 4 | 37 |
GO:0051084 | 'de novo' posttranslational protein folding | 1.80e-01 | 1.00e+00 | 2.342 | 1 | 4 | 37 |
GO:0045668 | negative regulation of osteoblast differentiation | 1.80e-01 | 1.00e+00 | 2.342 | 1 | 1 | 37 |
GO:0071377 | cellular response to glucagon stimulus | 1.80e-01 | 1.00e+00 | 2.342 | 1 | 1 | 37 |
GO:0018107 | peptidyl-threonine phosphorylation | 1.80e-01 | 1.00e+00 | 2.342 | 1 | 1 | 37 |
GO:0032880 | regulation of protein localization | 1.80e-01 | 1.00e+00 | 2.342 | 1 | 1 | 37 |
GO:0005245 | voltage-gated calcium channel activity | 1.80e-01 | 1.00e+00 | 2.342 | 1 | 1 | 37 |
GO:0007188 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway | 1.80e-01 | 1.00e+00 | 2.342 | 1 | 1 | 37 |
GO:0061024 | membrane organization | 1.83e-01 | 1.00e+00 | 1.362 | 2 | 5 | 146 |
GO:0001756 | somitogenesis | 1.84e-01 | 1.00e+00 | 2.304 | 1 | 1 | 38 |
GO:0070527 | platelet aggregation | 1.84e-01 | 1.00e+00 | 2.304 | 1 | 2 | 38 |
GO:0045740 | positive regulation of DNA replication | 1.84e-01 | 1.00e+00 | 2.304 | 1 | 2 | 38 |
GO:0001664 | G-protein coupled receptor binding | 1.84e-01 | 1.00e+00 | 2.304 | 1 | 1 | 38 |
GO:0043621 | protein self-association | 1.84e-01 | 1.00e+00 | 2.304 | 1 | 1 | 38 |
GO:0008033 | tRNA processing | 1.88e-01 | 1.00e+00 | 2.266 | 1 | 1 | 39 |
GO:0006383 | transcription from RNA polymerase III promoter | 1.88e-01 | 1.00e+00 | 2.266 | 1 | 3 | 39 |
GO:0031490 | chromatin DNA binding | 1.88e-01 | 1.00e+00 | 2.266 | 1 | 2 | 39 |
GO:0048469 | cell maturation | 1.88e-01 | 1.00e+00 | 2.266 | 1 | 1 | 39 |
GO:0001933 | negative regulation of protein phosphorylation | 1.88e-01 | 1.00e+00 | 2.266 | 1 | 1 | 39 |
GO:0007595 | lactation | 1.88e-01 | 1.00e+00 | 2.266 | 1 | 2 | 39 |
GO:0008017 | microtubule binding | 1.91e-01 | 1.00e+00 | 1.323 | 2 | 7 | 150 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.91e-01 | 1.00e+00 | 0.820 | 4 | 12 | 425 |
GO:0035019 | somatic stem cell maintenance | 1.93e-01 | 1.00e+00 | 2.230 | 1 | 2 | 40 |
GO:0000781 | chromosome, telomeric region | 1.93e-01 | 1.00e+00 | 2.230 | 1 | 2 | 40 |
GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway | 1.93e-01 | 1.00e+00 | 2.230 | 1 | 1 | 40 |
GO:0019722 | calcium-mediated signaling | 1.93e-01 | 1.00e+00 | 2.230 | 1 | 1 | 40 |
GO:0017148 | negative regulation of translation | 1.97e-01 | 1.00e+00 | 2.194 | 1 | 1 | 41 |
GO:0051259 | protein oligomerization | 1.97e-01 | 1.00e+00 | 2.194 | 1 | 2 | 41 |
GO:0050885 | neuromuscular process controlling balance | 1.97e-01 | 1.00e+00 | 2.194 | 1 | 1 | 41 |
GO:0045786 | negative regulation of cell cycle | 1.97e-01 | 1.00e+00 | 2.194 | 1 | 1 | 41 |
GO:0030521 | androgen receptor signaling pathway | 1.97e-01 | 1.00e+00 | 2.194 | 1 | 2 | 41 |
GO:0043195 | terminal bouton | 1.97e-01 | 1.00e+00 | 2.194 | 1 | 1 | 41 |
GO:0004722 | protein serine/threonine phosphatase activity | 2.01e-01 | 1.00e+00 | 2.159 | 1 | 1 | 42 |
GO:0071320 | cellular response to cAMP | 2.01e-01 | 1.00e+00 | 2.159 | 1 | 1 | 42 |
GO:0021987 | cerebral cortex development | 2.01e-01 | 1.00e+00 | 2.159 | 1 | 3 | 42 |
GO:0030155 | regulation of cell adhesion | 2.01e-01 | 1.00e+00 | 2.159 | 1 | 3 | 42 |
GO:0042147 | retrograde transport, endosome to Golgi | 2.01e-01 | 1.00e+00 | 2.159 | 1 | 3 | 42 |
GO:0005902 | microvillus | 2.01e-01 | 1.00e+00 | 2.159 | 1 | 2 | 42 |
GO:0014070 | response to organic cyclic compound | 2.06e-01 | 1.00e+00 | 2.125 | 1 | 3 | 43 |
GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity | 2.06e-01 | 1.00e+00 | 2.125 | 1 | 3 | 43 |
GO:0010212 | response to ionizing radiation | 2.06e-01 | 1.00e+00 | 2.125 | 1 | 1 | 43 |
GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 2.06e-01 | 1.00e+00 | 2.125 | 1 | 2 | 43 |
GO:0030198 | extracellular matrix organization | 2.08e-01 | 1.00e+00 | 0.932 | 3 | 3 | 295 |
GO:0008543 | fibroblast growth factor receptor signaling pathway | 2.08e-01 | 1.00e+00 | 1.239 | 2 | 4 | 159 |
GO:0007286 | spermatid development | 2.10e-01 | 1.00e+00 | 2.092 | 1 | 1 | 44 |
GO:0005871 | kinesin complex | 2.10e-01 | 1.00e+00 | 2.092 | 1 | 2 | 44 |
GO:0005080 | protein kinase C binding | 2.10e-01 | 1.00e+00 | 2.092 | 1 | 1 | 44 |
GO:0034613 | cellular protein localization | 2.10e-01 | 1.00e+00 | 2.092 | 1 | 1 | 44 |
GO:0045165 | cell fate commitment | 2.10e-01 | 1.00e+00 | 2.092 | 1 | 1 | 44 |
GO:0006892 | post-Golgi vesicle-mediated transport | 2.10e-01 | 1.00e+00 | 2.092 | 1 | 2 | 44 |
GO:0043005 | neuron projection | 2.12e-01 | 1.00e+00 | 1.221 | 2 | 4 | 161 |
GO:0043966 | histone H3 acetylation | 2.14e-01 | 1.00e+00 | 2.060 | 1 | 2 | 45 |
GO:0006626 | protein targeting to mitochondrion | 2.14e-01 | 1.00e+00 | 2.060 | 1 | 1 | 45 |
GO:0006094 | gluconeogenesis | 2.14e-01 | 1.00e+00 | 2.060 | 1 | 3 | 45 |
GO:0030136 | clathrin-coated vesicle | 2.18e-01 | 1.00e+00 | 2.028 | 1 | 1 | 46 |
GO:0021762 | substantia nigra development | 2.18e-01 | 1.00e+00 | 2.028 | 1 | 1 | 46 |
GO:0003707 | steroid hormone receptor activity | 2.18e-01 | 1.00e+00 | 2.028 | 1 | 1 | 46 |
GO:0019898 | extrinsic component of membrane | 2.18e-01 | 1.00e+00 | 2.028 | 1 | 1 | 46 |
GO:0045727 | positive regulation of translation | 2.18e-01 | 1.00e+00 | 2.028 | 1 | 4 | 46 |
GO:0007612 | learning | 2.18e-01 | 1.00e+00 | 2.028 | 1 | 1 | 46 |
GO:0045665 | negative regulation of neuron differentiation | 2.18e-01 | 1.00e+00 | 2.028 | 1 | 2 | 46 |
GO:0043406 | positive regulation of MAP kinase activity | 2.22e-01 | 1.00e+00 | 1.997 | 1 | 2 | 47 |
GO:0030216 | keratinocyte differentiation | 2.22e-01 | 1.00e+00 | 1.997 | 1 | 1 | 47 |
GO:0006921 | cellular component disassembly involved in execution phase of apoptosis | 2.22e-01 | 1.00e+00 | 1.997 | 1 | 5 | 47 |
GO:0008344 | adult locomotory behavior | 2.22e-01 | 1.00e+00 | 1.997 | 1 | 1 | 47 |
GO:0032526 | response to retinoic acid | 2.27e-01 | 1.00e+00 | 1.967 | 1 | 1 | 48 |
GO:0019827 | stem cell maintenance | 2.27e-01 | 1.00e+00 | 1.967 | 1 | 1 | 48 |
GO:0007266 | Rho protein signal transduction | 2.27e-01 | 1.00e+00 | 1.967 | 1 | 2 | 48 |
GO:0006397 | mRNA processing | 2.28e-01 | 1.00e+00 | 1.151 | 2 | 3 | 169 |
GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage | 2.31e-01 | 1.00e+00 | 1.937 | 1 | 2 | 49 |
GO:0050830 | defense response to Gram-positive bacterium | 2.31e-01 | 1.00e+00 | 1.937 | 1 | 1 | 49 |
GO:0030670 | phagocytic vesicle membrane | 2.31e-01 | 1.00e+00 | 1.937 | 1 | 3 | 49 |
GO:0019233 | sensory perception of pain | 2.31e-01 | 1.00e+00 | 1.937 | 1 | 1 | 49 |
GO:0038095 | Fc-epsilon receptor signaling pathway | 2.31e-01 | 1.00e+00 | 1.134 | 2 | 7 | 171 |
GO:0030424 | axon | 2.33e-01 | 1.00e+00 | 1.125 | 2 | 3 | 172 |
GO:0001948 | glycoprotein binding | 2.35e-01 | 1.00e+00 | 1.908 | 1 | 3 | 50 |
GO:0016049 | cell growth | 2.35e-01 | 1.00e+00 | 1.908 | 1 | 1 | 50 |
GO:0000287 | magnesium ion binding | 2.37e-01 | 1.00e+00 | 1.109 | 2 | 5 | 174 |
GO:0007254 | JNK cascade | 2.39e-01 | 1.00e+00 | 1.879 | 1 | 2 | 51 |
GO:0016607 | nuclear speck | 2.39e-01 | 1.00e+00 | 1.100 | 2 | 4 | 175 |
GO:0005905 | coated pit | 2.39e-01 | 1.00e+00 | 1.879 | 1 | 2 | 51 |
GO:0000902 | cell morphogenesis | 2.39e-01 | 1.00e+00 | 1.879 | 1 | 2 | 51 |
GO:0030900 | forebrain development | 2.39e-01 | 1.00e+00 | 1.879 | 1 | 1 | 51 |
GO:0001669 | acrosomal vesicle | 2.39e-01 | 1.00e+00 | 1.879 | 1 | 1 | 51 |
GO:0043401 | steroid hormone mediated signaling pathway | 2.43e-01 | 1.00e+00 | 1.851 | 1 | 1 | 52 |
GO:0006959 | humoral immune response | 2.43e-01 | 1.00e+00 | 1.851 | 1 | 1 | 52 |
GO:0000775 | chromosome, centromeric region | 2.43e-01 | 1.00e+00 | 1.851 | 1 | 2 | 52 |
GO:0007049 | cell cycle | 2.43e-01 | 1.00e+00 | 1.084 | 2 | 3 | 177 |
GO:0004197 | cysteine-type endopeptidase activity | 2.43e-01 | 1.00e+00 | 1.851 | 1 | 2 | 52 |
GO:0034976 | response to endoplasmic reticulum stress | 2.43e-01 | 1.00e+00 | 1.851 | 1 | 1 | 52 |
GO:0016042 | lipid catabolic process | 2.43e-01 | 1.00e+00 | 1.851 | 1 | 1 | 52 |
GO:0004672 | protein kinase activity | 2.45e-01 | 1.00e+00 | 1.076 | 2 | 2 | 178 |
GO:0060041 | retina development in camera-type eye | 2.47e-01 | 1.00e+00 | 1.824 | 1 | 3 | 53 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 2.51e-01 | 1.00e+00 | 1.797 | 1 | 2 | 54 |
GO:0009612 | response to mechanical stimulus | 2.51e-01 | 1.00e+00 | 1.797 | 1 | 2 | 54 |
GO:0019904 | protein domain specific binding | 2.51e-01 | 1.00e+00 | 1.052 | 2 | 6 | 181 |
GO:0043687 | post-translational protein modification | 2.51e-01 | 1.00e+00 | 1.052 | 2 | 4 | 181 |
GO:0000186 | activation of MAPKK activity | 2.51e-01 | 1.00e+00 | 1.797 | 1 | 1 | 54 |
GO:0005764 | lysosome | 2.53e-01 | 1.00e+00 | 1.044 | 2 | 2 | 182 |
GO:0046872 | metal ion binding | 2.53e-01 | 1.00e+00 | 0.357 | 10 | 24 | 1465 |
GO:0008233 | peptidase activity | 2.55e-01 | 1.00e+00 | 1.770 | 1 | 3 | 55 |
GO:0000226 | microtubule cytoskeleton organization | 2.55e-01 | 1.00e+00 | 1.770 | 1 | 3 | 55 |
GO:0032403 | protein complex binding | 2.59e-01 | 1.00e+00 | 1.020 | 2 | 7 | 185 |
GO:0008104 | protein localization | 2.59e-01 | 1.00e+00 | 1.744 | 1 | 3 | 56 |
GO:0004386 | helicase activity | 2.59e-01 | 1.00e+00 | 1.744 | 1 | 4 | 56 |
GO:0007613 | memory | 2.59e-01 | 1.00e+00 | 1.744 | 1 | 2 | 56 |
GO:0071300 | cellular response to retinoic acid | 2.59e-01 | 1.00e+00 | 1.744 | 1 | 2 | 56 |
GO:0043627 | response to estrogen | 2.63e-01 | 1.00e+00 | 1.719 | 1 | 2 | 57 |
GO:0030176 | integral component of endoplasmic reticulum membrane | 2.63e-01 | 1.00e+00 | 1.719 | 1 | 2 | 57 |
GO:0006879 | cellular iron ion homeostasis | 2.63e-01 | 1.00e+00 | 1.719 | 1 | 5 | 57 |
GO:0000724 | double-strand break repair via homologous recombination | 2.63e-01 | 1.00e+00 | 1.719 | 1 | 6 | 57 |
GO:0051291 | protein heterooligomerization | 2.63e-01 | 1.00e+00 | 1.719 | 1 | 1 | 57 |
GO:0012505 | endomembrane system | 2.63e-01 | 1.00e+00 | 1.719 | 1 | 2 | 57 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 2.64e-01 | 1.00e+00 | 0.473 | 6 | 19 | 811 |
GO:0005794 | Golgi apparatus | 2.66e-01 | 1.00e+00 | 0.529 | 5 | 14 | 650 |
GO:0002244 | hematopoietic progenitor cell differentiation | 2.67e-01 | 1.00e+00 | 1.694 | 1 | 1 | 58 |
GO:0005643 | nuclear pore | 2.71e-01 | 1.00e+00 | 1.669 | 1 | 4 | 59 |
GO:0005840 | ribosome | 2.71e-01 | 1.00e+00 | 1.669 | 1 | 2 | 59 |
GO:0001570 | vasculogenesis | 2.71e-01 | 1.00e+00 | 1.669 | 1 | 1 | 59 |
GO:0031966 | mitochondrial membrane | 2.71e-01 | 1.00e+00 | 1.669 | 1 | 1 | 59 |
GO:0045216 | cell-cell junction organization | 2.71e-01 | 1.00e+00 | 1.669 | 1 | 2 | 59 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 2.71e-01 | 1.00e+00 | 1.669 | 1 | 4 | 59 |
GO:0071356 | cellular response to tumor necrosis factor | 2.75e-01 | 1.00e+00 | 1.645 | 1 | 1 | 60 |
GO:0032481 | positive regulation of type I interferon production | 2.79e-01 | 1.00e+00 | 1.621 | 1 | 6 | 61 |
GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 2.79e-01 | 1.00e+00 | 1.621 | 1 | 3 | 61 |
GO:0043204 | perikaryon | 2.83e-01 | 1.00e+00 | 1.597 | 1 | 1 | 62 |
GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 2.83e-01 | 1.00e+00 | 1.597 | 1 | 2 | 62 |
GO:0000151 | ubiquitin ligase complex | 2.86e-01 | 1.00e+00 | 1.574 | 1 | 1 | 63 |
GO:0005901 | caveola | 2.86e-01 | 1.00e+00 | 1.574 | 1 | 3 | 63 |
GO:0000776 | kinetochore | 2.86e-01 | 1.00e+00 | 1.574 | 1 | 4 | 63 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 2.90e-01 | 1.00e+00 | 1.551 | 1 | 1 | 64 |
GO:0007059 | chromosome segregation | 2.90e-01 | 1.00e+00 | 1.551 | 1 | 3 | 64 |
GO:0006469 | negative regulation of protein kinase activity | 2.94e-01 | 1.00e+00 | 1.529 | 1 | 2 | 65 |
GO:0008144 | drug binding | 2.98e-01 | 1.00e+00 | 1.507 | 1 | 1 | 66 |
GO:0030141 | secretory granule | 3.02e-01 | 1.00e+00 | 1.485 | 1 | 2 | 67 |
GO:0001701 | in utero embryonic development | 3.08e-01 | 1.00e+00 | 0.837 | 2 | 6 | 210 |
GO:0007186 | G-protein coupled receptor signaling pathway | 3.11e-01 | 1.00e+00 | 0.617 | 3 | 5 | 367 |
GO:0008285 | negative regulation of cell proliferation | 3.11e-01 | 1.00e+00 | 0.617 | 3 | 11 | 367 |
GO:0035264 | multicellular organism growth | 3.13e-01 | 1.00e+00 | 1.422 | 1 | 1 | 70 |
GO:0034329 | cell junction assembly | 3.16e-01 | 1.00e+00 | 1.402 | 1 | 1 | 71 |
GO:0042383 | sarcolemma | 3.16e-01 | 1.00e+00 | 1.402 | 1 | 3 | 71 |
GO:0000165 | MAPK cascade | 3.20e-01 | 1.00e+00 | 1.382 | 1 | 2 | 72 |
GO:0004871 | signal transducer activity | 3.20e-01 | 1.00e+00 | 0.797 | 2 | 4 | 216 |
GO:0055037 | recycling endosome | 3.24e-01 | 1.00e+00 | 1.362 | 1 | 2 | 73 |
GO:0003729 | mRNA binding | 3.24e-01 | 1.00e+00 | 1.362 | 1 | 4 | 73 |
GO:0005765 | lysosomal membrane | 3.24e-01 | 1.00e+00 | 0.783 | 2 | 5 | 218 |
GO:0007265 | Ras protein signal transduction | 3.31e-01 | 1.00e+00 | 1.323 | 1 | 3 | 75 |
GO:0051897 | positive regulation of protein kinase B signaling | 3.31e-01 | 1.00e+00 | 1.323 | 1 | 1 | 75 |
GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 3.31e-01 | 1.00e+00 | 1.323 | 1 | 1 | 75 |
GO:0035666 | TRIF-dependent toll-like receptor signaling pathway | 3.34e-01 | 1.00e+00 | 1.304 | 1 | 2 | 76 |
GO:0006874 | cellular calcium ion homeostasis | 3.34e-01 | 1.00e+00 | 1.304 | 1 | 1 | 76 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 3.34e-01 | 1.00e+00 | 1.304 | 1 | 3 | 76 |
GO:0046474 | glycerophospholipid biosynthetic process | 3.34e-01 | 1.00e+00 | 1.304 | 1 | 3 | 76 |
GO:0030182 | neuron differentiation | 3.38e-01 | 1.00e+00 | 1.285 | 1 | 1 | 77 |
GO:0005622 | intracellular | 3.40e-01 | 1.00e+00 | 0.731 | 2 | 5 | 226 |
GO:0007229 | integrin-mediated signaling pathway | 3.42e-01 | 1.00e+00 | 1.266 | 1 | 2 | 78 |
GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 3.42e-01 | 1.00e+00 | 1.266 | 1 | 2 | 78 |
GO:0008270 | zinc ion binding | 3.42e-01 | 1.00e+00 | 0.300 | 7 | 12 | 1067 |
GO:0001822 | kidney development | 3.45e-01 | 1.00e+00 | 1.248 | 1 | 3 | 79 |
GO:0006334 | nucleosome assembly | 3.45e-01 | 1.00e+00 | 1.248 | 1 | 4 | 79 |
GO:0034138 | toll-like receptor 3 signaling pathway | 3.49e-01 | 1.00e+00 | 1.230 | 1 | 2 | 80 |
GO:0010629 | negative regulation of gene expression | 3.49e-01 | 1.00e+00 | 1.230 | 1 | 1 | 80 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 3.49e-01 | 1.00e+00 | 1.230 | 1 | 2 | 80 |
GO:0007565 | female pregnancy | 3.49e-01 | 1.00e+00 | 1.230 | 1 | 2 | 80 |
GO:0071222 | cellular response to lipopolysaccharide | 3.52e-01 | 1.00e+00 | 1.212 | 1 | 1 | 81 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 3.52e-01 | 1.00e+00 | 1.212 | 1 | 2 | 81 |
GO:0050796 | regulation of insulin secretion | 3.56e-01 | 1.00e+00 | 1.194 | 1 | 2 | 82 |
GO:0002576 | platelet degranulation | 3.56e-01 | 1.00e+00 | 1.194 | 1 | 4 | 82 |
GO:0001726 | ruffle | 3.56e-01 | 1.00e+00 | 1.194 | 1 | 4 | 82 |
GO:0004222 | metalloendopeptidase activity | 3.69e-01 | 1.00e+00 | 1.125 | 1 | 1 | 86 |
GO:0006898 | receptor-mediated endocytosis | 3.69e-01 | 1.00e+00 | 1.125 | 1 | 2 | 86 |
GO:0031225 | anchored component of membrane | 3.73e-01 | 1.00e+00 | 1.109 | 1 | 1 | 87 |
GO:0006355 | regulation of transcription, DNA-templated | 3.74e-01 | 1.00e+00 | 0.250 | 7 | 17 | 1104 |
GO:0006508 | proteolysis | 3.74e-01 | 1.00e+00 | 0.457 | 3 | 9 | 410 |
GO:0007160 | cell-matrix adhesion | 3.76e-01 | 1.00e+00 | 1.092 | 1 | 3 | 88 |
GO:0045471 | response to ethanol | 3.76e-01 | 1.00e+00 | 1.092 | 1 | 1 | 88 |
GO:0008134 | transcription factor binding | 3.78e-01 | 1.00e+00 | 0.609 | 2 | 8 | 246 |
GO:0009887 | organ morphogenesis | 3.79e-01 | 1.00e+00 | 1.076 | 1 | 2 | 89 |
GO:0042593 | glucose homeostasis | 3.79e-01 | 1.00e+00 | 1.076 | 1 | 1 | 89 |
GO:0005200 | structural constituent of cytoskeleton | 3.93e-01 | 1.00e+00 | 1.012 | 1 | 7 | 93 |
GO:0016311 | dephosphorylation | 3.96e-01 | 1.00e+00 | 0.997 | 1 | 3 | 94 |
GO:0005770 | late endosome | 3.96e-01 | 1.00e+00 | 0.997 | 1 | 1 | 94 |
GO:0004842 | ubiquitin-protein transferase activity | 3.97e-01 | 1.00e+00 | 0.551 | 2 | 4 | 256 |
GO:0034142 | toll-like receptor 4 signaling pathway | 4.02e-01 | 1.00e+00 | 0.967 | 1 | 2 | 96 |
GO:0001764 | neuron migration | 4.02e-01 | 1.00e+00 | 0.967 | 1 | 2 | 96 |
GO:0030426 | growth cone | 4.05e-01 | 1.00e+00 | 0.952 | 1 | 3 | 97 |
GO:0005178 | integrin binding | 4.05e-01 | 1.00e+00 | 0.952 | 1 | 2 | 97 |
GO:0005783 | endoplasmic reticulum | 4.10e-01 | 1.00e+00 | 0.299 | 4 | 9 | 610 |
GO:0006470 | protein dephosphorylation | 4.12e-01 | 1.00e+00 | 0.922 | 1 | 1 | 99 |
GO:0006629 | lipid metabolic process | 4.15e-01 | 1.00e+00 | 0.908 | 1 | 2 | 100 |
GO:0042803 | protein homodimerization activity | 4.19e-01 | 1.00e+00 | 0.282 | 4 | 11 | 617 |
GO:0000166 | nucleotide binding | 4.27e-01 | 1.00e+00 | 0.464 | 2 | 6 | 272 |
GO:0005975 | carbohydrate metabolic process | 4.31e-01 | 1.00e+00 | 0.453 | 2 | 5 | 274 |
GO:0003779 | actin binding | 4.32e-01 | 1.00e+00 | 0.448 | 2 | 7 | 275 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 4.32e-01 | 1.00e+00 | 0.448 | 2 | 6 | 275 |
GO:0008360 | regulation of cell shape | 4.34e-01 | 1.00e+00 | 0.824 | 1 | 1 | 106 |
GO:0007283 | spermatogenesis | 4.34e-01 | 1.00e+00 | 0.443 | 2 | 6 | 276 |
GO:0070588 | calcium ion transmembrane transport | 4.34e-01 | 1.00e+00 | 0.824 | 1 | 1 | 106 |
GO:0014069 | postsynaptic density | 4.34e-01 | 1.00e+00 | 0.824 | 1 | 1 | 106 |
GO:0016023 | cytoplasmic membrane-bounded vesicle | 4.37e-01 | 1.00e+00 | 0.810 | 1 | 3 | 107 |
GO:0001934 | positive regulation of protein phosphorylation | 4.40e-01 | 1.00e+00 | 0.797 | 1 | 5 | 108 |
GO:0006897 | endocytosis | 4.40e-01 | 1.00e+00 | 0.797 | 1 | 1 | 108 |
GO:0006935 | chemotaxis | 4.40e-01 | 1.00e+00 | 0.797 | 1 | 1 | 108 |
GO:0002224 | toll-like receptor signaling pathway | 4.43e-01 | 1.00e+00 | 0.783 | 1 | 2 | 109 |
GO:0030496 | midbody | 4.43e-01 | 1.00e+00 | 0.783 | 1 | 4 | 109 |
GO:0005938 | cell cortex | 4.43e-01 | 1.00e+00 | 0.783 | 1 | 3 | 109 |
GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 4.46e-01 | 1.00e+00 | 0.770 | 1 | 1 | 110 |
GO:0050900 | leukocyte migration | 4.49e-01 | 1.00e+00 | 0.757 | 1 | 1 | 111 |
GO:0042127 | regulation of cell proliferation | 4.49e-01 | 1.00e+00 | 0.757 | 1 | 4 | 111 |
GO:0020037 | heme binding | 4.49e-01 | 1.00e+00 | 0.757 | 1 | 2 | 111 |
GO:0006468 | protein phosphorylation | 4.56e-01 | 1.00e+00 | 0.269 | 3 | 10 | 467 |
GO:0006954 | inflammatory response | 4.58e-01 | 1.00e+00 | 0.377 | 2 | 6 | 289 |
GO:0007264 | small GTPase mediated signal transduction | 4.59e-01 | 1.00e+00 | 0.372 | 2 | 3 | 290 |
GO:0048015 | phosphatidylinositol-mediated signaling | 4.60e-01 | 1.00e+00 | 0.706 | 1 | 3 | 115 |
GO:0008289 | lipid binding | 4.63e-01 | 1.00e+00 | 0.694 | 1 | 1 | 116 |
GO:0006351 | transcription, DNA-templated | 4.73e-01 | 1.00e+00 | 0.091 | 9 | 25 | 1585 |
GO:0055114 | oxidation-reduction process | 4.75e-01 | 1.00e+00 | 0.227 | 3 | 11 | 481 |
GO:0007568 | aging | 4.83e-01 | 1.00e+00 | 0.609 | 1 | 3 | 123 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 4.94e-01 | 1.00e+00 | 0.563 | 1 | 5 | 127 |
GO:0008201 | heparin binding | 4.94e-01 | 1.00e+00 | 0.563 | 1 | 2 | 127 |
GO:0005856 | cytoskeleton | 4.96e-01 | 1.00e+00 | 0.271 | 2 | 8 | 311 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 5.02e-01 | 1.00e+00 | 0.529 | 1 | 3 | 130 |
GO:0030335 | positive regulation of cell migration | 5.02e-01 | 1.00e+00 | 0.529 | 1 | 6 | 130 |
GO:0030154 | cell differentiation | 5.20e-01 | 1.00e+00 | 0.207 | 2 | 5 | 325 |
GO:0006644 | phospholipid metabolic process | 5.21e-01 | 1.00e+00 | 0.453 | 1 | 5 | 137 |
GO:0044255 | cellular lipid metabolic process | 5.28e-01 | 1.00e+00 | 0.422 | 1 | 4 | 140 |
GO:0048471 | perinuclear region of cytoplasm | 5.31e-01 | 1.00e+00 | 0.106 | 3 | 12 | 523 |
GO:0016055 | Wnt signaling pathway | 5.31e-01 | 1.00e+00 | 0.412 | 1 | 6 | 141 |
GO:0005911 | cell-cell junction | 5.33e-01 | 1.00e+00 | 0.402 | 1 | 3 | 142 |
GO:0005215 | transporter activity | 5.41e-01 | 1.00e+00 | 0.372 | 1 | 1 | 145 |
GO:0005125 | cytokine activity | 5.43e-01 | 1.00e+00 | 0.362 | 1 | 1 | 146 |
GO:0007275 | multicellular organismal development | 5.50e-01 | 1.00e+00 | 0.125 | 2 | 5 | 344 |
GO:0001666 | response to hypoxia | 5.53e-01 | 1.00e+00 | 0.323 | 1 | 2 | 150 |
GO:0051260 | protein homooligomerization | 5.53e-01 | 1.00e+00 | 0.323 | 1 | 1 | 150 |
GO:0030246 | carbohydrate binding | 5.56e-01 | 1.00e+00 | 0.313 | 1 | 1 | 151 |
GO:0001077 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 5.56e-01 | 1.00e+00 | 0.313 | 1 | 2 | 151 |
GO:0007268 | synaptic transmission | 5.64e-01 | 1.00e+00 | 0.088 | 2 | 2 | 353 |
GO:0005788 | endoplasmic reticulum lumen | 5.70e-01 | 1.00e+00 | 0.257 | 1 | 1 | 157 |
GO:0005769 | early endosome | 5.72e-01 | 1.00e+00 | 0.248 | 1 | 2 | 158 |
GO:0006974 | cellular response to DNA damage stimulus | 5.72e-01 | 1.00e+00 | 0.248 | 1 | 8 | 158 |
GO:0046777 | protein autophosphorylation | 5.72e-01 | 1.00e+00 | 0.248 | 1 | 3 | 158 |
GO:0005198 | structural molecule activity | 5.74e-01 | 1.00e+00 | 0.239 | 1 | 4 | 159 |
GO:0007165 | signal transduction | 5.77e-01 | 1.00e+00 | -0.018 | 5 | 17 | 950 |
GO:0005516 | calmodulin binding | 5.81e-01 | 1.00e+00 | 0.212 | 1 | 2 | 162 |
GO:0006886 | intracellular protein transport | 6.05e-01 | 1.00e+00 | 0.117 | 1 | 4 | 173 |
GO:0005768 | endosome | 6.07e-01 | 1.00e+00 | 0.109 | 1 | 5 | 174 |
GO:0007155 | cell adhesion | 6.11e-01 | 1.00e+00 | -0.033 | 2 | 8 | 384 |
GO:0005509 | calcium ion binding | 6.12e-01 | 1.00e+00 | -0.066 | 3 | 8 | 589 |
GO:0031965 | nuclear membrane | 6.12e-01 | 1.00e+00 | 0.092 | 1 | 4 | 176 |
GO:0005667 | transcription factor complex | 6.16e-01 | 1.00e+00 | 0.076 | 1 | 6 | 178 |
GO:0005578 | proteinaceous extracellular matrix | 6.26e-01 | 1.00e+00 | 0.036 | 1 | 1 | 183 |
GO:0015629 | actin cytoskeleton | 6.26e-01 | 1.00e+00 | 0.036 | 1 | 5 | 183 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 6.42e-01 | 1.00e+00 | -0.026 | 1 | 4 | 191 |
GO:0004872 | receptor activity | 6.57e-01 | 1.00e+00 | -0.085 | 1 | 3 | 199 |
GO:0005789 | endoplasmic reticulum membrane | 6.64e-01 | 1.00e+00 | -0.176 | 3 | 10 | 636 |
GO:0016874 | ligase activity | 7.00e-01 | 1.00e+00 | -0.256 | 1 | 1 | 224 |
GO:0055085 | transmembrane transport | 7.64e-01 | 1.00e+00 | -0.454 | 2 | 8 | 514 |
GO:0006810 | transport | 7.67e-01 | 1.00e+00 | -0.525 | 1 | 1 | 270 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 7.68e-01 | 1.00e+00 | -0.410 | 3 | 11 | 748 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 7.70e-01 | 1.00e+00 | -0.541 | 1 | 6 | 273 |
GO:0016567 | protein ubiquitination | 8.01e-01 | 1.00e+00 | -0.673 | 1 | 5 | 299 |
GO:0008152 | metabolic process | 8.04e-01 | 1.00e+00 | -0.687 | 1 | 5 | 302 |
GO:0004674 | protein serine/threonine kinase activity | 8.14e-01 | 1.00e+00 | -0.734 | 1 | 6 | 312 |
GO:0035556 | intracellular signal transduction | 8.19e-01 | 1.00e+00 | -0.757 | 1 | 6 | 317 |
GO:0005886 | plasma membrane | 8.48e-01 | 1.00e+00 | -0.332 | 12 | 38 | 2834 |
GO:0015031 | protein transport | 8.55e-01 | 1.00e+00 | -0.928 | 1 | 4 | 357 |
GO:0043565 | sequence-specific DNA binding | 8.61e-01 | 1.00e+00 | -0.960 | 1 | 4 | 365 |
GO:0005887 | integral component of plasma membrane | 9.67e-01 | 1.00e+00 | -1.357 | 2 | 7 | 961 |
GO:0005576 | extracellular region | 9.79e-01 | 1.00e+00 | -1.483 | 2 | 9 | 1049 |
GO:0016021 | integral component of membrane | 9.98e-01 | 1.00e+00 | -1.404 | 5 | 15 | 2483 |